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Abstract
The principle aims of the work presented in this thesis were to further investigate the 
porcine acute phase proteins (APP) and determine the factors influencing the baseline 
concentrations of haptoglobin (Hp), C-reactive protein (CRP), Pig major acute phase 
protein (Pig-MAP) and transthyretin (TTR).
The APP are used as markers of inflammation and sub-clinical disease and are considered 
potential biomarkers for pig health and welfare. They have also been identified as a 
possible means of breeding for disease resistance, however little is known about the 
genetics of the porcine APP. This study investigated associations between the APP genes 
and baseline concentrations and the heritability of those concentrations.
An enzyme linked immunosorbent assay (ELISA) was developed for the measurement of 
porcine CRP, in-house methods were used for the determination of Hp and TTR and a 
commercial assay was used in the measurement of Pig-MAP. A population of pure line 
high health boars (n=~345) from 7 lines was used in the initial study each of which had an 
archived DNA sample and serum samples available for use.
Baseline herd concentrations of the 4 APP were determined and coiTelations between Hp 
and CRP, Hp and Pig-Map and CRP and Pig-MAP were identified. Significant differences 
were found between the 7 breeding lines in CRP, Pig-MAP and TTR concentrations, 
indicating that selective breeding for performance traits may also have affected innate 
immune traits such as APP concentrations.
i i
Single nucleotide polymoiphisms (SNP) were identified in the 4 APP genes and 17 were 
genotyped across the boar population with line differences apparent in their allele 
frequencies for CRP, Pig-MAP and TTR. Statistical analysis showed that there were 
significant associations between 3 of the SNP located in the Hp gene and Hp baseline 
concentrations (p<0.01); all 3 SNP were also in high linkage disequilibrium. The 
association indicates that Hp is under genetic control and would also be better suited to use 
as a biomarker due to the lack of line effects in the boars.
A heritability study was earned out utilising a mixed sex population of 297 animals (120 
male, 177 female) comprising 7 breeding lines located on 2 farms. Initial analysis 
identified significant differences between male and females in Hp concentration, between 
pig lines in Hp, CRP and TTR and between the 2 farm units for CRP concentrations. This 
study showed that the baseline concentrations of the 4 APP could be affected by a variety 
of factors such as sex, commercial line and individual farm units and this must be taken 
into account if they are to be used as biomarkers. Heritability was estimated at 0.15, 0.13, 
0.12 and 0.07 for Hp, CRP, Pig-MAP and TTR, respectively. All 4 APP show low 
heritability in serum concentration, this may prove problematic if they are utilised as a 
breeding trait.
Overall, the findings from this study indicate that baseline concentrations of porcine Hp, 
CRP, Pig-MAP and TTR are influenced by various factors including sex, breeding line, and 
farm unit and this must be taken into account before they are utilised as biomarkers. They
111
are traits of low heritability but the evidence suggests there may be a genetic component to 
their regulation thus requiring further investigation.
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Chapter I
1. Introduction
As farming has become more intensive and consumers are more aware of animal 
welfare issues, animal health and welfare has become an area of increasing concern. 
The intensive pig production industry is especially aware of this with new regulations 
and quality assurance schemes in place. However, in order to meet these requirements, 
new reliable and rapid methods of monitoring health are required; the acute phase 
proteins appear to meet these requirements. These proteins are involved in the acute 
phase response of an animal, which is an early non-specific response of an animal to 
inflammation, trauma, infection or stress (Petersen et a l, 2004, Toussaint et a l, 1995).
1,1. Acute Phase Response
The acute phase response (APR) is an inflammatory response which occurs in animals 
as a consequence of tissue injuiy, trauma or infection (Eckersall, 1995, Baumaim and 
Gauldie, 1994, Gmys et a l, 1994). It is part of the innate immune system and is a non­
specific response in that it can be stimulated by a variety of factors including viral, 
bacterial, fungal or parasitic infection, physical trauma such as surgery, injuries, bone 
fracture or bums, childbirth and others. These conditions induce a localised 
inflammatory response releasing soluble mediators which in turn cause a systemic 
response as shown in Figure 1.1 (Ceron et a l, 2005, Gruys et a l, 1994). The systemic 
response is charaeterised by fever, anorexia and metabolic changes, changes in 
production of endocrine hormones and decreased levels of semm calcium, iron and zinc.
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Further details of the systemic response are given in Table 1.1 In addition, the APR 
causes changes in the concentrations of the plasma proteins also known as acute phase 
proteins (APP) (Ceron et a l, 2005, Trey and Kushner, 1995, Gmys et a l, 1994).
Table 1.1: Systemic changes of the acute phase response.
Overall Change Selected specific changes
N euro endo crine Fever, anorexia, fatigue
Increase in corticotropin-releasing hormone, cortisol and 
corticotrophin
Increase in arginine vasopressin 
Decrease in insulin-like growth factor (IGF) I 
Increase in catecholamines
Hematopoietic changes Leukocytosis
Thrombocytosis
Metabolic Changes Muscle catabolism 
Decrease in gluconeogenesis 
Increased lipogenesis 
Increase lipolysis
Hepatic changes Increase in inducible nitric oxide synthase, heme 
oxygenase, metallothionein, tissue inhibitor of 
metalloproteinase-1
Other changes Decrease in serum levels of calcium, zinc, iron, vitamin A 
and rt-tocopherol
Increase in semm levels of copper
(Gabay and Kuslmer, 1999, Trey and Kuslmer, 1995, Gmys et a l, 1994)
The purpose of these physiological changes is to aid in the restoration of homeostasis 
and to remove the cause of the disturbance. This may be effected by destroying any 
infective pathogens, removing harmful molecules or products and activating tissue 
repair processes (Moshage, 1997, Trey and Kushner, 1995). The APR can he viewed as 
a primitive response that aids in the suiwival of an animal following injury and as such, 
only lasts 24-48 hours before the animal returns to normal homeostasis or a specific
immune response occurs (Baumami and Gauldie, 1994). However, the APR can 
convert to a clironic response if  the stimuli persist or the normal control mechanisms are 
dismpted. In these cases, tissue damage or further complications to the disease or injury 
may occur (Baumann and Gauldie, 1994).
1.1.1. Initiation of the Acute Phase Response
The APR is induced at the site of injury, specifically by tissue macrophages or blood 
monocytes. These cells are stimulated by mediators (e.g. transforming growth factor 
(TGF)-B, toll-like receptors), released fi'om cellular events such as mast-cell 
degranulation or platelet activation, by bacterial products such as lipopolysaccharide 
(LPS) and by the by-products of opsonins (Colditz, 2002, Suffredini et ah, 1999, 
Baumaim and Gauldie, 1994). Once stimulated, the macrophages release a broad range 
of pro-inflammatory cytokines including interleukin-1 (IL-1), interleukin-6 (IL-6) and 
tumour necrosis factor (TNF)-a Cytokines are intercellular signalling polypeptides 
which have pleiotropic activity and can act both at a local and systemic level. The pro- 
inflammatory cytokines can be broadly divided into two groups; the IL-1 type cytokines 
including IL-1 and TNF-a, and the IL-6 type cytokines including IL-6, interleukin-11 
(ÏL-11) and oncostatin M (GSM). (Gabay and Kuslmer, 1999, Baumann and Gauldie, 
1994).
At a local level, IL-1 type cytokines activate the stromal cells including endothelial cells 
and fibroblasts resulting in a secondary wave of cytokines that initiates the cellular and 
cytokine cascades involved in the APR process (Petersen et a l,  2004, Gabay and 
Kuslmer, 1999, Baumann and Gauldie, 1994). Most cytokines are synergistic and are
often counter regulated by other cytokines and cytokine receptors. They may also act in 
an additive or co-operative manner with the effect that most cells are not exposed to a 
single cytokine, but rather to a complex mixture of cytokines and other inter- and 
intracellular messenger molecules (Fitzgerald et a l, 2001, Gabay and Kuslmer, 1999, 
Trey and Kushner, 1995).
At a systemic level, IL-1 and IL-6 type cytokines act upon various organs including 
muscle, brain, mammary gland and the liver. The liver is the principal target of the 
systemic cytokines where they activate or suppress the expression of the APP genes in 
the hepatocytes. In turn, this leads to production of the APP and causes changes in ion 
and metabolic pathways (Murata et a l, 2004, Yoo and Desiderio, 2003, Baumann and 
Gauldie, 1994). Studies in mice have shown that a single inflammatory stimulus can 
stimulate 5-10% of the protein encoding portion of the genome, a large proportion of 
which is involved with immunity or intracellular signalling (Yoo and Desiderio, 2003).
1.1.2. Regulation of the Hepatic Acute Phase Response
The regulation of the hepatic APR is mider the influence of four major categories of 
factors; IL-1 type cytokines, IL-6 type cytokines, glucocorticoids and giowth factors 
(i.e. fibroblast gi'owth factor (FGF) and TGF-B). The eytokines are able to induce APP 
production while the growth factors and glucocorticoids mainly act as modulators of 
cytokine action (Yeager et a l, 2004, Jensen and Wliitehead, 1998, Moshage, 1997, 
Baumann and Gauldie, 1994).
1.1.3. IL-1 Type Regulation
There are two types of IL-1 receptor; type I (a transmembrane glycoprotein, ~80 kDa) 
and type II (a glycoprotein, -60  kDa), both belonging to the IgG superfamily. The type 
I receptor is responsible for the transmission of the IL-1 signal. After ligand binding, 
the type I receptor is phosphorylated at serine/threonine residues, the ligand-receptor 
complex is then internalised and translocated to the nucleus, stimulating gene 
transcription. The type II receptor does not generate a signal (Fitzgerald et ah, 2001, 
Moshage, 1997).
There are also two types of TNF-ce receptor; type I (55 kDa) and type II (75 kDa) both 
belonging to the IgG superfamily, however they are not homologous to IL-1 receptors 
(Fitzgerald et a i, 2001).
Once activated, both the TNF-a and IL-1 receptors initiate conversion of membrane 
sphingomyelin to ceramide via sphingomyelinase. The ceramide-activated protein 
kinases connect to several signalling pathways which lead to activation and 
translocation of the transcription factors activating protein 1 (AP-1) and nuclear factor 
(NF) kB which is involved in gene transcription of APP, many of which contain NF/cB 
and AP-1 response elements in their promoter regions. NF/cB is only activated after the 
phosphorylation and degradation of the inhibitoiy subunit IxB. The IL-1 signal also 
comiects to the mitogen activated protein (MAP)-kinase pathway as does the signal of 
IL-6, connecting the two signalling pathways (Moshage, 1997, Baumann and Gauldie, 
1994).
1.1.4. IL-6 Type Regulation
The IL-6 receptor (80 kDa) a  subunit forms a complex with two signal-transducing 
gpl30 B-subunits, the gpl30 subunit is common to all members of this family. Once 
activated, the IL-6 receptor complex activates JAK tyrosine kinases with subsequent 
tyi'osine phosphorylation of the signal transducers and activators of transcription 
(STAT) proteins. Following phosphorylation, ST AT protein homo- and 
heterodimerisation is induced and they are translocated to the nucleus where they bind 
to their response elements. This is through recognition of a CTGGGA motif in the APP 
genes (Moshage, 1997, Baumann and Gauldie, 1994).
1,1.5. The Role of Glucocorticoids and Growth Factors
Glucocorticoids and gi'owth factors, such as TGF-p interact with the regulation of the 
APR in various ways but most important are their interaction with the cytokines (Gabay 
and Kushner, 1999). The glucocorticoids affect IL-1 type and IL-6 type cytokines in 
different ways. They have an inhibitory effect on IL-1 gene transcription and decrease 
the stability of IL-1 mRNA (Fantuzzi and Ghezzi, 1993). Glucocorticoids can also 
show an inhibitory effect on IL-6 type cytokines. However, more importantly, they 
cause a decrease in IL-6 receptors in monocytes but not in hepatocytes and are therefore 
considered essential for the induction of hepatocyte IL-6 receptors by both IL-1 and IL- 
6 (Fantuzzi and Ghezzi, 1993). Alongside the glucocorticoids, giowth factors also 
interact with the APR. Transforming growth factor-p has been shown to increase IL-1 
mRNA and modulate the effects of IL-6. In addition, TGF-p has been found to directly
affect APP production by decreasing production of albumin and apolipoprotein A1 
mRNA in hepatocytes (Mackiewicz et a l,  1990).
1.1.6. Resolution of the Acute Phase Reaction
As continuation of the APR can cause tissue damage and complications, it is important 
that once it has achieved its function, the response can be rapidly ended. Despite the 
relatively short half-life of the cytokines involved, there are active inhibitory 
mechanisms in place, however the complete process is still unclear (Jensen and 
Whitehead, 1998, Baumann and Gauldie, 1994).
It does appear that the anti-inflammatory cytokines, IL-4 and IL-10, play significant 
roles in down-regulating the production of various cytokines. IL-4 is released by Th2 
lymphocytes and causes the down-regulation of TNF, IL-1 and IL-8; it also enhances 
apoptosis of monocytes. IL-10 is produced by Th2 lymphocytes, monocytes, 
macrophages and B cells and inhibits synthesis of IL-1, TNF, IL-6 and IL-8. The 
actions of these and corticosteroid, which inhibits production of many initial and 
secondary cytokines, appear to regulate the tennination of the APR (Jensen and 
Wliitehead, 1998, Baumann and Gauldie, 1994).
1.2. Acute Phase Proteins
The acute phase proteins (APP) are defined as a gi oup of plasma proteins that change in 
concentration by at least 25% due to either an internal or external trauma to an animal 
resulting in an APR. The change in concentration can be either an increase, termed
positive APP, (e.g. C-reactive protein (CRP), serum amyloid A (SAA), haptoglobin 
(Hp)) or a decrease, termed negative APP (e.g. albumin, transthyretin (TTR)) (Koj, 
1985, Pepys and Baltz, 1983, Kuslmer, 1982).
Once the APR is initiated, levels of serum APP change dramatically due to their altered 
production by the hepatocytes of the liver. The positive APP can be classified using the 
magnitude of their increase from baseline levels. They may he classified as major, for 
example CRP in man typically shows a 200 times increase; moderate, for example Hp 
shows a 10 times increase in pigs, or minor, such as ceruloplasmin which shows only a 
50% increase hom baseline levels in man (Bckersall, 2000b, Eckersall, 1995). The APP 
may also be divided into two gi'oups dependent upon the cytokine gioup that induces 
them. Based on evidence from human, rat and porcine studies, Type 1 APP are induced 
by IL-1 type cytokines and synergistically by IL-6 type, while type 2 APP are induced 
by IL-6 type cytokines and are not stimulated by IL-1 type cytokines which may 
actually have an inhihitory effect on them (Gonzalez-Ramon et a l , 2000, Suffi'edini et 
a l,  1999, Heinrich et a l,  1990).
In humans and dogs, an APR will show a rapid reaction of ‘major’ APP within 4 hours 
of a trauma, these tend to be major type 1 APP and show a dramatic increase in 
concentration before rapidly returning to noimal levels. The ‘moderate’ APP tend to be 
moderate type 2 APP which show a slower increase and may remain at elevated 
concentrations for up to two weeks before returning to baseline levels (Ceron et a l,  
2005, Eckersall, 2000b). However it is important to remember that the APR is species 
specific in that each species shows a different response not only in the kind of APP 
produced hut also the magnitude of their reaction and whether they are type 1 or type 2.
The one exception to this is that semm albumin appears to decrease in concentration by 
10 -  30 % in all mammalian speeies (Petersen et a l,  2004).
1.3.Porcine Acute Phase Proteins
Due to its status as an intensively farmed animal and its use in biomedical research as 
models for human disease, transgenic research and organ transplantation, the APR of 
the pig has been of interest for many years. Since 1987, studies have taken place 
investigating the porcine APP and their responses to inflammation, disease and trauma, 
with the view to using them as markers of disease and animal welfare (Eckersall, 1987). 
Here, the various individual porcine APP will be described before their applications in 
veterinary science, meat production and animal welfare are discussed.
The porcine APP include many which are found in other species as well as one species 
specific APP; pig major acute phase protein (Pig-MAP) (although homologues are 
found in other species). The various porcine APP are listed in Table 1.2 in their 
categories of major, moderate, minor and negative. Of these: Hp, CRP, Pig-MAP and 
the negative APP, TTR, will he discussed in gieater detail.
1 0
Table 1.2: Acute phase proteins of the pig
Major Moderate Minor Negative
C-reactive protein Pig-MAP Fibrinogen Albumin
Serum amyloid A Ceruloplasmin Transthyretin
Haptoglobin «i-acid glycoprotein Apolipoprotein A-1
Transferrin
(Parra et a l, 2006, Itoh et a l, 1993)
1.3.1. Haptoglobin
Porcine Hp is a plasma % sialoglycoprotein that hinds free haemoglobin (Hb). It is 
analogous to human haptoglobin type 1-1 and consists of two polypeptide chain types; a 
chains (—10 kDa) and heavier B chains (50 kDa). The two subunits are held together by 
disulfide bonds which also crosslink the a  subunits to fomi oligomers (Cigliano et al., 
2003, Heegaard et a l,  1998, Eurell et al., 1990). Haemoglobin is an oxygen-binding 
tetramer (o2B2) protein which contains a protoporphyrin ring complexed with heme. In 
humans and most likely pigs, the B chain of Hb contains two specific binding sites for 
Hp while the Hb a  chain contains one Hp binding site. The Hb oB dimers bind 
stoichiometrically to Hp oB subunits forming a soluble complex which enhances the 
toxic peroxidase activity of Hb (Petersen et a l,  2004, Langlois and Delanghe, 1996).
Haptoglobin perfonns a variety of roles in the affected animal but its primary function 
is presumed to be to prevent loss of iron and stop renal damage from occurring. When 
erythrocytes are destroyed, Hb is released into the circulatory system where it can pass 
through the glomerular filter and renal damage may occur. When Hp binds to Hb, the
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complex is not filtered through the glomeruli but instead transported to the liver for 
protein degradation and Fe^”^ recycling. This also has a bacteriostatic effect by 
restricting the Fe^ "^  availability required for bacterial giowth (Cigliano et a i,  2003, 
Langlois and Delanghe, 1996, Eaton et a l ,  1982).
In addition to the binding of free Hb, Hp also protects against free radical damage by 
superoxide (O^") and hydroxyl (OH) molecules. Free Hb allows the accumulation of 
OH molecules as Fe^^ can generate OH via the Fenton reaction; it can also catalyse the 
oxidation of low-density lipoproteins which damage vascular endothelial cells. The Hb- 
Hp binding complex thus prevents these occuiTences (Cigliano et a l,  2003, Langlois 
and Delanghe, 1996). The Hb-Hp complex also prevents fr ee Hb from interacting with 
endothelium-derived relaxing factor (BDRF) or nitric oxide (NO). Nitric oxide is 
produced by cells including cytokine-activated macrophages and large amounts are 
cytotoxic, providing a non-specific defence against microorganisms (Langlois and 
Delanghe, 1996).
Haptoglobin is also involved in immunomodulation via the binding of the Hb-Hp 
complex to CD11/CD18 receptors on gianulocytes and monocytes. These receptors are 
involved in cell to cell and cell to matrix interactions. In addition, the Hh-Hp complex 
is also recognised via CD 163, a specific surface receptor on macrophages, where it is 
then phagocytosed (Langlois and Delanghe, 1996). These roles and the other roles it 
perfoims are summarised in Table 1.3.
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Table 1.3: Functions of selected acute phase proteins.
Acute Phase Protein Function
Haptoglobin Binds with haemoglobin
Protects against fi'ee radical damage (anti oxidant) 
Bacteriostatic effect 
Immunomodulatory effect 
Angiogenic factor
C-reactive protein Opsonisation and phagocytic removal of cell debris 
Activation of complement
Modulation and interaction with platelets, macrophages, 
monocytes, lymphoid cells 
Binds with chromatin
Transthyretin Transport of retinol and thyi'oxin
Porcine Hp has shown value as a diagnostic marker of a variety o f conditions. In 
newborn piglets, baseline serum levels of Hp are initially very low, then reach a 
concentration of more than two-fold that of older animals before decreasing and 
returning to normal baseline levels of below 1 g/L at around 2-3 weeks of age (Martin et 
a l,  2005, Petersen et a l,  2004). There has been differences in baseline levels of Hp 
obseiwed between sexes with boars having lower levels than sows, and also between 
herds, with conventional herds having higher levels than specific pathogen free (SPF) 
herds (Gymnich and Petersen, 2004, Petersen et a l ,  2002b). During an APR, semm Hp 
concentrations generally increase more than 3-fold (but can be as much as 26-fold) and 
therefore it is considered a major porcine APP (Parra et a l ,  2006, Heegaard et al,
1998).
A rise in semm Hp can be induced by various means in pigs including inflammation 
caused by turpentine injection, infection with Actinobacillus pleuropneumoniae.
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Mycoplasma hyorhinis, Streptococcus suis, or Escherichia coli and LPS intake 
(Sorensen et a l ,  2006, Carroll et a l ,  2004, Hulten et a l ,  2003, Magnusson et a l,  1999, 
Dritz et a l ,  1996, Eckersall et a l,  1996). Studies also showed that Hp concentrations 
can he used to follow the time course of an infection and as a marker of treatment 
effieacy with levels rising before clinical signs are apparent (Hulten et a l,  2003, 
Petersen et a l ,  2002a).
In addition to infection, Hp can also be a marker of clinical signs as higher semm levels 
are associated with lameness, tail and ear bites, diarrhoea and respiratory disease. It can 
be associated with stress over a period of time (i.e. long-duration transport, routine 
changes) and can be used to differentiate between animals that will show a high and low 
weight gain at slaughter (Pineiro et a l ,  2007b, Saco et a l,  2003, Petersen et a l,  2002a, 
Petersen et a l ,  2002b, Eurell et a l ,  1992).
The variety of studies carried out and the potential as a marker for disease, treatment 
efficacy, stress and weight gain means that porcine serum Hp levels could he an 
extremely valuable diagnostic tool.
1.3.2. C-Reactive Protein
C-reactive protein was the first APP to be discovered in humans in 1930 and has 
remained one of the most widely researched and measured of the APP (Tillett and 
Francis, 1930).
A member of the pentraxin family of proteins, CRP consists of five identical non- 
covalently associated subunits of 23.4 IcDa each arranged symmetrically around a
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naturally formed pore (Volanakis, 2001, Burger et al., 1998). Based on the human 
stmcture, each subunit consists of 206 amino acids folded into two antiparallel B sheets 
with a flattened jellyroll topology. Each subunit, all with the same orientation, has a 
recognition face with a phosphocholine (PCh) binding site consisting of two bound 
calcium ions (Ca^ "^ ) and an adjoining hydrophobic pocket. Two oxygens of the 
phosphate gi'oup bind with the two Ca^^ while the choline group rests in the 
hydrophobic pocket. Two residues, Phe-66 and Glu-81 are also involved. Phe-66 
provides a hydrophobic interaction with the choline methyl gi'oups, while on the 
opposite end of the pocket, Glu-81 interacts with the positively charged choline nitrogen 
(Agrawal, 2005, Black et a l ,  2004, Volanakis, 2001).
The opposite face of the pentamer is the effector face; it is on this side that the 
complement Clq-binding site is located and the immunoglobulin FcR binding site is 
presumed to be. Residues including Asp-112 and Tyr-175, situated along a cleft 
extending from the centre of the sub-unit to the central pore are responsible for this 
binding, leading to complement activation. Compared to PCh binding, calcium is not 
required for Clq binding, however Clq must bind to more than one CRP pentamer 
before complement activation can occur (Agrawal, 2005, Black et a l ,  2004, Volanakis,
2001). This ability to bind not only PCh but also to initiate the classical complement 
system links the non-specific immune response to the specific adaptive immune 
response (Murata et a l,  2004).
C-reactive protein plays a variety of important roles in protection against infection and 
restoration of healthy tissue by eliminating damaged cells via the complement system 
and phagocytic cells. The primary CRP ligand, PCh, is found in the teichoic acids,
15
capsular carbohydrates and lipopolysaccharides of bacteria and other organisms. It is 
also present in the outer leaflet of most biological membranes as the polar head group of 
lecithin and sphingomyelin (Murata et a l ,  2004, Volanakis, 2001). However, in normal 
cells these polar heads are inaccessible to CRP; therefore CRP can only bind to these 
molecules in damaged or apoptotic cells.
Once CRP is bound to the surface of a damaged cell, it initiates the fonnation of C3 
convertase. This leads to binding of opsonic fragments of C3 to the activating surface 
of CRP. Phagocytosis of the opsonised particles and apoptotic cells can then take place 
through binding to the IgG receptor, FcR, on monocytes and macrophages (Black et a l,  
2004, Volanakis, 2001). The role of CRP in phagocytosis and other roles it plays are 
summarised in Table 1.3.
Porcine CRP was first detected in plasma samples taken from piglets with pyrexia 
(Eckersall, 1987). Later studies have looked at baseline and acute phase concentrations 
of CRP under various conditions and induced hy different means including tuipentine 
oil injection, experimental inoculation and stress (CaiToll et a l ,  2004, Eckersall et a l,  
1996). The baseline concentration of semm CRP in adult pigs is generally accepted to 
be under 100 mg/L and during an APR increases 1 0 - 1 5  times, categorising it as a 
major porcine APP (Parra et a l,  2006, Lampreave et a l ,  1994). CRP often reacts faster 
and returns to noimal quicker than most of the other porcine APP which makes it an 
ideal candidate as an early indicator of infection (Parra et a l ,  2006, Lauritzen et a l,  
2003, Heegaard et a l ,  1998). At the present time, CRP concentrations have heen 
studied in various disease models and overall levels correlate to the time course of 
treatment and severity of infection. Similar patterns have heen observed in animals
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under stress due to transport or changes in routine (Pineiro et a l,  2007b, Pineiro et a l,  
2007c). It has suggested that CRP can be used to identify animals with sub-clinical 
disease and in the assessment of stress (Murata et a l,  2004, Heegaard et a l,  1998, 
Eckersall et a l ,  1996).
1.3.3. Pig-Major Acute-Phase Protein
Pig-Major Acute-phase Protein (Pig-MAP) is a porcine specific plasma ü2-globulin 
(115 kDa) which is homologous to inter-ce-trypsin inliibitor heavy chain 4 (ITIH4) in 
humans. Both are members of the inter-ce-trypsin inhibitor (led) heavy chain family 
(Martin et a l ,  2005, Pineiro et a l,  1999, Lampreave et a l ,  1994).
The lcd family is a group of related plasma protease inhibitors. These proteins are 
foiined fi-om a variety o f multi-polypeptide molecules, each with different assemblies 
from a group of four distinct polypeptides. This group consists of throe related heavy 
(H) chains; HI, H2, H3 and a light chain called bikunin. The hikunin chain contains 
two Kunitz-type protease inhibitor domains which are bound to the heavy chains via 
glycosaminoglycan bridges (Pineiro et a l ,  1999, Sailer et a l,  1996). However, 
although Pig-MAP (and ITIH4) shows significant sequence homology with HI, H2 and 
H3, they do not link to bikunin and subsequently they lack the protease inhibitory 
function. It is not clear what function Pig-MAP performs during an APR but it may 
play a role during gestation by protecting the uterus from the inflammatory response 
induced by the attacliment of the conceptus to the uterine epithelium (Martin et a l,  
2005).
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Martin et al. (2005) showed that during the first days of life, Pig-MAP serum 
concentrations increased rapidly fiom close to 0 to 1.6 g/L and remained high until 
weaning before dropping to adult baseline concentrations of aroimd 0.4 -  0.6 g/L 
(Martin et a l,  2005, Carpintero et a l ,  2005). In an APR, Pig-MAP serum 
concentrations rise hy at least five times and remain elevated for several days with a 
maximum concentiation reached 24-48 hours after initiation of the APR (Heegaard et 
a l,  1998, Alava et a l,  1997).
A rise in serum Pig-MAP can be induced by turpentine injection, A. pleuropneumoniae, 
S. suis, Aujeszky’s virus and surgery. In addition, pigs exposed to stressful situations 
consistently show a rise in Pig-MAP levels (Pineiro et a l,  2007c, Heegaard et a l,  1998, 
Alava er a/., 1997).
As a pig specific APP, Pig-MAP shows gi'eat promise as a marker of infection and 
serum levels show a good conelation with disease. However, more extensive and 
wider-ranging studies need to be performed to examine its function and concentrations 
under differing conditions.
1.3.4. Alpha-1-Acid Glycoprotein
Alpha-1-Acid glycoprotein (AGP), also known as orosomucoid, is a negatively charged 
glycoprotein of 41-43 kDa, of which 45% consists of carbohydrate. It is considered 
part of the immunecalin family, a family o f proteins which modulate immune and 
inflammation. The precise function of AGP is unknown but studies have shown that it
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may depend on the carbohydrate content which alters during an immune event 
(Hochepied et a l ,  2003, Fournier et a l ,  2000).
At birth, AGP concentrations in piglets are extremely high (14.3 mg/ml) and gradually 
decrease to adult baseline concentrations (1.4 mg/ml) by 20 weeks of age (Itoh et a l,  
1992). However, there are conflicting opinions as to whether AGP should be 
considered an APP in pigs. This stems from the lack of response of AGP to LPS 
stimulation suggesting that AGP may only be a minor indicator of inflammation 
(Eckersall et a l ,  1996, Lampreave et a l ,  1994). Despite the lack of response to LPS, 
AGP does show significantly higher concentrations in pigs exposed to A. 
pleuropneumoniae and M  hyopneumoniae indicating that it may be useful as a potential 
marker of disease, however more research is needed in this area (Itoh et a l,  1992).
1.3.5. Negative Acute Phase Proteins
The concentration of negative APP decreases during the APR, this may allow the amino 
acids used in their production to be diverted to the production of APP which will aid 
with immediate survival of trauma or infection, however the exact function is unknown. 
In pigs, the negative APP include albumin, transferrin, transthyi'etin (TTR) and 
apolipoprotein A-1 (ApoA-1) with the latter two being particularly indicative of an APR 
(Campbell et a l,  2005, Lampreave et a l,  1994).
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i. 3.5.1. Tran sthy retin
Transthyretin is a homotetrameric protein (55 kDa) consisting o f 4 identical subunits 
each 127 amino acids long. Each monomer is made up of 8 p-strands organised into 2 
four stranded P-sheets and 1 short ct-helix. The 2 dimers create a chamiel where 2 
hoimone binding sites are located and two retinol-binding protein (RBP) binding sites 
are found on the surface of the molecule (Eneqvist et a l ,  2003, Monaco et a l,  1995). 
The porcine isoform of the protein shares 85% homology with the human form, and 
differs by the addition of 3 extra amino acids at the C-terminus (Gly-Ala-Leu), this 
gives it a subunit length of 130 amino acids (Duan et a l,  1995).
Transthyretin is a transport protein, and as such, is involved in the transport of thyroxine 
and RBP in complex with vitamin A. Without the presence of transport proteins such as 
TTR, thyi'oxine would move into the lipid membranes from the blood, causing an 
uneven distribution of the homione (Eneqvist et a l,  2003, Duan et a l,  1995). In 
humans, decreasing serum levels of TTR are used as indicators of malnutrition and 
have a strong correlation with patient outcome; continually low semm concentrations 
indicate a requirement for nutritional support (Beck and Rosenthal, 2002).
Recent studies in pigs have shown baseline levels to be -  300/xg/ml with the 
concentration falling significantly following infection with S. suis (Campbell et a l ,  
2005). However, unlike CRP, Hp and Pig-MAP, there appears to he no significant 
effect of stress on TTR levels (Pineiro et a l ,  2007b, Pineiro et a l ,  2007c)
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As with other APP, more studies need to be carried out to define not only the precise 
functions of this APP but also differences in concentrations due to age, breed, farm 
location and health status and also their values of markers of infection.
1.4. Applications of Acute Phase Proteins in Veterinary Diagnostics
As has heen discussed, porcine APP can be used to not only monitor inflammation but 
also as markers of disease and sub-clinical infection. These properties make them a 
useful tool in porcine health and pig production systems.
1.4.1. Marker of Health Status
Many studies have focussed on measuring APP during infection with various infectious 
agents; in particular Hp is recognised as an especially valuable non-specific marker o f 
disease. On famrs, raised APP levels can be used to identify animals with sub-clinical 
disease. This allows not only early treatment of infection but would allow isolation of 
an infected animal, hence preventing the spread of disease within intensive systems 
(Petersen et a l,  2004, Knura-Deszczka et a l, 2002, Eckersall, 2000a). Animals 
suffering from disease also suffer hom associated staiwation and therefore negative 
energy balance as muscles are catabolised to provide amino acids for APP production 
and as an energy source (Gmys et a l,  2005). Early detection of an APR would ensure 
treatment of these animals and allow feed formulations to be adapted to a change in 
nutrient requirements such as increased tryptophan or L-arginine (Bmins et a l,  2002). 
This would ensure that animals do not lose condition and hence help to avoid lower 
profit margins.
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1.4.2. Marker of Health and Welfare
It has been accepted, for some time now, that stress in production animals can have 
detrimental effects on their performance. Pigs are known to be susceptible to stress, 
particularly those carrying the halothane gene. Stress in the animal can be associated 
with a variety of factors including enviromnent, handling, transport, social environment, 
genetics and the sex of the animal (Salak-Jolinson and McGlone, 2007, Mob erg and 
Mench, 2000). These studies have shown that Hp, Pig-MAP and CRP can he used as 
indicators of stress due to transport, routine disruption and environmental factors such 
as hygiene, with levels of these APP rising in response to the perceived stress. 
However, it can be difficult to separate the effects of trauma or subclinical disease from 
the effects of stress (Pineiro et a l ,  2007b, Saco et a l,  2003). It is biologically possible 
for stress to cause a change in APP concentrations tlnough the sympatho-adrenal and 
hypothalamic-pituitary-adrenal (HPA) axes. Activation of these axes, results in 
production of catecholamines and glucocorticoids, both of which are involved with 
cytokine induction and therefore APP production (Murata, 2007).
The measurement of APP could have potential use in not only identifying animals 
suffering from severe stress but also in general welfare management, i.e. high APP 
levels indicate underlying problems whether these are hygiene or disease related 
(Murata, 2007). This would not only be of use to the stockman but could also be 
incoiporated into the welfare schemes now associated with pork production.
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1.4.3. Use in Meat Inspection
As meat production has become increasingly industrialised and food safety has become 
of paramount importance to both producer and consumer, additional and more efficient 
methods of assessing meat quality have been sought. Many investigations into this area 
have centred on blood based sampling of animals entering the production line and the 
use of on-farm tests in the form of biosensors (Hiss et a l,  2003, Toussaint et a l,  1995). 
As APP levels have been shown to be consistently elevated in those animals with sub- 
clinical infection, inflammation and stress (all with adverse effects on meat quality or 
hygiene), they could provide an ideal screening tool in meat production systems 
(Eckersall, 2000a, Saini et al., 1998, Toussaint et a l,  1995). Studies have shown that 
APP concentrations can be measured in meat juice and that the measurements correlate 
with Hp semm levels (Gutierrez et ah, 2008, Hiss et ah, 2003). Cunently, meat juice 
can be used as an assessment of pork quality therefore it may be possible to incorporate 
the measurement of APP into post-slaughter tests at the abattoir. This would provide 
not only an indication of pork quality but also general health and welfare status (BPEX, 
2002).
l.S.Acute Phase Index
The use of APP in veterinary diagnostics has major potential hut there are several APP 
to choose from and some may be better indicators or markers than others for particular 
diseases. It is possible that this can be overcome with the use of an acute phase index 
(API) based upon the prognostic inflammatory and nutritional index (PINI) used in 
human patients and the bovine API (Gmys et a l,  2006, Ingenbleek and Carpentier, 
1985). This index uses a selection of values from fast and slow reacting positive and
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negative APP to give a more reliable parameter for measuring health than the individual 
APP values and a preliminary formula has been suggested for use in pigs:
CRP tor SAA) x Hp (or plasma viscosity)
Albumin x Vit. A*
* TTR could be substituted for Vit. A as during an APR they are found in com plex w ith one another.
However, further studies are required to verify this and calculate acceptable values 
before it can be used (Gruys et a l ,  2006, Toussaint et a l,  1995).
1.6. Genetics of Acute Phase Proteins
hi order to be useful as markers of disease, it is necessary to understand the relationship 
between the production of the APP in question (both at baseline and stimulated levels) 
and disease. By looking at the genetics of the APP, we can gain an understanding of 
what regulates their production and identify any associations with disease and/or the 
organism’s ‘normal’ status. However, very few studies have been earned out in 
livestock species including pigs. In recent years, a great deal of research has centred 
around the genetics of the human APP, in particular CRP, and at the present time, this is 
the most understood of the APP, although some studies have been and are being earned 
out into other APP such as haptoglobin, transthyi'etin and ITIH4.
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1.6.1. Genetic Studies of Human Acute Phase Proteins
1.6.1.1. Haptoglobin
Haptoglobin in humans is located on chromosome 16q22 and has a polymoiphism in the 
a  protein giving two variants of HP-1. This has led to tliree major phenotypes: HP-1,1, 
HP- 2,1 and HP-2,2 (NB: porcine Hp is homologous to HP-1,1). Studies have shown 
that Hp serum levels vary with Hp phenotype, typically in the order HP-1,1 > HP-2,1 > 
HP-2,2. (Cox et a l,  2007, Langlois and Delanghe, 1996). A single nucleotide 
polymorphism (SNP) located in the promoter region of Hp is thought to be responsible 
for the differences in phenotype. Single nucleotide polymorphisms occur when one 
nucleotide is substituted for another. They can be located in the coding regions of genes 
and if they result in an amino acid change they can directly affect protein function 
(Beuzen et a l ,  2000). The SNP, a 61A-C substitution, is associated with decreased Hp 
levels with the C-allele closely associated with undetectable Hp levels (Maeda, 1991). 
In addition, a novel SNP 101C-G substitution has also been found to be associated with 
semm Hp concentrations (Teye et a l ,  2003).
Presently, no heritability studies have been earned out for Hp in human populations, 
however, studies indicate that Hp genotype is related to race. The two SNP mentioned 
above are found in persons of African origin whilst other SNP are found in persons of 
Asian and European descent (Teye et a l ,  2006). This means that if Hp genotype is to 
be used as a biomarker, then race must be taken into account during testing and when 
performing in-depth studies.
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1.6.1.2. C-Reactive Protein
The CRP gene is located on human cliromosome lq23 (Walsh et a l,  1996), and consists 
of two exons and one intron containing a polymorphic (GT) repeat (Szalai et a l,  2002, 
Lei et a l,  1985). Thirteen alleles of the GT repeat were identified, corresponding to 
introns containing 9 to 25 repeats (GT^ to GT^^) and giving rise to 38 genotypes. Three 
of these genotypes GT^^ ’^ ,^ GT and GT account for 78% of all Caucasians. The 
GT*  ^ and GT^  ^ alleles were designated alleles and further analysis revealed that
the number of CRP^°'^ alleles earned hy an individual significantly affected CRP levels. 
Specifically, those individuals canying the alleles had a two-fold lower CRP
serum concentration than those individuals carrying other genotypes (Szalai et a l,  
2002).
Further studies have examined the association between SNP and serum concentrations. 
A number of SNP have been detected in CRP that have associations with CRP 
concentrations (Wang et a l ,  2006, Suk et a l ,  2005, Brull et a l ,  2003). Some of the 
SNP published are found to be in linkage disequilibrium (LD) with each other which 
may explain some of the associations, however, those SNP that are not in LD may have 
individual effects on CRP levels or may work in tandem (Miller et a l,  2005). More 
work is needed in this area, but it is clear that CRP levels are under genetic control.
Large scale familial studies have also been carried out to obtain an estimate of CRP 
baseline concentration heritability in order to determine what proportion of the total 
variation can be attributed to genetic effects. The studies found that CRP levels have a 
high heritability (h^) with estimates of 0.39, 0.4 and 0.52 (MacGregor et a l ,  2004, 
Vickers et a l,  2002, Pankow et a l ,  2001).
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1,6.1.3. In terleukin-6
It should be noted, that studies have also reported that polymorphisms within the IL-6 
gene are significantly associated with CRP levels (Vickers et a l ,  2002). As previously 
discussed, IL-6 is involved with the expression of CRP and as such it is hypothesised 
that a SNP in IL-6 could affect CRP levels via IL-6 gene transcription and the 
subsequent effect of differing cytokine levels on CRP gene expression (Vickers et a l,
2002). However, further studies will be needed to clarify this hypothesis.
1.6.1.4. ITIH4 and Transthyretin
Both ITIH4 (human homologue to Pig-MAP) and TTR have been associated with 
pathological conditions in a limited number of studies. The ITIH4 gene is located on 
human chromosomal region 3p21.1-p22 which has been described as a possible 
quantitative trait locus (QTL) for the condition dyslipidemias (Yuan et a l,  2000, Jean et 
a l,  1997). Single nucleotide polymorphisms have been located in this gene and in 
particular a C/T substitution within intron 17. Although no association studies have 
been carried out between this SNP and ITIH4 concentrations, an association has been 
found between the polymorphism and total plasma cholesterol concentration. 
Specifically it was found that the C allele is associated with significantly higher 
cholesterol concentrations (Fujita et a l,  2004).
The TTR gene is located on human chromosome 18ql2.1 and is composed of four exons 
(Tsuzuki et a l,  1985). Many SNP (>80) within the TTR gene have been identified, a 
number of these are associated with amyloidosis and cardiomyopathy and cause a 
mutated version of the protein to be synthesised (Saraiva, 2002). The TTR gene has also
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been reported to be implicated with the pathophysiology of schizophrenia. However an 
association study between genotype and TTR levels earned out as part of a wider study 
looking at schizophrenia found that there was no association between serum 
levels and the genotypes of the two SNP studied in this case (Ruano et a l,  2007).
Using the evidence gained from genetic studies of the human APP, it can be predicted 
that some, if  not all of the porcine APP may be under the control of polymorphisms 
and/or may be associated with certain pathological conditions or immune function. 
Studies have mapped the porcine APP genes and these will be discussed in detail in 
Chapter 4. If porcine APP genes are shown to be under genetic control, this may have 
implications for commercial breeding companies, particularly in terms of breeding for 
immune function or disease resistance.
1.7.Breeding for Disease Resistance
Disease can be a major issue in intensive breeding systems causing animal welfare 
problems and ultimately leading to a loss of profit. At the present time, disease control 
can be broadly divided into thiee main areas;
-  Preventative: vaccination, controlled entry into animal housing
-  Treatment: antibiotics, antihelminthics, culling when necessary
-  Breeding for disease resistance
The first two have been the methods of choice for many years, however they do have 
disadvantages, namely eost, consumer demand for produce fiee from antibiotics,
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availability of drugs, legislation and ensuring that treatment and prevention progi'ams 
are followed (Visscher et a l,  2002, Muller and Brem, 1991). The third option, breeding 
for resistance, is becoming more viable and is possibly a favourable alternative. The 
advantages of this method include simplicity and low cost (when a breeding progi am is 
in place), improved animal health and welfare and increasing availability of moleeular 
markers as selection tools (Nicholas, 2005, Montaldo and Meza-Herrera, 1998). It is 
not without disadvantages, although there are compelling arguments against them. 
Stear et a l  (2001) divided the disadvantages into three areas; sustainability, feasibility 
and desirability and argued that these concerns could be addressed.
Genetic resistance to specific diseases has been recognised for some time, examples 
include Brucella suis and E. colt in pig, foot rot in sheep and scrapie in sheep (Chang 
and Stear, 2006, Drogemuller et al., 2001, Whittington and Nicholls, 1995, Cameron et 
al., 1942). In these instances, the genotype susceptible to the disease has been
identified. The use of molecular markers has allowed individuals carrying the
susceptible genotype to be either culled or withdrawn from the breeding population 
(Wilkie and Mallard, 2000).
Breeding for generalised resistance to disease and in particular sub-clinical disease is 
more problematic as the desired phenotypic traits have first to be identified. The innate 
immune system appears to be a logieal target as it is non-specific and can recognise a 
large number of pathogens, as previously discussed. In addition, various components of 
the innate immune system can be easily measured and associations with disease 
susceptibility and production traits can be calculated (Clapperton et a l,  2005b, Colditz, 
2002).
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1.7.1. Breeding for Resistance in Pigs
In pigs, a number of studies have centred on aspects of innate immune traits and have 
identified several areas of interest. One of the most important, from a breeding 
perspective, is that pigs show genetic variation both within and between breeds in innate 
immune traits such as monocyte number, interleukin-2, neutrophil number and porcine 
mannan-binding lectin A which has also been shown to be heritable (Landrace h^=0.8, 
Duroc h^=0.15) (Juul-Madsen et al., 2006, Clapperton et al., 2005b). These results 
indicate that this may lead to variation in disease resistance which could be a useful 
breeding tool. It is also possible that the response of an animal to disease may be of an 
interest, if  an immune trait can be measured before and after an immune event, it would 
be possible to determine whether the response of an animal is determined by its genetic 
background or whether this is a heritable trait.
The other main area o f interest is associations between iimate immune traits and 
production traits. Studies by Clapperton et al (2005) and Galina-Pantoja et al (2006) 
reported that immune traits can have strong associations with production traits in 
healthy animals and that these associations can have negative effects. In particular, 
lymphocytes expressing CD 16+, CD2+/CD16+ and CD8+ receptors were assoeiated 
with reduced average daily gain, with a higher frequency of these lymphocytes having 
an overall negative effect on production traits (Galina-Pantoja et a l,  2006). 
Interestingly, a similar study found no association with CD8+ and performance but did 
find that as monocytes, NK cells and B cell proportions increased the performance of 
the pigs decreased (Clapperton et a l ,  2005a). In contrast, earlier studies used the 
production of Yorkshire pigs bred for HIR (high) and LIR (low) antibody and cell- 
mediated immune response. In these studies, HIR pigs had a better rate of weight gain
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and responded better to vaccination, however some stimuli provoked more 
inflammation than in LIR pigs (Wilkie and Mallard, 1999).
Although it appears to be possible to breed for innate immune traits, there is an effect on 
production traits and this needs to be taken into account before breeding schemes are 
put in place.
As has been discussed, the use of porcine APP as biomarkers of health is a possibility 
for future pig production but more research is required to increase the basic 
understanding of the porcine APP concentrations and the factors influencing them. The 
objectives of the work presented in this thesis are;
a) to deteimine the baseline concentrations of 4 porcine APP (Hp, CRP, Pig-MAP 
and TTR) in a high health boar population and identify any differences between 
breeding lines;
b) to identify polymoiphisms in the 4 porcine APP genes and use them to genotype 
a population of high health boars;
c) using the data gained fi-om objectives a) and b), to detennine whether there is an 
association between APP genotypes and APP baseline concentrations;
d) to carry out a study of the heritability of APP baseline concentrations in high 
health pigs.
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Chapter II
2. Development of an Assay for the Measurement of C- 
Reactive Protein in Porcine Serum
2.1.Introduction
The measurement of APP in pigs provides a non-specific indication of infection, 
inflammation or trauma. C-reactive protein is considered a major APP in pigs and is 
therefore particularly useful as a marker of disease. Although commercial assays were 
available to measure porcine CRP in serum; with a high number of samples to be 
processed these can prove to be costly. Therefore the development of an in-house assay 
for porcine CRP (pCRP) was undertaken with the objective of establishing a reliable, 
robust and more cost effective method than those previously available.
2.1.1. Use of Immunoassays in Measuring Acute Phase Proteins
The majority of assays used for measurement of APP in livestock are now reliant upon 
the use of antibody-based assays. The main exception to this is the automated 
biochemical Hp assay which is based on haemoglobin (Hb) binding (Eckersall et a l ,
1999); this will be discussed in further detail in Chapter 3.
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2.1.2. Background
The immunoassay first originated in 1959 with an assay for insulin and is based upon 
the reversible reaction between an antigen and its specific antibody ( Y alow and Berson, 
1959). Since then, immunoassays have been developed to include a wide range of 
techniques for the detection and quantification of the antibody-antigen reaction, and an 
enormous selection of different labels and detection systems are now available; for 
example, fluorescence and chemiluminescent systems (Ronald and Stimson, 1998).
The first immunoassays were based upon the use of radioisotope labelling, Imown as 
radioimmunoassay (RIA). The antigen of interest was labelled with a radioisotope 
which competed with the unlabelled antigen (present in the sample) for binding to the 
antibody. After incubation, the bound and free fractions were separated and the 
radioactivity of the separated fi*actions measured (Wu, 2006). However, this teclmique 
had its disadvantages, in particular the health hazards and waste disposal problems 
associated with working with radioactive isotopes.
The original RIA used polyclonal antibodies from human sources or those produced in 
animals. The problems of limited supply and multispecific binding were overcome by 
the diseovery and production of monoclonal antibodies (Kohler and Milstein, 1975). 
These antibodies can have a high specificity towards the original antigen and large 
quantities of monoclonal antibodies with the same specificity can be produced. Both 
polyclonal and monoclonal antibodies are commonly used in immunoassays with the 
choice of antibody being dependent on antibody specificity and assay performance 
optimisation (Wu, 2006, Ronald and Stimson, 1998). One of the advantages of 
antibody-based methods is the wide range of assay formats available including single
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radial immunodiffusion (SRTD), enzyme linked imunosorbent assay (ELISA) and 
immunoturbidimetric assays (Eckersall, 1995). The most common of these assays will 
be discussed in relation to measuring APP, and more specifically porcine CRP.
2.1.2.1. Single Radial Immunodiffusion
Single radial immunodiffusion (SRID) is an immunoprécipitation technique in which 
the antigen is placed in a well within an agar gel containing antibody and diffuses out 
into the gel. A ring-shaped precipitate forms when antibody and antigen are present in 
the coiTect proportions so that the ring diameter correlates with the concentration of 
antigen. The diameter of the rings is measured and the test can be calibrated using 
standards of Imown concentration (Mancini et a l ,  1965). The SRID is a simple and low 
cost method of determining antigen concentration. However it has disadvantages such 
as the incubation time (24 -  48 Irrs), the sensitivity of the technique and the possibility 
of human error in measuring the preeipitate ring. Porcine CRP has been measured 
using SRID and has a high correlation with some ELISA results, however, it is not the 
method of choice due to the incubation time and sensitivity, particularly with low 
concentrations (Burger et a l ,  1998).
2.1.2.2. Sandwich or double antibody ELISA
The double antibody (sandwich) is the most common format for this type of 
immunoassay due to its high specificity, and uses two antibodies, ideally raised to two 
different epitopes of the antigen. Using two specific antibodies improves the specificity 
of the assay as generation of the signal requires both antibodies to bind. The capture
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antibody is linked to a solid support such as the walls of ELISA plate wells and the 
sample dispensed in buffer into the well (this may be preceded by a blocking step). Any 
antigen in the sample will bind to the antibody so that when a second, generally enzyme 
labelled (for example, alkaline phosphatase) antibody is applied, the concentration of 
antigen ean be detected by use of the signal generated from the enzyme labelled 
antibody. This format has the advantages of being highly specific and sensitive, 
although it camiot be used for small molecules or where two separate binding sites are 
not available (Ronald and Stimson, 1998). Commercial sandwich ELISA are available 
and have been validated and used in studies of pig APP (Tecles et al., 2007, Parra et ai, 
2006, Heegaard et al., 1998).
2.1.2.3. Ligand-Binding ELISA
This assay uses a ligand linked to a solid support in order to capture the antigen. An 
antibody can then be applied, followed by a secondary enzyme conjugated antibody to 
detect the antigen. This approach has been used to measure both canine and porcine 
CRP. In both cases, the ligand is phosphorylcholine conjugated to bovine semm 
albumin (PC-BSA). The phosphoryleholine binds to CRP in the presence of CaCh 
(Sorensen et al., 2006, Eekersall et al., 1996, Eckersall et al., 1989b). In the porcine 
assays, Sorensen et al. (2006) used an anti-pig CRP monoclonal antibody whilst 
Eckersall et al. (1996) used an anti-human CRP antibody which showed cross-reactivity 
to porcine CRP. The eross reaetivity of anti-human CRP to porcine CRP has been 
validated for use in ELISA, and this has been exploited for use in other assay formats 
(Kjelgaard-Hansen et a l ,  2007, Lauritzen et a l,  2003, Burger et a l,  1998).
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2.1,2.4, Turbidimetric Immunoassays
Turbidimetric immunoassays (TIA) involve the detection of an antibody-antigen 
complex either by eye (fonnation of a visible precipitate) or by quantitative methods 
e.g. turbidity or nephelometry, based on the change in light absorption or change in light 
scattering properties of the complex. Antibody readings can be enhanced by the use of 
particles when the antibody or ligand is adsorbed onto the particle, which causes a 
larger or more easily detected complex to be formed in the presence of antigen and 
allows lower concentrations to be measured more effectively (Ledue and Rifai, 2001, 
Ronald and Stimson, 1998). The relationship between antigen and antibody is shown in 
Figure 2.1 and it is important that the optimum antibody to antigen ratio (below the area 
of equivalenee) is used to avoid false and highly inaccurate results. Advantages of TIA 
are the ability to use automated analysers giving high thi'oughput of samples, and in 
some cases they have extremely high sensitivity (Ledue et a l,  1989). Using the cross 
reactivity reported between anti-human CRP and porcine CRP, two commercial human 
TIA have been validated for use with poreine samples. The use of these two assays 
shows the potential of using cross-reactivity between species, however, each batch of 
antibody must be validated before use (Kjelgaard-Hansen et a l ,  2007).
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Figure 2.1 : The Heidelberger-Kendall curve showing the general relationship 
between antigen concentration and absorbance (turbidity).
The aim of this study was to develop and validate a sensitive immunoassay to allow 
quantitative measurement of CRP in porcine semm. Initially samples were measured 
using a commercial ELISA assay; however development of an ‘in-house’ assay was 
considered more desirable. Several approaches were tried in the development of the in- 
house assay for pCRP including TIA and ELISA (both sandwich and ligand-binding). 
After assessing the alternatives, a ligand-binding ELISA using PC-BSA and anti-human 
CRP was chosen as the most suitable method and validated using the commercial assay 
as a comparison method. This ELISA was then used to determine CRP concentrations 
in a population of high health boars (See Chapter 3) and their progeny (See Chapter 5).
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2.2.Material and Methods
Ail reagents were obtained from Sigma-Aldrich, Poole, UK unless otherwise stated. 
Double distilled water was used tluoughout.
2.2.1. Samples
A selection of porcine serum samples were made available for use in assay validation 
from the Faculty of Veterinary Medicine, University of Glasgow. The CRP content of 
these samples had been previously measured using the Tridelta PHASE™ RANGE 
Porcine C-reactive Protein Assay (Tridelta Development Pic., Co. Wicklow, Ireland) 
with samples being stored at -20°C until required. Additional semm samples were 
prepared from porcine blood collected from local abattoirs. This was incubated at 37°C 
for 30 min before the unclotted haction was removed and centrifuged at 1853 xg for 10 
mill to remove debris. The resulting semm was stored at -20°C until required.
2.2.2. Determination of CRP
The CRP content of additional serum samples, the standard pool and the internal 
controls for the ELISA was quantified using the Tridelta ELISA. This is a 
commercially available kit and has been extensively used in previous published studies, 
as such, it was considered validated for use as a reference tool. The ELISA is a solid 
phase sandwich immunoassay using a horse-radish peroxidase (HRP) conjugated anti- 
porcine CRP antibody.
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The assay was used according to the manufacturer’s protocol. Briefly, samples were 
applied at a 1:100 dilution in assay buffer to precoated microtitre plates and incubated 
for 15 min. After washing, the monoclonal conjugated antibody was applied and 
incubated before washing again. Tetra methyl benzidine (TMB) substrate solution was 
then added and the final absorbance read at 450 nm using the FLUOstar OPTIMA 
platereader (BMG Labtech Ltd., Aylesbury, UK). The results were analysed and 
calculated by the associated FLUOstar Optima Software V I.32.
In order to develop and validate an in-house assay for pCRP, several assay formats were 
investigated. Three of the fonnats will be described here starting with the successful 
assay. In all cases, the assay validation process was completed in a similar fashion 
unless preliminary results indicated that the assay was inferior and further investigation 
would be without merit.
2.2.3. Development of ELISA using Anti-Human C-Reactive Protein
A ligand-binding ELISA was developed for the measurement of CRP in serum. In this 
method, PC-BSA was coated onto microtitre plates and the CRP in diluted serum 
samples bound specifically to the PC-BSA coating. A rabbit anti-human CRP antibody 
(Sigma), assessed for cross-reactivity with porcine CRP by immunoblotting, was then 
applied. After washing, a horseradish peroxidase conjugated goat anti-rabbit secondary 
antibody (Abeam, Cambridge, UK) was applied and after washing, detected with use of 
tetra methyl benzidine substrate (KPL, Gaithersburg, MD, U SA ).
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2.2.3.1. Purification o f  Porcine CRP
Porcine CRP for use in assessing cross-reactivity was obtained from acute phase sera by 
affinity chromatogi'aphy using the AKTA FPLC system (Amersham Biosciences, 
Uppsala, Sweden) running Unicom v4 software. Sera was obtained and prepared as 
previously stated from pigs known to have tested positive for salmonella or E. coli. 
Acute phase sera were pooled and approximately 12 ml applied at 0.5 ml/min to a 5 ml 
immobilized jo-Aminophenyl phosphoryl choline gel (Pierce Bioteclinology, Rockford, 
II. USA) equilibrated with 0.1 M Tris, 0.1 M NaCl (VWR hitemational Ltd., 
Lutterworth, UK), 2 mM CaCb, pH 8-8.5. The column was washed with this binding 
buffer until the absorbance returned to baseline levels (approximately 12-15 column 
volumes). The bound CRP was eluted with 0.1 M Tris, 0.1 M NaCl (VWR 
International Ltd.), 2 mM EDTA (May & Baker Ltd, Dagenham, UK) pH 8-8.5 at 
0.5ml/min. The CRP containing fraction was collected and buffer exchanged into 0.01 
M sodium phosphate, 0.09 M NaCl (VWR International Ltd.) using centricon 
centrifugal filter devices (Millipore, Bedford, UK). This process was repeated in order 
to achieve a high purity of sample.
2.2.3.2. Gel Electrophoresis
The CRP containing fraction was assessed for homogeneity by SDS-PAGE, following 
reduction by mercaptoethanol. A 20 pi aliquot of CRP or semm (each aliquot was 
prepared from the same pool of CRP or serum throughout the development process) was 
mixed with 40 pi sample buffer reducing agent (3.55 ml dH%0, 1.25 ml 0.5 M Tris, 2.5 
ml glycerol, 2.0 ml 10% (w/v) SDS, 0.2 ml 0.5% (w/v) bromophenol blue) containing
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5% v/v mercaptoethanol and heated for 5 min at 99°C. Aliquots of 20 pi of each 
sample and 10 pi of protein standards (Bio-Rad, UK) were applied to a SDS-PAGE gel 
(12% resolving, 4% stacking) and ran at 200V for approximately 30 to 45 min. The 
resulting gel was stained with Coomassie Brilliant Blue R-250 (500 ml methanol, 100 
ml acetic acid, 400 ml dH20, 4 g Coomassie Blue Stain, mixed thoroughly and filtered) 
for 1 hr and destained in a solution of 75 ml acetic acid (VWR Chemicals, 
Leicestershire, UK), 200 ml methanol and 750 ml dHzO.
2.2,3.3. Mass Spectrom etry
To confirai the presence of porcine CRP, the relevant bands were cut out hom the 
Coomassie Blue stained gel and were sent to The Sir Henry Wellcome Functional 
Genomics Facility at the University of Glasgow for mass spectrometry (MS) analysis. 
The bands were trypsin digested and the extracted peptides were desalted manually 
before using Q-Star Pulsar™ LC/MS/MS (Applied Bio systems, UK) for sequence 
analysis of the peptides. The resulting LC/MS/MS data were then searched in-house 
using Mascot™ software (www.matrixscience.comi equipped with translated databases 
(NCBI) for protein identification.
2.2.3,4. Immunoblotting
To confirm cross reactivity of anti-human CRP and porcine CRP, immunoblotting was 
performed. Proteins (including human CRP (Sigma)) were transferred hom SDS- 
PAGE acrylanhde gels onto nitrocellulose membranes (BioRad) at lOOV for 1 hi* using 
the Mini Trans-Blot cell (Bio-Rad) in transfer buffer (25 mM Tris, 192 mM glycine, pH
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8.3, 20% (v/v) methanol). Following protein transfer, the membranes were blocked 
with 1% (w/v) BSA in Tris buffered saline (TBS) with 1% v/v Tween-20, (100 mM 
Tris, 150 mM NaCl (VWR International Ltd.), pH 7.4 (TTBS)). The membranes were 
then incubated for 1 hr with rabbit anti-human C-reactive Protein (IgG fraction) (C3527, 
Sigma) diluted 1:1000 in TTBS, washed in TTBS and then incubated with HRP 
conjugated goat anti-rabbit IgG (Abeam, UK) diluted 1: 2000 in TTBS for 30 min. The 
membrane was washed with TTBS tlu'ce times and developed using the Opti-4CN 
Substrate Kit (BioRad).
2.2.3.5. Conjugation o f  Phosphocholine to Bovine Serum Albumin
All reactions were earned out at room temperature unless othemise stated and were 
based on the protocol of Eckersall et al. (1989a). Cytidine-5’-diphosphocholine 
(CDPC) (75 mg) in 0.5 ml 1 M NaOH, pH 8.4 was oxidised for 20 min in 2.5 ml 0.1 M 
sodium periodate (in 0.1 M NaOH, pH 8.4). Following oxidation, the remaining 
periodate was destroyed by addition of 0.15 ml IM ethylene glycol. Bovine serum 
albumin (140 mg) was dissolved in 5 ml 0.01 M NaHCOs, pH 9.6 and added to the 
activated CDPC. The pH of the reaction was maintained at pH 9.6 for 1 hi- using 5% 
(w/v) Na2CÜ3, after which, reduction was performed overnight using 5 ml 0.5M sodium 
borohydride. The resulting solution was dialysed overnight at 4°C against 0.05 M Tris, 
pH 7.4, with 3 changes of buffer. To detei-mine the outcome of the conjugation, the 
absorbance of the conjugate was measured at 280 nm and 270 nm using a Hitachi U- 
1500 Spectrophotometer with a successful conjugation shown by a shift in absorbance 
maximum from 280 nm to 270 nm due to the presence of conjugated PC-BSA.
42
2.2.3.6. Preparation o f  Stan dard Pool o f Porcin e Serum
A  pool of porcine serum was made (n=10), and the pCRP concentration was determined 
by use of the Tridelta ELISA to be 70 mg/L. This pool was aliquoted and stored at 
-20°C until use as a standard in the pCRP assay.
2.2.3.1. Reagents and Buffers
The different buffers used throughout the assay are detailed below. The coating buffer 
was 0.01 M NaHCO], pH 9.4. The assay buffer was TBS-CT (0.05 M Tris, 0.15 M 
NaCl (VWR International Ltd.), 0.02 M CaCh, 0.1% Tween-20, pH 7.6); this buffer 
was made fresh every day. All buffers and reagents were applied at 200ql per 
microwell.
2.2.3.8. Assay Procedure
The assay conditions were optimised to achieve the best perfonnance from the assay as 
described in section 2.3.3.9. The following protocol describes the final optimised 
conditions.
Coating
Two hundred microlitres of PC-BSA (diluted 1:400 in coating buffer) was applied to 
each microwell of a microtitre plate (Costar®, Corning Incorporated, Corning, NY, 
USA) and incubated at 4°C overnight. Coated plates could be prepared up to 3 days in 
advance.
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Washing
The ELISA plate was washed by filling the wells with assay buffer, shaking the plate 
and decanting. This was repeated 3 times.
Blocking
Unoccupied binding sites were blocked with 250 pi of 1% (w/v) BSA in saline applied 
to each microwell and the plate incubated at 37°C for 1 hr. This was followed by 
washing in assay buffer as described.
Sample Dilution and Loading
Either sample or standard (200 pi) was applied in duplicate and incubated at 37°C for 1 
hi' followed by washing in assay buffer. The standards (equivalent to a range 0 - 7 0  
mg/L) were prepared by diluting a pooled serum standard 1:1000 in assay buffer and 
serially diluting to give concentrations of 70, 35, 17.5, 8.75, 4.38 and 2.19 pg/L. 
Samples were diluted 1:2000 in assay buffer. Samples reading outside the range of the 
assay were re-assayed at an appropriate dilution. Internal controls of high, mid and low 
concentrations (determined previously by the commercial ELISA) were applied in 
duplicate and a blank (assay buffer only) applied in quadruplicate.
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Primary Antibody Addition
Rabbit anti-human C-reactive Protein (IgG fraction) (Sigma) diluted 1:3000 in assay 
buffer was dispensed (200 pi) to each well and incubated at 37°C for 1 hr followed by 
3x washing in assay buffer.
Secondary Antibody Addition
HRP conjugated goat anti-rabbit IgG (Abeam) diluted 1:5000 in assay buffer was 
applied (200 pi) and incubated at 37°C for 1 hr followed by 3x washing in assay buffer.
Substrate Addition
Tetra methyl benzidine (KPL) was prepared according to manufacturer instructions and 
200 pi dispensed into each well. The ELISA plate was incubated at room temperature 
for approximately 5-7 minutes to allow the colour to develop. The enzyme reaction was 
stopped by the addition of 100 pi of 1 M HCl.
Absorbance
The absorbance was measured at 450 nm using the FLUOstar OPTIMA platereader 
(BMG Labtech Ltd.) and the results analysed and calculated by the associated 
FLUOstar Optima Software V1.32 R2 using a 4 Parameter fit standard curve plotted on 
a linear scale.
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2.2.3.9. Assay Optimisation
Antibody Concentration
The optimal dilution of the antibody was deteirained by varying the antibody 
concentrations while keeping other variables constant. The aim was to identify the 
concentration of antibody that gave the maximum optical density (OD) for the highest 
standard and gave a straight standard cuiwe, with low OD for the blanks. This was 
repeated using varying concentrations (1:2000 to 1:5000) of the primary antibody in 
order to find the optimal combination. The secondary antibody was optimised in a 
similar fashion
Optimisation o f Standard and Sample Dilution
The standard pool was diluted at varying concentrations and then serially diluted in 
order to achieve standard curves over different ranges. The aim was to achieve a 
straight standard curve over a wide range of OD. Internal standards and samples were 
diluted at varying concentrations until they were able to be read on the linear section (0 
-  35 mg/L) of the standard curve.
Blocking Agents
The ELISA was earned out using 5% (w/v) dried milk in saline or 1% (w/v) BSA in 
saline at the blocking step and the optical density for the blank samples were compared 
over 5 separate occasions.
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2.2,3.10. Assay Validation
Specificity
Specificity was assessed by immunoblotting of purified pCRP and porcine acute phase 
sera as previously described in Section 2.2.3.4.
Precision
Intra-assay precision was determined by calculating coefficients of variation (CVs) of 
three samples with different CRP concentrations, replicated 4 times in the same assay 
run. To determine the inter-assay precision, CVs were calculated for the duplicates of 
the same semm samples over 21 runs during the use of the assay.
Accuracy
Accuracy was investigated by linearity under dilution of 3 semm samples with varying 
CRP concentration.
Limit o f  detection
The limit of detection was calculated as the lowest concentration of CRP which could 
be distinguished from a zero value, and was taken as the mean +2 standard deviations of 
4 replicates of the blank samples.
47
2.2,3.11. Comparison to Oth er Meth ods
In order to confiiin that the assay developed was comparable to the existing commercial 
assay, the concentration of CRP in 57 previously analysed (Tridelta ELISA) serum 
samples were also measured on the in-house ELISA. The results were compared using 
regi'ession analysis.
2.2.4. Development of a Sandwich ELISA using Anti-Porcine CRP
2.2.4.1. Purification o f  Porcine CRP and Antibody Production
Purification of porcine CRP was earned out previous to this study by Dr F. M. 
Campbell (Faculty of Veterinary Medicine, University of Glasgow) and two antibodies 
produced; a polyclonal sheep anti-porcine CRP (BS/PTU, SNBTS, Penicuik, UK) and a 
chicken anti-porcine CRP (IgY antibody) (BS/PTU, SNBTS). These antibodies were 
made available for validation and use during this study.
2.2.4.2. Cross reactivity o f Anti-Porcine CRP to Antigen
hi order to test the reactivity of the antibody, gel electrophoresis of purified pCRP and 
porcine acute phase sera was carried out as previously described and the proteins 
transferred onto nitrocellulose membranes (BioRad) at lOOV using the Mini Trans-Blot 
cell (Bio-Rad) in transfer buffer (25 mM Tris, 192 mM glycine, pH8.3, 20% (v/v) 
methanol). Following protein transfer, the membranes were blocked with 10% (w/v) 
non-fat milk in Tris buffered saline (TBS), (50 mM Tris, 100 mM NaCl (VWR 
International Ltd), pH 7.4) with 0.1% (v/v) Tween-20 (TTBS). The membranes were
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incubated for 1 hr with either sheep anti-porcine CRP diluted 1:500 in TTBS or chicken 
anti-porcine CRP diluted 1:500 in TTBS , washed in TTBS and then incubated with 
HRP conjugated goat anti-sheep IgG (Abeam) diluted 1:1000 in TTBS for 30 min or 
HRP conjugated goat anti-chicken IgY (Abeam) diluted 1:1000 in TTBS for 30 min. 
The membrane was then washed with TTBS three times and developed using the Opti- 
4CN Substrate Kit (BioRad).
2.2.4.3. Antibody Processing
In order to remove non-specific antibodies from the antibodies to pCRP, the anti-serum 
was adsorbed against a solid phase reagent prepared fr om CRP depleted porcine serum 
by glutaraldehyde (Avrameas and Temynck, 1969) prepared as below. This technique 
is based upon the covalent cross-linking of proteins with glutaraldehyde which provides 
specific and efficient immunoadsorbents for the purification of antibodies (or antigens).
2.2.4.4. Preparation o f  Immunoadsorbent
One millilitre of IM acetate buffer pH 5 was added to 10ml of porcine CRP-depleted 
serum (the by-product of the purification of pCRP (Section 2.2.41). The pH of the 
solution was checked for acidity (< pH 5 desired) and if required, more buffer was 
added until <pH 5 was reached. Thiee millilitres of 2.5% aqueous glutaraldehyde was 
added drop wise to this solution while stimng gently and within 30 minutes a gel was 
formed. Gentle stimng continued for 3 hr at room temperature.
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The resulting gel was mixed with 200 ml 0.2M phosphate buffer pH 7.2 -  7.4 (0.2 M 
Na2HP0 4 2 H2 0 , 0.2 M NaH2P0 4 2 H2 0  mixed to pH) and homogenised (Ultra-turrax 
T25, Janke & Kunkel, IKA® Labortechnik, Germany) before being centrifuged at 1210 
xg for 15 min at 4°C. The supernatant was removed and the process repeated one time. 
The gel was then mixed with 200 ml 0.1 M Glycine-HCl buffer pH 2.8, homogenised, 
centrifuged at 1210 xg for 5 min at 4°C and the supernatant removed. This was again 
repeated. The gel was then washed with 0.2 M phosphate buffer pH 7.2 -  7.4 and 
centrifuged at 1210 xg for 5 min at 4°C and the supernatant removed. The optical 
density (OD) of the supernatant was read at 280nm and the process repeated until the 
OD of the supernatant read 0. The gel was then immediately used or stored in 
phosphate buffered saline (PBS) at 4°C.
2.2.4.5. Use o f Immunoadsorbent
To a volume of the immunoadsorbent gel, an equivalent volume of antibody was added. 
This solution was mixed overnight at 4°C and then centrifuged at 1210 xg for 15 
minutes at 4°C. The supernatant (adsorbed anti-porcine CRP) was removed and stored 
for use. The immunoadsorbent was washed tlu*ee times with PBS, two washes with 
O.IM Glycine-HCl pH 2.8 and tlnee washes with saline. The gel was then ready for 
further use or stored in PBS at 4°C.
Following adsorption, the specificity of the antibody was checked by gel electrophoresis 
and immunoblotting as described above.
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2.2.4.6. Purification o f  Sheep Anti-Porcine CRP IgG Fraction
The IgG fraction was purified from the antiserum by affinity cluomatography using an 
AKTA FPLC system (Amersham Biosciences) running Unicom v4 software. Ten 
millilitres of the adsorbed antiseram was applied at 1 ml/min to a 5 ml HiTrap Protein G 
HP column (Amersham Biosciences) equilibrated with 20 mM sodium phosphate pH 7. 
The column was washed with this buffer until the absorbance returned to baseline 
levels. The bound IgG was eluted with 0.1 M Glycine-HCl, pH 2.7 at 5ml/min. The 
IgG containing fraction was collected, buffer exchanged and concentrated into TBS 
using Centricon centrifugal devices (Millipore) and stored in aliquots at -20°C. The 
specificity of the antibody was checked by immunoblotting as previously stated.
2.2.4.7. Purification and Processing o f  Chicken Anti-Porcine CRP IgY
Purification of chicken anti-porcine CRP IgY was carried out by Mrs M. Robinson 
(Faculty of Veterinary Medicine, University of Glasgow) using the Eggcellent™ 
Chicken IgY Purification Kit (Pierce, Rockford, IL. USA). The purified antibody was 
then processed as described in Section 2.3.4.5.
2.2.4.8. Biotinylation
The IgG fraction of the sheep anti pCRP antibody was then biotinylated. This process
was carried out by Dr. L. Bence (Faculty of Veterinary Medicine, University of
Glasgow) using an ImmunoProbe™ Biotinylation Kit (Sigma).
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2.2,4.9. Preparation o f  Standard Pool
As previously stated in Section 2.3.3.6.
2.2.4.10. Reagents and Buffers
The different buffers used throughout the assay are detailed below. The coating buffer 
was 50 mM NaHCOs, pH 9.6. The assay buffer was TTBS (50 mM Tris, 100 mM NaCl 
(VWR International Ltd.), 0.05% (v/v) Tween-20, pH 7.4). All buffers and reagents 
were applied at 100 pi per microwell.
2.2,4.11. A ssay Procedure
The following protocol describes the best optimised conditions for this assay.
Adsorbed chicken anti-porcine CRP IgY (200pl), at a concentration of 500 ng/well, 
diluted in coating buffer was bound to microtitre plates (Maxisorp, Nunc, Demnark) and 
incubated for 2 hi* at 37°C. The plate was then blocked with 250pl of 1% (w/v) BSA in 
assay buffer for 1 hi* at 37°C. Following incubation, the plate was washed 3 times in 
assay buffer, and then standards or samples were applied for llir at 37°C. Following 
incubation, the plate was washed 3 times and biotinylated sheep anti-porcine CRP IgG 
was applied at 1:2000 (diluted in assay buffer) and the plate incubated for 1 In* at 37°C. 
Following washing, streptavidin peroxidase (Abeam) (1:1000 dilution) was applied and 
the plate incubated for 1 hr at 37 °C. Thi'ee washes in assay buffer followed and then 
freshly made TMB (KPL) applied. The colour was allowed to develop at room
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temperature and the reaction stopped by the addition of 50 pi 1 M HCl. The absorbance 
was measured at 450 nm using the FLUOstar OPTIMA platereader (BMG Labtech Ltd.) 
and the results analysed by the associated FLUOstar Optima Software V1.32 R2 using a 
4 Parameter fit standard cuiwe plotted on a linear scale.
2,2,4.12. Assay Optimisation
Assay optimised as previously described in Section 2.2.3.9.
Antibody Concentration
This was earned out as previously described, by applying varying concentrations 
(1:2000 to 1:5000) of biotinylated anti-porcine CRP.
Optimisation o f Standard and Sample Dilution
The standard pool was diluted at varying concentrations and then serially diluted in 
order to achieve standard curves over different ranges. Samples were diluted at varying 
concentrations until they were within the linear section of the standard curve.
Blocking Agents
This was carried out as previously described in Section 2.2.3.9.
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2.2.4.13. Comparison to Other Methods
In order to confirm that the assay developed was comparable to the existing commercial 
assay, 17 serum samples which had previously been measured using the commercial 
assay were also measured on the ELISA. The conelation between the two CRP values 
was then analysed using Microsoft Excel.
2.2.5. Development of immunoturbidimetric assay
2.2.5.1. A ntibody Preparation
Polyclonal sheep anti-porcine CRP was adsorbed as previously described in Section
2.3.4.5. and the IgG fraction purified as described in Section 2.2.4.6.
2.2.5.2. Preparation o f  Standards
Sera from animals with known high concentrations of CRP were pooled and the CRP 
concentration quantified using the Tridelta ELISA. The pool had a concentration of 125 
mg/L. Standards over a range of 0 - 125 mg/L were then prepared by dilution of the 
pool in TBS (50 mM Tris, 150 mM NaCl (VWR International Ltd.), pH 7.4).
2.2.5.3. Assay Procedure
The following protocol describes the best optimised conditions for this assay on a Cobas 
MIRA analyser (Roche Diagnostics, Switzerland).
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The analyser was programmed to mix 150pl of assay reagent (6% (w/v) polyethylene 
glycol in TBS) with 7.5pl of serum (standard or sample) in a reaction cuvette. Twenty 
five microlitres of antiserum was then added and the increase in absorbance at 340 nm 
was monitored every 25 seconds for a total of 25 readings. In order to calculate the 
concentration of CRP in samples, the change in absorbance from each sample was 
compared to the results obtained using the standard curve, with results reported in mg/L. 
To aid assay development, raw data was consulted showing the change in absorbance at 
each individual assay point within each sample or standard.
2.2.5.4. Assay Optimisation
Antibody
Both adsorbed sheep anti-porcine CRP antisemm and the IgG fraction of the antisera 
were utilised and the results compared.
Antibody Volume
A range of antibody volumes (25 -  35 pi) were tested in order to find the optimal 
volume for the assay
Number o f Readings
The number of readings (at 25 sec intervals) was varied from 25 to 35 until the optimal 
condition for the assay was found.
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2.2.5.5. Comparison to other methods
In order to confirm that the assay developed was comparable to the existing commercial 
assay, the concentration of 15 serum samples which had previously been measured were 
also measured using this assay. The correlation between the two assays was then 
analysed.
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2.3.Results
2.3.1. Development of ELISA using Anti-human CRP
2.3.1.1. Purification o f  Porcin e CRP
As shown by the chromatograms in Figure 2.2, the purification step on affinity 
cliromatography yielded a distinct single peak eluting after the buffer changed to 0.1 M 
Tris, 0.1 M NaCl, 2 niM EDTA, pH 8-8.5, in both primary and repeat column runs. The 
eluted sample, as shown in Figure 2.3, consisted of 2 bands of 23 and 27 kDa and two 
bands at approximately 60 kDa and 110 kDa. The bands at 23 and 27 kDa were 
confimied as porcine CRP after MS fmgeiprint data was examined using Mascot™ 
MS/MS Ions Search Analysis. This showed protein identity matches to accession 
number AB005546 (porcine CRP). See Appendix A for printout of the Mascot'^*^ 
search. The 60kda band was identified as porcine serum albumin, the 110 kDa was not 
analysed at this time.
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Figure 2.2: Elution profile of porcine CRP obtained from affinity 
chromatography. A: Primary purification of porcine CRP from serum using affinity 
cfu omatography. B: Repeated purification of porcine CRP from eiuate obtained in A. 
Initial buffer was 0.1 M Tris, 0.1 M NaCl, 2 mM CaClz, pH 8-8.5 and was changed to 
0.1 M Tris, 0.1 M NaCl, 2 mM EDTA, pH 8-8.5 as indicated.
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Figure 2.3: SDS-PAGE showing porcine acute phase serum (Lane 1) and purified 
porcine CRP after primary and repeat chromatography (Lane 2).
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2.3.1.2. Cross Reactivity between anti human CRP and porcine CRP
Western blotting showed cross-reactivity between the porcine CRP band at 23 kDa and 
anti-human CRP (Figure 2.4) with a minor band at 20 kDa but no reaction with the 27 
kDa, 60 kDa or the -110 kDa bands on the gel. In addition, human CRP was run as a 
positive control and showed similar reactivity at 25 kDa.
2.3.1.3. Conjugation o f  phosphorylcholine to bovine serum albumin
After the conjugation there was a shift in absorbance maximum in the reaction ftom 
0.484 at 280 nm to 0.532 at 270 nm. The concentration of PC-BSA stock solution was 
assessed as a relative value using the extinction co-efficient of BSA which is 0.67. The 
calculated value was 72.2. Future batches of the PC-BSA will be diluted to this 
concentration for future use.
2.3.1.4. Preparation o f  Standard Pool
The standard pool of serum was detei*mined by the commercial assay to have a CRP 
concentration of 70 mg/L.
2.3.2. Assay Optimisation
During assay optimisation, graphical results are shown after the blank OD has been 
subtracted from the raw data, unless other-wise stated.
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2.3.2.1. Antibody concentrations
During the optimisation process, a range of primary antibody concentrations were 
assessed, however, the final optimisation step compared the two dilutions; 1:2000 and 
1:3000 as shown in Figure 2.5A. A final concentration of 1:3000 was chosen as it gave 
a reasonably steep cuiwe and covered a wide range of OD values whilst giving lower 
blank readings than the 1:2000 dilution.
The secondary antibody was optimised in a similar fashion and the final optimisation 
process used 2 dilutions; 1:4000 and 1:5000 as shown in Figure 2.5. A secondary 
antibody concentration of 1:5000 was chosen as it resulted in a smoother curve, gave a 
good range of OD values and had lower blank readings. It also had a reasonable 
development time (-10 min) whilst the 1:4000 dilution developed overly fast (-3 min).
2.3.2.2. Optimisation o f  standard and sample dilution
The assay optimisation process required the preparation of a working standard curve. 
This was achieved by diluting the standard pool in assay buffer at a 1:1000 dilution and 
serial dilutions to give standards of 2.19 -  70 pg/L. An example of the standard cuiwe is 
shown in Figure 2.6. Samples were diluted until they read accurately on the linear 
portion of the standard curve. Dependent upon the CRP content, this was at either 
1:2000 or 1:4000 in assay buffer.
2.3,2.3. Blocking agen ts
The results of the blank samples with the different blocking agents are shown in Figure
2.7. Both blocking agents gave similar OD values however 1% BSA was chosen over
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5% milk as it gave consistent values for OD whereas 5% milk showed some 
fluctuations.
During optimisation, each step was assessed by running samples which had previously 
been measured on the commercial assay. If there was little correlation between results 
of the two assays, the optimisation step was continued until the correlation was 
considered acceptable.
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Figure 2.4: Cross reactivity of porcine CRP and anti-human CRP. A: SDS- 
PAGE gel o f human CRP (Lane 1) and porcine CRP (Lane 2). Double arrows 
indicate position of porcine CRP at 27 and 23 kDa. B: Western blot with anti-human 
CRP showing reactivity with human CRP (Lane 1) and porcine CRP (Lane 2). 
Double arrows cross reactivity at 23 kDa and at a ~20 kDa band not visible on the 
SDS-PAGE gel. No cross-reactivity was seen with the 27 kDa band.
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Figure 2.5: Optimisation of antibody concentrations for the developed ELISA. A:
The effect of the anti-human CRP concentrations at 1:2000 and 1:3000. The 1:3000 
dilution gave a range of OD values and lower blanks than 1:2000. B: The effect of the 
HRP conjugated antibody concentrations at 1:4000 and 1:5000. The 1:5000 dilution 
gave a range of OD values and lower blanks than 1:4000.
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Figure 2.6: Standard curve obtained from optimised standard pool dilution.
Standard pool diluted 1:1000 to 70 pg/L, then by serial 1:2 dilution.
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Figure 2.7; Effect of different blocking agents on the zero value of the blank 
samples on 5 separate occasions.
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2.3.3. Assay Validation
2.3.3.1. Precision
The intra-assay CYs were in the range of 1.98 -  11.63% and inter-assay CVs were in 
the range of 5.75 -  10.43%, showing acceptable precision (Table 2.1).
2.3.3.2. Accuracy
Accuracy was investigated by serial dilution of 3 serum samples and is shown in Figure
2.8. The tln-ee samples show linearity then plateau out at low dilution and are parallel to 
the standards. Diluted sample concentrations were taken from the linear portion of the 
cui've (this is the most precise and accurate area o f the curve).
2.3.3.3. Limit o f detection
The minimum detection limit significantly different from the blank samples was taken 
as the CRP concentration at 2 standard deviations (SD) from the mean of blank sample 
(n=4). This resulted in a limit of detection of CRP in serum of 0.016 mg/L.
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Table 2.1: Inter- and intra-assay precision results obtained for ELISA with serum 
samples.
n Intra-assay n Inter-assay
CRP (mg/L) ±SD CV CRP (mg/L) ±SD CV
Sample 1 4 240 ± 5 1.98 21 236 ± 14 5.75
Sample 2 4 565 ± 66 11.63 21 446 ± 47 10.43
Sample 3 4 109 ± 4 3.22 21 105 ± 6 6.13
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Figure 2.8: Linearity of 3 porcine serum samples after serial dilution. Example of 
standard cui've included for comparison.
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2.3.3.4. Comparison to other methods
The concentrations of CRP in the serum samples measured by both the commercial 
assay and the developed assay are shown in Figure 2.9. A total of 57 serum samples 
were measured by both assays and the comparison between them revealed a significant 
conelation of r = 0.841 (p<0.001) and regi'ession equation of y=1.1495x + 11.146.
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Figure 2.9: Correlation between measurements of CRP in 57 serum samples using 
a commercial ELISA (Phase Range™ Porcine C-reactive protein assay, Tridelta 
Development Pic., Ireland) (horizontal axis) and the developed ELISA (vertical 
axis).
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2.3.4. Development of Sandwich ELISA
2.3.4,1. Adsorption o f Sheep Anti-porcine CRP with Depleted Serum
Sheep anti-porcine CRP was adsorbed against depleted serum (as described in Section 
2.3.4.3), the cross-reactivity of the adsorbed antisera was assessed by western blot as 
demonstrated in Figure 2.10.
2.3.4.2. Preparation o f  IgG Fraction o f  Sheep Anti-porcine CRP
As shown by the clii'omatogram in Figure 2.11, the purification of IgG on a Protein G 
column yielded a distinct single peak. The specificity of this antibody was then checked 
against pCRP and porcine acute phase sera using SDS-PAGE and western blotting as 
shown in Figure 2.10.
2.3.4.3. Cross Reactivity o f  Sheep Anti-porcine CRP to Porcine CRP
Western blotting showed cross-reactivity between all tlii'ee fractions of the sheep anti- 
porcine CRP (anti-CRP, adsorbed anti-CRP and adsorbed anti-CRP IgG and porcine 
CRP) as shown in Figure 2.10. Cross-reactivity can be seen against the pCRP bands 
and 2 bands at ~ 50 and 75 kDa. The IgG haction was then chosen for biotinylation and 
use as a signal antibody in the sandwich ELISA assay.
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23.4.4. Cross reactivity o f chicken anti-porcine CRP to porcine CRP
Western blotting showed cross-reactivity between the two fractions of the chicken anti- 
porcine CRP; anti-CRP and adsorbed anti-CRP as shown in Figure 2.12. Reactivity was 
seen against the pCRP bands at 23 and 27kDa and bands at ~ 50 and 75 kDa. The 
specificity of the anti-serum can be seen to increase with the processing steps and the 
adsorbed fraction was chosen for use as capture antibody in the sandwich ELISA assay.
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Figure 2.11; Elution profile of sheep anti-porcine CRP IgG obtained from affinity 
chromatography on a Protein G HP column.
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Figure 2.12: Cross reactivity between chicken anti-porcine CRP fractions and 
porcine acute phase serum (Lane 1) and porcine CRP (Lane 2). A: Western blot 
with chicken anti-porcine CRP. B: Western blot with adsorbed chicken anti-porcine 
CRP. CRP bands are indicated by double arrows at 27 kDa and 23 kDa.
76
2.3.4.5. Assay Optimisation
Antibody Concentration
During the optimisation process, a range of biotinylated anti-porcine CRP IgG 
concentrations were used. The two most effective, 1:2000 and 1:5000 are shown in 
Figure 2.13. The 1:2000 dilution was selected as it gave a wider range of OD values 
and gave a reasonably steep curve when compared to the 1:5000 dilution.
Optimisation o f  Standard and Sample Dilution
In order to achieve a working standard curve, a pool of serum standard was diluted in 
assay buffer at a 1:1000 dilution. An example of a standard curve is shown in Figure
2.14. Samples were diluted until they could be read on the linear portion of the curve.
Blocking Agents
The results of the blank samples with the different blocking agents are shown in Figure
2.15. 1% BSA was chosen over the 5 % milk as it gave consistently lower OD values.
2.3.4.6. Comparison to other methods
The concentrations of CRP in the serum samples measured by both the Tridelta ELISA 
and the developed sandwich ELISA are shown in Figure 2.16. An outlier was apparent 
(at -1000 mg/L by the commercial ELISA), however considering the high concentration 
it is possible that the measurement by the commercial ELISA is inaccurate, the value 
was left in the analysis for a true representation. The comparison between them 
revealed a low correlation of r=0.44 and a regression equation of y=0.2036x.
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Figure 2.13: Optimisation of antibody concentrations for the developed ELISA.
The effect ofbiotinylated sheep anti-porcine CRP IgG concentrations at 1:2000 and 
1:5000. The 1:2000 dilution gave a wider range of CD values and a smoother curve 
than the 1:5000 dilution.
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Figure 2.14: An example of a standard curve obtained from optimised standard 
pool dilution. Standard pool diluted 1:1000, then by serial 1:2 dilution.
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Figure 2.15: Effect of different blocking agents on the zero value of the blank 
samples.
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Figure 2.16: Correlation between measurements of CRP in serum samples using a 
commercial ELISA (Phase Range *^'  ^Porcine C-reactive protein assay, Tridelta 
Development Pic., Ireland) (horizontal axis) and the developed ELISA (vertical 
axis).
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2.3.5. Development of an Immunoturbidimetric Assay
2.3,5.1, Assay Optimisation
Antibody Choice
The two antibody preparations selected for this assay; adsorbed sheep anti-porcine CRP 
and sheep adsorbed anti-porcine CRP IgG, were compared. The effect of these two 
antibodies on the calibration curve obtained on the MIRA analyser is shown in Figure 
2,17. The adsorbed Anti-CRP was chosen for use and further development as it had 
much higher rate of reactions with a max of 0.19 (Figure 2.17B) than the IgG fraction 
with a max of 0.04 (Figure 2.17A).
Antibody Volume
The effect of changing the antibody volume in the reaction is shown in Figure 2.18. 
Similar results were obtained for the 3 volumes tested; however, a volume of 25 pi was 
selected as it gave a linear calibration curve and prevented wastage of antibody.
Reaction Time
The effect of changing the reaction time by adjusting the number of readings in each 
reaction during the assay is shown in Figure 2.19. Twenty-five readings (625 sec) were 
chosen for use as this gave a linear calibration curve with a shorter assay time.
82
Limit o f Detection
Blank samples (assay buffer) were assessed in each assay mn. However, a value of 
>0.08 mg/L was frequently given for these samples and low pCRP concentrations (<5 
mg/L) were unable to be determined accurately.
2.3.5.2. Comparison with other methods
The concentrations of CRP in the serum samples measured by both the Tridelta ELISA 
and the developed immunoturbidimetric assay are shown in Figure 2.20. Two outliers 
were apparent measured at approximately 25 and 55 mg/L by the commercial assay, 
however the immunoturbidimetric assay consistently measured them higher. These 
were left in the correlation analysis to represent the true nature of the assays. The 
comparison between them revealed a correlation of r=0.62 and regression equation of 
y=1.0268x+ 10.413.
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Figure 2.17: Comparison of antibodies for use in immunoturbidimetric assay. A:
Calibration curve when sheep anti-porcine CRP IgG used in assay. B: Calibration 
cui*ve when using adsorbed sheep anti-porcine CRP in assay. Note difference in scale 
of y-axis.
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Figure 2.18: Comparison of antibody volumes for use in immunoturbidimetric 
assay.
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Figure 2.18: Comparison of antibody volumes for use in immunoturbidimetric 
assay. A: Calibration curve when 35 |.il of antibody used. B: Calibration curve when 
30 pi of antibody used. C: Calibration curve when 25 pi of antibody used.
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Figure 2.19: Comparison of the number of readings during reaction.
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Figure 2.19: Comparison of the number of readings during reaction. A:
Calibration curve showing effect of 25 readings. B: Calibration cuiwe showing effect of 
30 readings. C: Calibration curve showing effect of 35 readings. Changing the number 
of readings had little effect on rate of reaction.
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Figure 2.20: Correlation between simnltaneons measurements of CRP in serum 
samples using a commercial ELISA (Phase Range™ Porcine C-reactive protein 
assay; (horizontal axis) and the developed assay (vertical axis).
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2.4,Discussion
C-reactive protein is considered a major APP in pigs and is frequently measured in 
health studies (Petersen et a l, 2001), A commercial assay has been validated for use in 
the measurement of porcine CRP but the use of commercial assays can prove costly and 
the results may be imprecise, particularly at low concentrations (Tecles et a l, 2007). 
Various ‘in-house’ assays have been developed including ELISA and 
immunoturbidimetric assays and have been validated for use (Sorensen et a l,  2006, 
Kjelgaard-Hansen et aL, 2003). A number of these assays are based upon the cross 
reactivity o f porcine CRP with human anti-CRP. The aim of this study was to develop 
an in-house ELISA for the measurement of porcine CRP in serum which would later be 
used in a study of a commercial pig population.
Previous to this study, porcine CRP had been purified and two polyclonal antibodies 
produced; a sheep anti-porcine CRP and a chicken anti-porcine CRP. Initial results 
revealed a high amount of non-specificity in both antibodies when tested against acute 
phase sera and CRP by immunoblotting. Processing of the antibodies by using a solid 
phase porcine serum depleted of CRP removed some of the non-specific reaction, and in 
the case of the adsorbed sheep anti-porcine CRP, an IgG fraction was purified from the 
adsorbed antisera using a Protein G HP column, which also improved specificity. 
Immunoblotting still showed slight background reactivity using the adsorbed anti- 
porcine CRP IgG against acute phase porcine serum and in particular a band was 
present at ~105-115kDa. However, as the pCRP bands appeared stronger in the 
western blot than the non-specific binding, the antibody was considered suitable for use, 
particularly in the sandwich ELISA where the specificity of 2 antibodies was combined.
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Two assay formats were initially developed with these antisera; an 
immunoturbidimetric assay and a sandwich ELISA. The immunoturbidimetric assay 
which would have the advantage of being an automated assay, used the sheep anti- 
porcine CRP. Initial optimisation showed that the absorbed antibody gave higher rates 
of reaction than the absorbed IgG fraction and this was further optimised with regards to 
number of readings and volume of antibody added to the reaction mixture. A small 
number of samples were tested on this assay (n=15) and the initial coiTelation was 
1- 0 .6 2 . Although further work could have improved the assay its major disadvantage 
assay was its inability to detect pCRP at low concentrations (<5 mg/L) thus lower 
values of CRP, which are expected in healthy pigs (for example, the commercial herd 
analysed in chapter 3 had CRP concentrations ^ .9  mg/L), could not be read accurately 
by the analyser. As a result a different assay format was tried.
The sandwich ELISA used both the sheep anti-porcine CRP IgG and a biotinylated 
aliquot of the adsorbed chicken anti-porcine CRP. Optimisation of the protocol led to a 
working assay. The assay gave a low correlation (r= 0.44) to CRP concentrations 
determined by the Tridelta assay and on closer inspection, some values varied gi*eatly 
from the previous results. These discrepancies could be attributed to two factors; a) the 
Tridelta ELISA was inaccurate or b) the antibodies were showing non-specific 
reactions. The Tridelta ELISA has been used in the calibration of assays previous to 
this study (Martinez-Subiela et al., 2007, Sorensen et al., 2006), and as a result it was 
deemed that the antibody specificity may have been the factor at fault and development 
of this assay was halted.
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Porcine CRP shows considerable homology to human CRP and cross-reactivity between 
porcine CRP and anti-human CRP has been shown previously (Kjelgaard-Hansen et a l, 
2003, Heegaard et a l, 1998, Eckersall et a l, 1996). Porcine CRP was purified from 
serum and revealed four distinct bands on SDS-PAGE gels, The bands at 23 and 27 
kDa have been reported previously (Martinez-Subiela et a l, 2007) and mass 
spectrometry analysis confrmied porcine CRP identity. The third band was identified as 
semm albumin which has not been removed during the purification process. The fourth 
band (-105-115kDa) has not been described in published papers but may be uni'educed 
CRP (the theoretical mass of CRP is 117 kDa) or an aggi*egate; however this has not 
yet been confirmed by mass spectrometry. The molecular weight of this band does 
conespond to the pentameric structure of the protein. If this were the case, it would 
partially explain the background reactivity observed in the sheep and chicken anti- 
porcine CRP antisera. Immunoblotting with anti-human CRP revealed cross-reactivity 
with the CRP band at 23 kDa and was used as the basis of a ligand binding ELISA. 
Differences in the CRP band patterns and cross-reactivity could be due to changes in the 
glycosylation of CRP as this has been reported in humans (Das et a l , 2003) but as yet, 
no research has been carried out in pigs. A band at 20 IdDa also showed cross-reactivity 
with anti-human CRP which was not visually apparent on SDS-PAGE gels. The 
identity of this band is unknown and has not been previously described in published 
papers but may be a degradation product.
PC-BSA binds to CRP and is produced in a simple reaction, however it should be noted 
that the concentration varies greatly by batch and the ratio of PC to BSA can also vary. 
This entails the production of a sufficient volume for each study and the dilution of the 
PC-BSA in coating buffer should be optimised for each batch. During assay
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development, several factors were optimised including antibody concentrations and 
blocking agents. Dilution of the standard pool and samples revealed parallel curves 
with a plateau at low dilutions.
Assay validation showed that the assay performance was within acceptable limits with 
inter-assay CV values in the range of 5.75-10.43% and intra-assay CV values in the 
range of 1.98-11.63%. In general, CV values should be lower than 10% , however in the 
case of immunoassays, they can be accepted until 20%, particularly if the concentrations 
of the analyte are low (FDA, 2001). The coiTelation with this assay and the Tridelta 
assay was significantly high (r^=0.84, p<0.001), with outliers predominantly in the 
higher range of CRP concentrations. These would be fmlher diluted in practice.
The advantages of this assay over the previously described assays were the specificity 
of the antibody to porcine CRP, the ELISA format allowing high throughput of samples, 
the precision and the low limit of detection. The only disadvantage of this assay is the 
reliance on species cross-reactivity as this must be checked with each batch of antibody. 
This could be overcome by the production of a monoclonal antibody to porcine CRP but 
unfortunately this was beyond the time constraints of this study.
The assay was considered validated for use and was used in the measurement of porcine 
serum samples in Chapter 3 and Chapter 5 o f this thesis.
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Chapter III
3, Acute Phase Protein Concentrations in Serum in a High 
Health Boar Population
3.1. Introduction
A number of studies have shown that APP concentrations in pigs can be indicative of 
the health status of both individual animals and also the herd as a whole (Petersen et a l, 
2002a, Burger et a l,  1992, Hall et a l, 1992, Eckersall, 1987). However, the vast 
majority of these studies have also shown that APP levels may vary not only due to 
health status but also age, breed, sex, faim location and husbandry techniques. In order 
for APP concentrations to be used successfully as health markers, it is first necessary to 
investigate the baseline concentrations of a herd (measured under typical conditions 
with no apparent disease) and to ascertain whether the baseline concentrations are 
influenced by the genetic background of the animal. This allows a ‘normal’ range of 
values to be categorised and used as a reference for future measurements.
3.1.1. APP Concentrations in Healthy Pig Populations
As previously mentioned there is a number of porcine APP. In this study, four APP 
were chosen to be measured. The four selected are among the most widely used and 
investigated APP and are examples of major (CRP and Hp), pig-specific (Pig-MAP) and 
negative (TTR) proteins. This approach allowed the use of commercial tests where 
appropriate and reference material was available for each.
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3,1,1,1, Haptoglobin
As previously discussed, noimal levels of Hp in pigs are generally <1 g/L but there are 
age related changes (Martin et a l, 2005, Petersen et a l, 2002b). Studies have shown 
that specific pathogen free (SPF) pig herds have a significantly lower Hp serum 
concentration than conventional herds (Petersen et a l, 2002b). Interestingly, there are 
significant breed differences in Hp serum concentrations with Meishan pigs showing 
higher Hp concentrations than both the Landrace and Yorkshire breeds (Sutherland et 
a l, 2006). A similar study in commercial pig lines showed a significant difference 
between two lines, however, this was based on only 18 pigs per line (Frank et a l, 2005). 
hi contrast, it has been reported that no differences occur in Hp concentration between 
Meishan and Large White (LW) breeds (Clapperton et a l, 2005b).
3.1.1.2. C-Reactive Protein
Normal concentrations of CRP are reported to be below 100 mg/L but little research has 
been performed to examine the effects of age or the difference between SPF and 
conventional herds of pigs on semm concentrations (Pallares et a lln  press). However, 
one study has been carried out in which a significant difference was found between the 
CRP serum concentrations of two different commercial lines (Frank et a l, 2005).
3.1.1.3, Pig-MAP
Normal concentrations of Pig-MAP are categorised as being 0.4 -  0.6 g/L and changes 
in concentrations (a sharp increase followed by a gradual decrease) due to age are 
exhibited until weaning (Martin et a l, 2005, Carpintero et a l, 2005). Differences in
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Pig-MAP semm concentration between breeds has been reported with Meishan pigs 
having a significantly higher Pig-MAP concentration than LW (Clapperton et a l, 2007).
3.1.1.4, Transthyretin
Very few studies have been earned out in which the baseline concentrations of TTR 
have been measured. The two most significant studies show a gi*eat deal of variance in 
their noimal measurements with reports of a mean of approximately 300 pg/ml 
(Campbell et a l, 2005) and approximately 150 pg/ml (Pineiro et a l, 2007b). No 
studies have been carried out to investigate the effects of breed, sex or fami health status 
on TTR serum concentrations.
3.1.2. Correlations between APP Concentrations
Several studies have investigated the coiTelation between APP concentrations in pigs. It 
has been reported that Pig-MAP and Hp are significantly correlated (r = 0.57; p<0.05), 
and it is hypothesised that this may be due to both being induced by IL-6 and having 
similar kinetics o f production (Clapperton et a l, 2007, Pineiro et a l, 2003). The 
studies found no coiTclations between either Hp or Pig-MAP and AGP or TTR.
The aim of this study was to detemiine the concentrations of four APP (Hp, CRP, Pig- 
MAP and TTR) in a high health boar population. In addition to the average herd APP 
concentrations, the difference in APP concentrations across pig lines was also 
investigated.
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3.2.Materials and Methods
3.2.1. Animals
A high health population of 397 boars was made available for this study by Genus, Pic
(PIC). The pigs were bom between April 2004 and December 2005 and were bled at
approximately 7 months o f age and again approximately 1 month later. The population 
comprised 7 pig lines representing current commercial sire and dam line genetics;
-  Line A: Landrace {n = 47)
-  Line B: Large Wliite (LW) ( n - 52)
-  Line C: Duroc (n = 65)
-  Line D: Synthetic pure line (75% Duroc, 25% LW) (n = 43)
-  Line E; Synthetic pure line (Hampshire based) (/i = 78)
-  Line F: Synthetic pure line bred for growth (« = 56)
-  Line G: Synthetic pure line bred for growth (derived from Line F) {n = 57)
3.2.2. Experimental Design
The plan for the experimental design is given in Figure 3.1. Pigs were bom on 1 of 2 
sites (lA  and IB) which consist of breeding, gestation, fan'owing and nursery units. All 
pigs were processed within 24 lir of birth; each pig was weighed, identified with ear 
tags, a tissue sample taken for DNA and given an iron dextran injection. At weaning 
(approx 16 days), pigs were transferred to nursery units where they were housed until 
70 days of age. At this time pigs were put ‘on-tesf, pigs were screened and the best
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pigs grouped by line and transfened to sites 2A/B. At this point, pigs were fed by 
electronic feeders in order to gauge feed intake. Off-test measurements for the pigs 
were leg score (front and back), muscle score, weight, teat number, real time ultrasound 
of the 10^ '^  rib areas and feed intake calculated. If selected, pigs were transported to an 
isolation unit (3) before being transferred to the main unit (4), Animals were culled 
from these units if performance traits were not of high enough standard and this was 
assessed on a weekly basis, A few animals were then moved onto the Genesis unit 
(Site 5),
1A -  (n=56) -► 2A
Cull from 3 
4
Cull from 4 
4
18 — (n=349) -► 28
3 -  
(n=397) (n=281)
>  5
(n=4)
8irth W eaning 81ood
collection
8lood 8lood 
collection collection
Figure 3.1: Experimental timeline describing movement of pigs through farm sites 
and blood collection points. lA: Aurora GN, IB: Bluegiass (GN), 2A: Wright’s 
isolation, 2B: Mt, Gilead (nursery), 3: KY AI Isolation, 4: KY AI, 5: Genesis. Blood 
collection was dependent upon age and took place on site 3 at seven months of age and 
either site 4 or 5, approximately one month later.
3.2.3. Farm Health Status
The fanns were all considered to be of a high health status and were porcine 
reproductive and respiratory syndrome (PRRS) negative, M  hyopnenmoniae negative 
and swine influenza vims (SIV) negative. Boars at site lA  (Figure 3.1) were routinely
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vaccinated for H. parasuis, erysipelas and ileitis and for erysipelas and ileitis at site IB. 
Monthly bleeds were carried out by a licensed vet in order to check for notifiable 
diseases and for certification puiposes.
3.2,4. Blood Collection
Blood was obtained by a licensed vet by puncturing the external jugular vein and 
collecting into anticoagulant (EDTA). Tubes were mixed several times and stored on 
ice until returned to the laboratory. Upon return, tubes were centrifuged at 800 xg for 
10 min and the plasma decanted and frozen at -80°C until shipment on ice to the UK, 
On arrival in the UK, tubes were stored at -20°C until required for analysis. Throughout 
this thesis, the samples are refeixed to as serum samples.
3.2.5. Determination of Acute Phase Protein Concentration
Unless otherwise stated, all chemical reagents were purchased from Sigma-Aldrich, 
Poole, UK. Double distilled water was used tlnoughout.
3.2.5.1. Haptoglobin
The concentration of Hp in serum was measured using an automated biochemical assay 
(Eckersall et a l ,  1999). This assay utilises the imiate peroxidase activity of the 
haemoglobin-haptoglobin (Hb-Hp) complex which can be quantified at low pH, The 
use of the novel reagent chromogen, (International Patent Application no. 
PCT/GB98/03407) prevents interference from serum albumin interacting with haem
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from lysed cells which can produce false positive results. A working solution of 
haemoglobin (Hb) was prepai'ed by adding 56 pi of a stock solution of equine Hb (30 
g/L) to 25 ml 0.9% (w/v) NaCl. The substrate was prepared by the addition of 100 pi of 
H2O2 to 25 ml H2O. The reagent used was a stock solution of chromogen buffer 
(courtesy of Mary Waterston, Faculty of Veterinary Medicine, University of Glasgow), 
Standards were prepared using bovine acute phase semm with a Hp concentration of 
1.48 g/L (calibrated against the European Standard for the porcine acute phase proteins: 
European Concerted Action QLK5-CT-1999-0153) and diluted to 0.73 g/L, 0.38 g/L 
with 2% BSA and using the 2% BSA as a zero. Control samples of semm with known 
Hp concentrations, 0.9% NaCl and 2% BSA were run in each assay.
The following protocol for the measurement of Hp on the Cobas MIRA analyser (Roche 
Diagnostics Ltd., Switzerland) was used. Serum (3.5 pi sample or standaid) was mixed 
with 100 pi Hb in the reaction cuvette. After 50 sec, 45 pi chromo gen reagent was 
added, and after a further 25 sec, 25 pi substrate was added. The absorbance at 600 mn 
was measured and the difference in absoiption over the next 50 sec was used to 
calculate a standard curve. The change in absorbance of the samples was compared to 
the standard curve and the results were reported as g/L.
3.2,5.2. C-Reactive Protein
The concentration of CRP in serum was determined using the ligand-binding assay 
developed in Chapter 2. Internal controls were mn in each assay.
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3.Z5.3. Pig-MAP
A  commercial ELISA (PigMAP Kit ELISA, PigCHAMP Pro Europa, Segovia, Spain) 
was used for the measurement of Pig-MAP in serum. This is a sandwich ELISA based 
upon 2 monoclonal antibodies and has been calibrated against a standard of known Pig- 
MAP concentration, according to the European Standard for the porcine acute phase 
proteins.
The assay was used according to the manufacturer’s protocol with all steps carried out 
at room temperature (RT). Briefly, samples and internal controls were applied at a 
1:1000 dilution in assay buffer to antibody coated microwells and incubated for 30 min. 
After washing 4 times with buffer the peroxidase conjugated antibody was applied and 
incubated for 30 min before washing again. Clnomogen substrate solution was added 
and 30 min later, stop solution added, the final absorbance was read at 450 nm using the 
FLUOstar OPTIMA platereader and the results calculated by the associated FLUOstar 
Optima Software V1.32.
3.2.5.4. Transthyretin
A modified in-house ELISA technique was followed to determine the concentration of 
TTR in serum (Campbell et a l,  2005). Microtitreplates (96 well, Nunc) were coated 
with 100 pl/well of either serum samples or internal controls (diluted 1:2000 with 50 
mM NaHCOs, pH 9.6) or purified human prealbumin (TTR) (Sigma) at concentrations 
of 2, 1, 0.5, 0.25, 0.125, 0.0625, and 0.0312 pg/ml (diluted in 50mM NaHCOa.pH 9.6). 
The plates were then incubated overnight at 4°C. Following incubation, the samples
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were decanted and any unbound sites blocked with 250 jal 5% (w/v) non-fat milk in 
PBS-Tween (0.12 M NaCl, 0.02 M Na2HP0 4 , pH 7.4, 0.1% (v/v) Tween 20) for 30 min 
at room temperature. The plates were then washed tlrree times with PBS-Tween before 
100 jul of sheep polyclonal to prealbumin (sheep anti-human TTR, Abeam, Cambridge, 
UK) (diluted 1:5000 with PBS-Tween) was added to each well and the plates incubated 
for 1 hi' at 37°C. Following incubation the plates were washed tliree times in PBS- 
Tween then 100 pi o f HRP conjugated donkey anti-sheep IgG (Sigma) (diluted 1:5000 
in PBS-Tween) was added to each well and the plates incubated at 37°C for 30 min. 
Following three washes in PBS-Tween, 100 pi of fresh TMB substrate solution (KPL) 
was added to each well and the reaction stopped after 7 to 10 minutes with 50 pi of 1 M 
HCl. The absorbance was read at 450 mn using the FLUOstar OPTIMA platereader 
(BMG Labtech Ltd.) and the results calculated by the associated FLUOstar Optima 
Software V I.32.
3.2.6. Data Analysis
Statistical analysis was carried out using SAS 9.1 software (The SAS Institute, Cary, 
NC, USA). All data was log transformed prior to analysis in order to render skewed 
data as close to normal distributions as possible. Correlations between the APP were 
analysed using the PROC CORR function of SAS 9.1. Associations between pig line 
data were analysed using the General Linear Model (GLM) procedure of SAS 9.1.
1 0 2
3.3. Results
3.3.1. Precision of APP Tests
The intra and inter-assay coefficients of variation (CVs) are shown in Table 3.1. Intra­
assay CVs for the CRP ELISA have already been reported in Section 2.3.5.1. Pig-MAP 
was measured using a commercial assay which has previously been validated for use 
(Tecles et al., 2007), and as such, intra-assay CVs were not calculated for this assay.
3.3.2. Correlation between APP Concentrations from Repeated Sampling
Two bleeds were taken from most pigs. Statistical analysis showed that the 2 bleeds 
were significantly correlated in all 4 of the proteins; Hp, r = 0.301 (p < 0.0001, n=397), 
CRP, r = 0.269 (p < 0.0001, n=395), Pig-MAP, r = 0.210 (p = 0.002, n=396) and TTR, r 
= 0.599 (p < 0.0001, n=397). This enabled the average of the 2 bleeds to be used for 
further analysis.
3.3.3. Serum Concentrations of APP in a High Health Herd
Serum concentrations of Hp, CRP, Pig-MAP and TTR across a high health herd are 
shown in Figures 3.2 -  3.5 respectively. The mean Hp, CRP and Pig-MAP 
concentrations were 0.4 g/L (range = 0 -2 .8  g/L), 29.85 mg/L (range = 0.9 -485 .2  
mg/L) and 1.2 mg/ml (range = 0.1 -  9.6 mg/ml), respectively. The mean TTR 
concentration was 337.6 pg/ml (range = 119.2 — 820.3 pg/ml). Summary values are 
shown in Table 3,2.
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Table 3.1: Intra- and inter-assay coefficients of variation (CVs) for Hp, CRP, Pig- 
MAP and TTR assays.
Intra-assay Inter-assay
n Mean (SD) CV% n Mean (SD) CV%
Hp (g/L) 6 0.37 (0.02) 5.08 26 0.29 (0.06) 20.06
6 0.65 (0.03) 4.07 26 0.70 (0.11) 16.24
6 0.92 (0.05) 4.91 26 1.03 (0.15) 14.41
CRP (mg/L) - - - 21 85.8 (12.1) 14.13
- - - 21 182.1 (31.1) 12.96
- - - 21 276.3 (35.8) 17.08
Pig-MAP - - - 22 0.7 (0.3) 42.63
(mg/ml) - - - 22 2.0 (0.5) 22.83
TTR (pg/ml) 6 148.6 (7.7) 5.16 31 144.01 (30.4) 21.13
6 285.8 (6.9) 2.40 31 275.6 (73.9) 26.82
6 312.0 (6.7) 2.15 31 366.5 (113.9) 31.07
Intra-assay CVs for CRP lave been previously reported. Pig-MAP has previously been
validated for use.
Table 3.2: Summary values of Hp, CRP, Pig-MAP and TTR concentration in a 
high health herd.
Hp (g/L) CRP (mg/L) Pig-MAP (mg/ml) TTR (pg/ml)
n 397 395 396 397
Min. 0.0 0.9 0.1 119.2
Max. 2.8 485.2 9.6 820.3
Median 0.3 13.5 1.1 323.8
Mean 0.4 29.8 1.2 337.6
SEM 0.02 2.7 0.04 5.53
SD 0.37 54.49 0.78 110.26
Abbreviations: no. o]"pigs. SEM: standard eiTor of the mean. SD: standard
deviation
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Figure 3.2: Serum concentrations of Hp (g/L) in a high health pig herd (n = 397).
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Figure 3.3: Serum conceutrations of CRP (mg/L) in a high health pig herd (n 
395).
106
□  □  n
0 0.5 1.25 1.75 2.25 2.75 3.25 3.75
Pig-MAP (mg/ml)
Figure 3.4: Serum concentrations of Pig-MAP (mg/ml) in a high health pig herd (n 
= 396).
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Figure 3.5: Serum concentrations of TTR (pg/ml) in a high health pig herd (n 
397).
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3.3.4. Correlations between APP Concentrations
Con*elations between the 4 measured APP are shown in Table 3.3. There was a 
significant conelation between Hp and CRP (p < 0.0001), between Hp and Pig-MAP (p 
< 0.0001) and between CRP and Pig-MAP (p < 0.0001) (see also Figures 3.6 - 3.8). 
There was no correlation found between TTR and any of the other 3 proteins.
Table 3.3: Correlation coefficients (r) describing the relationship between Hp, 
CRP, Pig-MAP and TTR.
Hp CRP Pig-MAP TTR
Hp 0.537* 0.295* 0.064
CRP 0.537* 0.336* 0.040
Pig-MAP 0.295* 0.336* 0.105
TTR 0.064 0.040 0.064
* p <0.0001
Note: Analysis carried out using log-transfonned data.
3.3.5. Comparison of Serum Concentrations of APP across Pig Lines
Semm concentrations of Hp, CRP, Pig-MAP and TTR in all lines are shown in Figures 
3.9 - 3.12 respectively. Summary values are given in Tables 3.4 - 3.7. There was no 
significant difference in Hp concentration between pig lines. There was a significant 
difference found between lines for CRP (p = 0.0121), Pig-MAP (p = 0.0426) and TTR
(p < 0.0001).
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Figure 3.6: Plot of Pig-MAP vs. Hp. Data was log transformed before analysis. 
Abbreviations: ImeanHp, log transformed haptoglobin; ImeanMAP, log-transformed 
Pig-MAP.
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Figure 3.7: Plot of Hp vs. CRP. Data was log transformed before analysis. 
Abbreviations: ImeanHp, log-transformed Haptoglobin; ImeanCRP, log-transformed 
C-reactive-protein.
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Figure 3.8: Plot of CRP vs. Pig-MAP. Data was log transformed before analysis. 
Abbreviations: ImeanCRP, log-transformed C-reactive protein; ImeanMAP, log- 
transfoimed Pig-MAP.
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Figure 3.9: Hp concentration (g/L) across 7 pig lines. The line within the box marks 
the median; the boundaries of the box represent the 25th and 75th percentiles; whiskers 
above and below the box indicate the 10th and 90th percentile and the points outside the 
end of the whiskers are outliers. Line A: Landrace; Line B: LW; Line C: Duroc; Line 
D: Synthetic pure line; Line E: Synthetic pure line; Line F: Synthetic pure line bred for 
growth; Line G: Synthetic pure line bred for growth.
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Figure 3.10: CRP concentration (mg/L) across 7 pig lines. The line within the box 
marks the median; the boundaries of the box represent the 25th and 75th percentiles; 
whiskers above and below the box indicate the 10th and 90th percentile and the points 
outside the end of the whiskers are outliers. Line A: Landrace; Line B: LW; Line C: 
Duroc; Line D: Synthetic pure line; Line E; Synthetic pure line; Line F; Synthetic pure 
line bred for growth; Line G: Synthetic pure line bred for gi'owth.
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Figure 3.11: Pig-MAP concentration (mg/ml) across 7 pig lines. The line within the 
box marks the median; the boundaries o f the box represent the 25th and 75th 
percentiles; whiskers above and below the box indicate the 10th and 90th percentile and 
the points outside the end of the whiskers are outliers. Line A: Landrace; Line B: LW; 
Line C: Duroc; Line D: Synthetic pure line; Line E: Synthetic pure line; Line F; 
Synthetic pure line bred for growth; Line G: Synthetic pure line bred for growth.
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Figure 3.12: TTR concentration (pg/ml) across 7 pig lines. The line within the box 
marks the median; the boundaries of the box represent the 25th and 75th percentiles; 
whiskers above and below the box indicate the 10th and 90th percentile and the points 
outside the end of the whiskers are outliers. Line A: Landrace; Line B: LW; Line C: 
Duroc; Line D: Synthetic pure line; Line E: Synthetic pure line; Line F: Synthetic pure 
line bred for growth; Line G: Synthetic pure line bred for growth.
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3.4.Discussion
The aim of this study was to examine semm concentrations of four APP (Hp, CRP, Pig- 
MAP and TTR) in a high health boar population. The study included determining 
average ‘herd’ baseline concentrations, identifying correlations between the APP and 
determining if any differences in semm concentration occuned between pig lines.
Baseline APP serum concentrations were determined using a variety of assays (3 ‘in- 
house’ and 1 commercial assay). The assays were validated for use by running internal 
controls and determining intra- and inter-assay CVs. Intra-assay CVs were below 10% 
which is optimal for analytical detenninations. Inter-assay CVs were within the range 
of 12 -  43%, with the highest CV value occurring for an internal control in a 
commercial assay (pig-MAP). Values of up to approximately 30% are acceptable for 
ELISA (this accounts for the CRP and TTR assays) and were deemed acceptable for 
Hp, particularly towards the lower and upper limits of detection and it was deemed not 
necessary to repeat these assays (FDA, 2001). The Pig-MAP ELISA has been 
previously validated for use by Tecles et al. (2006) in which it also showed a high CV 
of 23.1%. Taking this into account, also with the fact that only the internal control of 
low Pig-MAP concentration at 0.66 g/ L showed a CV of 43%, and the cost (both time 
and monetary), it was decided not to repeat the Pig-MAP assays (Tecles et al., 2007).
This study used boars from a high health herd with similar housing and husbandry 
regimes and had blood collected at approximately the same age which was repeated a 
month later. The APP seium concentrations from the two bleeds were shown to be 
significantly con*elated and therefore it was possible in the statistical analysis to use the 
average of both the bleeds. By taking this approach, and minimising treatment
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differences between the boars, the concentration of semm APP could be considered to 
be an average baseline level and any differences in concentration should therefore 
theoretically be due to genetic differences between the animals.
Across the boar population, the average baseline concentrations of Hp, CRP and TTR 
were within the reported ranges for healthy animals (Campbell et a l ,  2005, Petersen et 
a l,  2002b, Heegaard et a l ,  1998) and showed a distinct trend towards the lower range 
of Hp and CRP concentration and the higher range of TTR concentration. In all three 
cases, there were very few boar samples with APP concentrations outside the mean 
concentration ± 2SD; this indicates that there was no sub-clinical disease or underlying 
problems, as would be expected in a high health herd. In the case of Pig-MAP, baseline 
concentrations have previously been categorised as between 0.4 and 0.6 mg/ml after 
weaning (Caipintero et a l ,  2005, Martin et a l,  2005). This study showed an average 
baseline Pig-MAP concentration o f 1.19 mg/ml, almost twice the previous reports. This 
might have sparked concern if Pig-MAP had been the only protein measured, as it 
would indicate a possible health and welfare issue. However, a recent study also 
reported baseline concentrations closer to 1 mg/ml (Clapperton et a l,  2007). The 
difference between these values could be due to a number of factors such as age, sex 
and breed but it does highlight two important issues; first that it is necessary for baseline 
APP concentrations to be adjusted for factors such as sex and/or be determined for 
individual famis or herds. Secondly, measurement of at least two APP is recommended 
in order to gain a better understanding of what biological processes are occumng.
The study of baseline concentrations of the porcine APP has also raised questions over 
the classification of the APP as major or moderate. Historically, pCRP has always been
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considered a major APP due to its dramatic and almost inunediate increase 
(approximately 10-15 times) in concentration during an APR (Parra et a l,  2006, 
Lampreave et a l ,  1994). However, the baseline concentration of pCRP is considered 
high for a major APP, particularly when compared to the baseline concentrations of 
human (~1 mg/L) (Danesh et a l,  2004, Pepys and Hirschfield, 2003) or dog (<10 mg/L) 
(Ceron et a l ,  2005) . This had led to questions over its categorisation as a major APP 
and is an area which should be further investigated.
Analysis of the herd APP concentrations showed a significant correlation between Hp 
and CRP, Hp and Pig-MAP and Pig-MAP and CRP. The correlation between Hp and 
Pig-MAP has previously been reported, however no studies had been earned out 
investigating the relationship with CRP. All 3 proteins are stimulated by IL-6 
(Gonzalez-Ramon et a l ,  2000, Kushner and Rzewnicki, 1994), and it has been 
hypothesised that this may be responsible for the con*elation between them (Clapperton 
et a l ,  2007). It is worth noting that in this study, the highest correlation was found 
between CRP and Hp both of which are considered major APP, with lower correlations 
found between either of these and Pig-MAP, a moderate APP. This suggests that 
correlation between APP is affected by multiple factors and not just the mediator 
stimulating their synthesis. This is further corroborated by the lack of correlation with 
transthyretin, a negative APP. The coiTelation between baseline concentrations of Hp, 
CRP and Pig-MAP could be put to a practical use as it means that only two APP need to 
be measured. These could be chosen on the grounds of cost, speed or availability of 
assays, or it could be considered that measurement of one major and one moderate APP 
is more appropriate.
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The concentration of APP was compared between 7 lines comprising pure European 
breed lines and synthetic lines. Studies have indicated that there are significant breed 
and/or line differences in CRP and Pig-MAP particularly between Asian and European 
breeds (Clapperton et a l ,  2007, Frank et a l,  2005). There are conflicting reports 
concerning Hp, with one study indicating that differences occur between Asian and 
European breeds (Sutherland et a l ,  2006) and one study finding no difference 
(Clapperton et a l,  2005b). This study found that there were no line differences for Hp 
serum concentration supporting the latter study (neither of these studies included Asian 
breeds). Differences between lines were discovered for CRP, Pig-MAP and TTR serum 
concentrations. In particular, differences in CRP concentration were found between 
Line A (Landrace) and Lines C (Duroc), F and G (both synthetic pure lines bred for 
growth), with Line A showing a lower mean CRP concentration than the others. 
Differences in Pig-MAP concentration occuned between Line E (Synthetic pure line 
based on Hampshire) and Lines A, B (LW), F and G, with Line E showing a higher 
mean Pig-MAP concentrations than the other lines. Differences in TTR concentration 
occuned between almost every line (Line E>Line B>Line D>Line C>Line F>Line G) 
but of particular interest were Line F and G. Line G is derived from Line F, yet they 
have significantly different TTR concentrations, this may be an effect of selecting for a 
particular trait.
The differences in APP concentrations between lines are likely to be genetic and could 
be attributed to polymoiphisms in the genes controlling APP production; either the APP 
genes themselves or possibly the genes involved in control mechanisms such as the 
cytokine genes. However, there is obviously a clear difference between the lines and 
this has also been shown for other immune traits (Clapperton et a l ,  2005b, Sutherland
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et a l,  2005). As yet, the underlying cause and puipose of this difference is unknown. 
This study also shows the effect that differential selection could have on an immune 
trait, as exhibited in Lines F and H; however, elucidation of this outcome would require 
further investigation.
This study has determined the average baseline APP serum concentrations for a high 
health boar population (as determined by industry standards) and identified line 
differences in baseline CRP and TTR semm concentrations that have not been 
previously reported. It also provides further evidence for line differences in Pig-MAP 
semm concentration, hi addition, overall correlations between CRP and Hp and Pig- 
MAP concentrations have been identified and a previously reported correlation between 
Hp and Pig-MAP coiToborated. This data adds to our knowledge of APP biology in 
pigs, particularly the effect of selective breeding and has identified areas requiring 
further investigation such as identification of factors affecting APP baseline 
concentrations i.e. line and the effects of selective breeding on immune traits such as the 
APP.
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Chapter IV
4. Identification of Single Nucleotide Polymorphisms in Acute 
Phase Protein Genes
4.1.Single Nucleotide Polymorphisms
Single nucleotide polymoiphisms (SNP) involve the substitution of one nucleotide for 
another and are nomially bi-allelic but can have three or even four alleles. Most SNP are 
located in non-coding regions of the genome and although it is thought they may contribute 
to gene expression, they usually have no direct impact on the phenotype of an individual. 
However, these non-coding SNP can be in high or complete linkage disequilibrium (LD) 
with causative mutations and these can still be used as markers. Single nucleotide 
polymoiphisms occurring in the coding regions of genes can alter the structure or function 
of the encoded proteins and are the cause of most of the known inherited monogenic 
disorders (Syvanen, 2001, Landegren et ah, 1998). There are four major reasons for the 
interest in SNP as genetic markers. Firstly, they are more prevalent in the genome than 
other types of polymorphisms, occumng approximately every 1000 base pair (bp) in 
humans (Landegren et al,  1998); approximately every 500 bp in mice and cattle (Lindblad- 
Toh et a l,  2000, Heaton et al, 2001) and approximately every 400 bp in pigs (Jungeriiis et 
al, 2003). In addition, they generally give rise to large sets of markers lying near or in the 
locus of interest. Secondly, some SNP in genes can change the amino acid sequence of a 
protein (known as non-synonymous SNP), directly affecting protein shucture or expression 
levels and can be considered candidate alterations for genetic mechanisms in disease.
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Thirdly, they are stably inherited, making them ideal for long-term selection progiammes 
and finally, typing systems for SNP can offer high throughput and efficiency, leading to 
large power in genetic analyses (Beuzen et al., 2000, Landegren et al., 1998).
4.1.1. Single Nucleotide Discovery and Genotyping
The simplest and most common method of SNP discovery is to target an area of interest in 
the genome, for example one containing candidate genes. Regions of the genes can then be 
sequenced following PCR amplification of either individual or pooled DNA and SNP 
identified manually or by the use of computer software (Vignal et al, 2002).
4.1.2. Use of BAG End Sequencing
Bacterial artificial chromosomes (BAG) are common vectors used for cloning up to 300 kb 
of genomic sequence. They are a valuable resource for whole genome and targeted genome 
sequencing and are currently being used in the porcine genome sequencing project 
fhttp ://W W W , sanaer.ac.uk/Proiects/S scrofa/manning.shtmlL BAG end sequences (BBS) 
can be mapped against the human genome and sequences selected that lie in the region of 
human genome in which the genes of interest lie. This approach has been used in human, 
mouse and cattle projects enabling detailed physical maps to be made. Additionally, BBS 
can be used to generate oligonucleotides to be used for amplifying and sequencing genomic 
DNA (Fahi'enki'ug et al, 2001, Suzuki et al, 2000). Several porcine genomic BAG
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libraries are available (Anderson et al, 2000, Suzuki et al, 2000, Rogel-Gaillard et al, 
1999).
4.1.3. Genotyping
Once SNP have been identified there are a large number of techniques available for SNP 
genotyping as indicated in Table 4.1, each with its own advantages and disadvantages. 
Three specific techniques were used in this study and will be discussed in greater detail.
Table 4.1: Single Nucleotide Polymorphism (SNP) Genotyping Methods
Method Advantages Disadvantages Features
PCR-RFLP Low cost 
Simple
Qualitative visual
interpretation
Not all SNP are part o f a
restiiction site
Traditional method
MALDI-TOF MS High throughput 
High sensitivity 
Multi-plexing capacity
Cost
Susceptible to contamination
Gene-Chip
Microairays
High probe density Cost
High failure rate
High tech manufacturing 
process
SNaPshot® Multi-plexing capacity Size separation step Can be perfonned on 
capillary DNA 
sequencers
Pyiosequencing'^ High throughput 
Sensitive
Difficult to multi-plex 
Cost
Dedicated instrument
TaqMan^ Simple Cost Quantitative real-time 
PCR
FRET primers Simple Cost Universal FRET pnmers
Coded microspheres Multiplexing capacity Microspheres not widely 
avaialble
Flow cytometric 
detection
Abbreviations; PCR-RFLP: polymerase chain reaction-resti*iction fragment length polymorphism; 
MALDI-TOF MS: matrix-assisted laser desorption ionisation time-of-flight mass spectrometiy; FRET: 
fluorescence resonance energy transfer. (Isler et a l ,  2007, Landegren et a l ,  1998, Syvanen, 2001)
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4.1.3.L PCR-RFLP
PCR-restriction fragment length polymorphism (PCR-RFLP) was one of the first 
genotyping techniques to be used. It is a simple and powerful technique; however it can be 
time-consuming and inconvenient. Following amplification of the DNA region of interest, 
PCR-RFLP uses the ability of restriction enzymes to cleave the DNA sequence at particular 
sites. If a SNP creates or removes a restriction endonuclease recognition site, then the DNA 
sequence acquires or loses the ability to be cleaved at that particular recognition site. If no 
site is present, then enzyme digestion will result in a long fragment, if a recognition site is 
present, then digestion will results in two shorter fragments. If a recognition site is present 
in only one allele (for example, a heterozygous individual), digestion will result in one long 
and two shorter fragments (Beuzen et al, 2000). The main disadvantage to this technique 
is that some polymorphisms do not result in the creation or disruption of restriction 
endonuclease sites, leading to the use of alternative techniques.
4.1.3.2. Pyrosequencing®
Pyrosequencing® (Biotage, Uppsala, Sweden) is a relatively new technique, first described 
in 1998 (Ronaghi et al, 1998), and provides genotyping results in context of the 
neighbouring DNA sequence. It is a high throughput (96 samples in 5-7 min after PCR 
and clean-up steps), accurate and low cost technique, and it is seen by many as the future 
for genotyping (Pati et al, 2004, Ahmadian et al, 2000, Ronaghi et al, 1998).
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The Pyi'osequencing® technique is based on the detection of released pyi’ophosphate (PPi) 
during DNA synthesis and is summarised in Figure 4.1. Following PCR amplification of 
the target DNA sequence, the sequencing primer is hybridised to a single stranded template 
isolated from the PCR reaction using streptavidin beads to capture the biotinylated template 
and incubated with the enzymes; DNA polymerase, ATP sulfurylase, luciferase and 
apyi'ase, and the substrates adenosine 5’phosphosulfate (APS) and luciferin (Step 1). Four 
enzymatic reactions then follow. These start with the addition of one of four 
deoxyiibonucleotide triphosphates (dNTPs) with DNA polymerase to catalyse the 
incoiporation of the dNTP complementary to the base present in the DNA template. The 
incoiporation is accompanied by a release of PPi in proportion to the amount of dNTP 
incorporated (Step 2). ATP sulfurylase then converts PPi into ATP in the presence of APS; 
this drives luciferase-mediated conversion of luciferin to oxyluciferin and generates visible 
light in amounts proportional to the amount of ATP. The light emitted is detected by a 
camera and is visualised as a peak in a pyrogram™, with the height proportional to the 
number of nucleotides incoiporated (Steps 4 and 5). Apyi'ase is added to degiade 
unincorporated dNTPs and excess ATP prior to the addition of the next dNTP (Step 4). 
Addition of the dNTPs is performed one at a time. As this continues, this allows the 
complementary DNA strand to be synthesised and the sequence to be deteimined (Isler et 
a l, 2007, Ronaghi, 2003, Ronaghi et a l, 1998).
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Figure 4.1: The chemistry of Pyrosequencing®, step 2 to step 5. Reproduced with 
permission of Biotage, Uppsala, Sweden.
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4.1.33. SNaPshor
SNaPshot® (Applied Biosystems, Foster City, CA, USA) is a single base extension method 
of genotyping. It is a consistent and easy to use method with a fairly high throughput of up 
to 9216 samples in 24 hours using the ABI 3100, 3130 or 3700 PRISM® sequencer 
(Applied Biosystems). Following amplification of the target DNA sequence, residual 
primers and unincorporated dNTPs are removed by treatment with shrimp alkaline 
phosphatase (Exosap). The extension primer then targets the sequence immediately 
upstream of the SNP site and is extended by a single base in the presence of all four 
fluorescently labelled dideoxy nucleotides (ddNTPs). Each fluorescent ddNTP emits a 
different wavelength when excited by the laser and the signal is conveited into a specific 
colour for each base. The size of product is the length of the initial probe plus one 
fluorescent base. The genotypes are then deteiTnined by the colour and location of the peak 
that is generated by the emitted fluorescence (Pati et a i, 2004, Turner et al., 2002).
4.1.4. Preliminary Analysis of Genotyping Data
Before caiTying out in-depth analysis or an association analysis, preliminary analyses 
should be carried out in order to identify areas of concern, for example, missing data or 
unusual patterns. The 2 most common tests are detailed below.
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4.1.4.1. Hardy- Weinberg Equilibrium
In a large, random-mating population where no selection, mutation or migration is 
occurring, the gene and genotype frequencies are constant from generation to generation 
and a simple relationship between them can be described. A population in this state is in 
Hardy-Weinberg equilibrium (HWE). The relationship is that if the gene frequencies of 2 
alleles of the parents are p  and q, then the genotype fr’equencies of the progeny are 2pq 
and q .^ In order to test for HWE, a chi-square (X^) goodness-of-frt test can be used 
(Balding, 2006, Falconer and Mackay, 1996).
4.1.4.2. Linkage Disequilibrium
Linkage disequilibrium is the non-random association of alleles at 2 or more loci in a 
population and as stated in Section 5.1 is commonly used in indirect association studies. 
Linkage disequilibrium provides infonnation on population structure and can also be used 
to map genes or quantitative trait loci (QTL). Although commonly used in human 
population studies, it is becoming increasing popular in livestock studies and has been 
shown to be common and significant in sheep, cattle and pigs (Nsengimana et a l, 2004, 
McRae et a l, 2002). Linkage disequilibrium can be measured in a number of ways, the 
most common being Lewontin’s D' and r .^ Lewontin’s D' has a range of 0 to 1 and was 
designed for use with loci with 2 or more alleles. It is particularly useful in animal studies 
due to its ability in handling multi-allelic data. A D' value of 1 (complete LD) means that 
at least 1 allele at each locus is completely associated with an allele at the other locus 
(Devlin and Risch, 1995, Lewontin, 1964). The measurement of r^  also has a range of 0 to
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1 and is the coirelation of determination for alleles at 2 loci. An r^  value of 1 (perfect LD) 
means that each allele at each locus is completely associated with 1 allele at the other locus 
and that allele frequency at each loci is identical (Du et a l, 2007, Ardlie et a l, 2002).
4.1.5. Porcine APP Genes
The four porcine APP genes that this study focused on; CRP, Hp, Pig-MAP and TTR, have 
been previously sequenced and polymoiphisms published in some genes, however little 
further work has been carried out. Each of the genes is briefly discussed below.
4.1.5.1. Haptoglobin
The porcine Hp gene (accession no.: AF492467) is located on SSC6  and is 83% 
homologous to the human haptoglobin cel S. The cDNA is 1182 bp in length with 138 bp of 
3’ untranslated region (3’ UTR). One SNP has been identified in exon 5 of the coding 
sequence at nt 624 (Ponsuksili et a l, 2002). The SNP, a non-synonomous C-T substitution 
which changes serine to proline, may prove to be of significance in teims of protein 
function or expression.
4.1.5.2. C-Reactive Protein
The porcine CRP gene (accession no.: AB005545) is located on Sus scrofa chromosome 
(SSC) 4 and is 1792 bp (cDNA) long. Two SNP have been reported, the first, a C-T 
substitution at position nucleotide (nt) 788 rs located within the 3’ UTR. The second is a 
G-A substitution at position nt 1271 also in the 3’ UTR (Chomdej et a l, 2004).
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4.I.5.3. Pig-MAP
The pig-MAP gene or porcine ITIH4 (accession no.: S82800), is located on SSCI3 and 
shows homology (65%) with human ITIH4 (Baskin et a l, 1998, Hashimoto et a l, 1996). It 
is 2952 bp (cDNA) in length and contains an Acil restriction fragment length 
polymorphism, however no further details on the precise SNP location are available 
(Baskin et a l, 1998).
4.1.5.4. Transthyretin
The porcine TTR gene (accession no.: X82258), is located on SSC6  and shares 85% 
homology with human TTR gene. The cDNA is 591 bp in length and contains a silent A-T 
substitution at nt 462 within exon 4 (Archibald et a l, 1996, Duan et a l, 1995).
The aim of this study was to identify SNP in 4 porcine APP genes; CRP, Hp, pig-MAP and 
TTR and select a manageable number of SNP to be genotyped across the boar population in 
which APP protein levels had previously been measured. This work was cairied out in the 
Genus, Pic. molecular biology laboratory, Kentucky, USA.
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4.2.Materials and Methods
4.2.1. Samples
The tissue samples used in this work were obtained from Genus, Pic. Tail samples were 
collected from piglets following company protocol and frozen at -20°C. A pool of porcine 
DNA was also made available for PCR optimisation and SNP discovery. This pool 
contained DNA from animals of the lines used within this study.
4.2.2. Gene Selection
As previous work in this thesis has centred on the proteins; Hp, CRP, Pig-MAP and TTR, 
the genes for these four proteins were chosen as candidate genes in order to identify any 
SNP and possible associations with phenotype, i.e. basal APP concentrations. Each of the 
four genes has been sequenced in the pig and this data was utilised during primer design. 
Porcine BAC-end sequences (PigEBAC) with homology to human chromosome 1, (CRP), 
chromosome 16 (Hp), chromosome 3 (ITIH4 -  also refened to as pig-MAP) and 
chromosome 18 (TTR) were identified via Ensemble (www.ensembl.ora/index.htmll and 
this data was also utilized during primer design.
4.2.3. DNA Isolation
DNA was isolated from porcine tail tissue using DNeasy® 96 Tissue kits (Qiagen Inc., 
Valencia, CA, USA) following the manufacturer protocol. In short, approximately 20 mg
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of tissue was cut from each sample and incubated overnight at 55°C in a proteinase K 
solution to lyse the tissue. Following complete lysis, the DNA was bound to the DNeasy® 
membrane and washed twice to remove residual contaminants. The purified DNA was 
eluted twice from the membrane using elution buffer, the first elution yields up to 7 5 % of 
the DNA from the membrane and the second increases yields by up to 25%. The purified 
DNA was then frozen at -20°C until use.
4.2.4. SNP Discovery
4.2.4.1, Prim er Design
PCR primers were designed using Primer3 software (http://frodo.wi.mit.edu/cai- 
bm/primer3/primer3 www.cgif and according to the following conditions:
a) the pioduct size was between 450 and 600 bp in length although shorter or longer 
fragment lengths were used when necessary, for example, spanning an intron
b) the oligonucleotide size was between 2 0  and 30 nucleotides in length
c) the primers contained approximately equal numbers of each nucleotide and avoided 
lengths of repeating nucleotides
d) Tm target was 60°C
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4.2.4,2. PCR Optimisation
In order to perform SNP discovery, PCR conditions had to be optimised for each set of 
primers. In order to avoid contamination of samples, stringent conditions were followed 
during preparation of the PCR. In the Genus laboratory in Franklin, KY, PCR preparation 
was canied out in a dedicated lab using dedicated instruments and reagents for PCR 
preparation. Master mixes were used where possible to reduce pipetting steps and potential 
contamination. Negative controls were included in each reaction using Gibco™ Ultrapure 
water (QH2O) (Invitrogen, Carlsbad, CA, USA) instead of DNA. All chemical reagents 
were purchased from Sigma-Aldrich, St. Louis, MO, USA unless othei*wise stated.
4,2,43. PCR for Sequencing
Three different optimized PCR conditions were used for preparing the sequencing reaction, 
they were:
1. A  10 fx\ reaction containing 1 gl porcine genomic DNA, 0.2 mM each dNTP 
(Applied Biosystems, Foster City, CA, USA), 1 pi lOx PCR buffer (Applied 
Biosystems), 1.5 mM MgCl2 (Applied Biosystems), 0.5 U Amplitaq Gold® DNA 
polymerase, and 0.25 mM each foixvard and reverse primer (Qiagen Operon Inc., 
Huntsville, AL, USA) was prepared. The mixture was placed in GeneAmp® PCR 
System 9700 thermal cycler with a heated lid (Applied Biosystems) and underwent 
initial dénaturation at 94“C for 12 min This was followed by 16 cycles of 
amplification with a dénaturation step at 94“C for 30 sec and annealing step for 30
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sec. The annealing step used a touchdown program to decrease the temperature 
from 71°C to 55°C in TC steps each cycle. This was followed by an extension step 
at 72®C for 30 sec. Following the 16 touchdown cycles, 25 cycles of 94®C for 30 
sec, 55”C for 30 sec and 72“C for 30 sec were performed which were then followed 
by a final extension step at 72®C for 7 min. The samples were then held at 4°C. 
Details of primers and expected product sizes for these conditions can be found in 
Table 4.2.
2. A 10 pi reaction containing 1 pi porcine genomic DNA, 0.2 mM each dNTP, 1 pi 
lOx PCR buffer, 2.5 mM MgCl2 , 0.5 U Amplitaq Gold® DNA polymerase and 0.5 
mM each forward and reverse primer was prepared. The mixture was placed in 
GeneAmp® PCR System 9700 thermal cycler with a heated lid and underwent initial 
dénaturation at 94°C for 12 min. This was followed by 38 cycles of amplification 
with a dénaturation step at 94“C for 30 sec and annealing step at 55°C for 30 sec. 
This was followed by an extension step at 72‘^ C for 30 sec. Following the 38 cycles, 
a final extension step at 72"C for 7 min occurred. The samples were then held at 
4"C. Details of primers and expected product sizes for these conditions can be 
found in Table 4.3.
3. As reaction 2 except using an annealing temperature of 65°C for 30 sec. Details of 
primers and expected product sizes for these conditions can be found in Table 4.4.
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Table 4.2; Primers and expected product sizes for optimised PCR conditions 1.
F orw ard
P rim er
Sequence (S' to 3') Reverse
P rim er
Sequence (S' to 3') Size
CRP BES- 
IF
CTCCTCAGTCCAAGCAAACC CRP BES- 
IR
CCTGTGGCAAGGATACCAGT 523
CRP BES- 
2F
CCCTCATTCCCTGATTCTGA CRP BES- 
2R
CCGAATCCTTAACCCACTGA 569
CRP BES- 
3F
TTTCCATGGCTCAGGAAACT CRP BES- 
3R
TTGGGGCTTTCACAAATAGG 460
CRP BES- 
4F
TTGTAAAGGCGCAGGGTATT CRP BES- 
4R
TGTTGCTGTGGCTATGGTGT 460
CRP BES- 
5F
CCATGCAGTACAGTGGGAAA CRP BES- 
5R
CCACAATGGGAACTCCAAA
A
532
CRP BES- 
6F
GTTCATTTTTGGCCACGTCT CRP BES- 
6R
ATCCCAAAGGCAACATTCTG 488
CRP BES- 
7F
GGGGACCCAATAAGCAAAAT CRP BES- 
7R
TCTCTCCATGATGGGTGTCA 283
CRP BES- 
8F
TTTTAGGGCCACTCTTGCAG CRP BES- 
8R
CCACAGCAGAACTCCTTCCT 359
CRP BES- 
9F
GCTAAGCGTCCTACCTGGAA CRP BES- 
9R
GGGATGATGAGGTCTCCTTG 487
CRP BES- 
lOF
CTCTGAAGAGGGCTGCTGAC CRP BES- 
lOR
TGCAACTAGATCATGCACAA
A
494
CRP-IF AATTCGGCACGAGAGACATC CRP-IR ATAGACACGCAGGCACACA
G
565
CRP-2F TTGTCTTCCCCAAAGAGTCG CRP-2R CCCACATGTTCACATCTCCA 480CRP-3F CTGGGGGCTTTGAGAAGAAC CRP-3R TTTAATTGGCCTGGGATGTG 410CRP-4F CTGTGCCAAGCAAAGGATCT CRP-4R CCTCAGCTGAAGGAATTGG
A
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CRP-5F ATTCCTTCAGCTGAGGTTGC CRP-5R GGGGAGAATGCTGGAAAAA
T
454
HP-BES-IF ACTGGTGGCAAGTCCATTGT HP-BES-
IR
TACACCACAGCCACAGCAA
C
214
HP-BES-2F TGGCTCAGCAGTTGACAAAC HP-BES-
2R
GCAACCTACACCACAGCTCA 464
HP-BES-3F AACCCTGGCAGCTACACATC HP-BES-
3R
GCATGGTCCTTCCTACCTGA 503
HP-BES-4F CAGGAGGCTTTTCTCTGCAC HP-BES-
4R
GAGAACCCAGACACCAGAG
C
324
HP-BES-5F TCAGGATTTCTGTGGGAAGG HP-BES-
5R
GGGCTACACCCCAGACTAC
A
482
HP-BES-6F AAGTGACCAGAAGCCGAGAA HP-BES-
6R
AACGCCCTATACCTCCCTTG 275
HP-BES-7F CCGCAGAGTGGGTTAAGGAT HP-BES-
7R
AGGGTCTCTCCTGTGGCATA 460
HP-BES-8F GTGGGAACTGGGTCCATAAA HP-BES-
8R
CTCCCTTTCCTTCTCCCTTG 512
HP-BES-9F GCGTGCAAAAGCAAAACATA HP-BES-
9R
CATCATTGGCAGTGCTTTGT 458
HP-BES-
lOF
TAGAGATCACTGGGCCTGCT HP-BES-
lOR
GACCCAGTGGAAGGTTTTGA 522
H P-IF GGCAGCTTTTTGCAGCAG H P-IR CGTGCGCAGTTTGTAGTAGG 426
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F orw ard
P rim er
Sequence (S' to 3 ') R everse
P rim er
Sequence (S' to 3 ') Size
HP-2F GCTACGTGGAGCACATGGTT HP-2R TGCTTCACATTCAGGCAGTT 900
HP-3F CTGCCTGAATGTGAAGCAGT HP-3R GGTGAGGTTATGGTGGGAG
A
153
HP-4F AGAACCCAGTGGATCAGGTG HP-4R ACGGTGCTGCCTTCGTAGTA 496
HP-5F ACGCCAACCTCAACTTTACG HP-5R GGGCTCAAAGGAAGCTCTTT
A
492
ITIH4 BES 
-IF
CCAGGACTTGCACTCCTTTC ITIH4 BE 
S-IR
TTTTCCCACCAACACTGGTC 447
ITIH4 BES 
-2F
ATGGGCAGCATCACTTCTCT ITIH4 BE 
S-2R
ATACCCACTGCCACCTGAAG 479
ITIH4 BES 
-3F
TTCTTTTTATGGTCGCACCTG ITIH4 BE 
S-3R
TTTTTGCTTCATCCCAGAGA 481
ITIH4 BES 
-4F
TGCAAAGAAGTTCATTCTGTC
CT
ITIH4 BE 
S-4R
TTTATCCCTTCAAAGGTTCA
AAT
578
ITIH4 BES 
-5F
CACACCTGTGGCCCTAAAAA ITIH4 BE 
S-5R
TTGATTTTTCCTTGCTGGGT
A
467
ITIH4 BES 
-6F
TCTCCCTGCATCCTGTTTTC ITIH4 BE 
S-6R
TTGGCTGAAGTCAAGACTCG 464
ITÎH4 BES
-7F
ÀGGGAGTGCTGTCCAGAGAA ITIH4 BE 
S-7R
CATTACGGAGCAGTGAAGC
A
586
ITIH4 BES 
-8F
CAGAATTCCCAACCACGTCT ITIH4 BE 
S-8R
ACCAAGCGGCTCAGATAAA
A
478
ITIH4 BES 
-9F
CTTGGATCCCAAATTGCTGT ITIH4 BE 
S-9R
CTGGCTCTGTGGGTTAAGGA 539
ITIH4 BES 
-lOF
GGCAGAGAAGAGGGAGACCT ITIH4 BE 
S-IOR
CAGGGTGGAAAGGTTAGCA
G
493
ITIH4-1F GTGGACTCCAAGGTCTCGTC ITIH4-1R GGTGATGAAAGCCTTCTTGG 123
ITIH4-2F ATCGATGGTGTGACCTACCC ITIH4-2R CCTCTGCCAGTTCATTGGTC 622
ITIH4-3F GGCATCAGCTTTCTGGAGAC ITIH4-3R TGTCCGGTTCACATCATAGC 718
ITIH4-4F GATTCAAGCCGACACTGTCC ITIH4-4R GGATTTTCCTGCCCCTCAT 1158
ITIH4-5F CGGAGGTCTGGTCTGCAATA ITIH4-5R ATCGGTGAGGAGGATGATG
A
717
ITIH4-7F TCCTGAGCCCCAAGTACATC ITIH4-7R GTTCTTGGCCTTCAGGTTTG 409
ITIH4-8F GAGCCCTGAGCTTGTCACTC ITIH4-8R GAGTGGGTGTTCCCCTGTC 452
ITIH4-9F GACAGGGGAACACCCACTC ITIH4-9R TGGATGTTCTGTCTCCCACA 366
ITIH4-10F TGTGGGAGACAGAACATCCA ITIH4-10R TACGGGAAAACGGATGAGA
A
555
ITIH4-11F AAGGACAAGCCCAAGGTTTT ITIH4-11R TCATGTGACGTTTCATCAGG 1016
ITIH4-12F GAGGTGCTATCCGTTCCTGA ITIH4-12R TGCTTGAGGTCCACACAGAG 421
ITIH4-13F CAGCTCTGTGTGGACCTCAA ITIH4-13R TCCTTCCACTTGTACGCAGA 1208
ITIH4-14F TGGCCACTATGAGAGGGAGA ITIH4-14R CCGGGCATCACTGAGTAGA
G
162
ITIH4-15F GACAAGGCGGGACTTCTTCT ITIH4-15R CACTGTTCGCTTGCTGTCAT 341
ITIH4-16F ATGACAGCAAGCGAACAGTG ITIH4-16R ATCTCCCCATGATGTTCCAG 714
TTR BES- 
IF
ACTAGCCTGGGAACCTCCAT TTR BES- 
IR
AAGCCCTGGAAGTTGAGAC
A
483
TTR BES- 
2F
TGCATCTTTCTGCTGGACTG TTR BES- 
2R
GTGTGCCTCAGCTTTCTTCC 476
TTR BES- 
3F
CCAGTTGTGGCTCAGCAGTA TTR BES- 
3R
AAGCAGCCTTCACAGAGAC
C
458
TTR BES- 
4F
ATGCAGAAAAAGCATTTGAC
A
TTR BES- 
4R
GTCTCTTCAGCAAGTGGTGC
T
450
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F orw ard
P rim er
Sequence (S' to 3 ’) Reverse
P rim er
Sequence (S' to 3 ') Size
TTR BES- 
5F
ATGGCTGGGTCACTTTTCTG TTR BES- 
5R
TCTGAGCTCCTCCCACAACT 355
TTR BES- 
6F
TGGCCCATAGACACGTTACA TTR BES- 
6R
AGGACGTGCGTAAGGAGAG
A
505
TTR BES- 
7F
TTCTCCTGCCTTCTCCTTTG TTR BES- 
7R
CTCCCATAGGCTGGATGAAA 482
TTR BES- 
8F
TCTCCCTACTCCCGATGGAT TTR BES- 
8R
ATGCAGTCCCTTTGAGGAGA 588
TTR BES- 
9F
AATTTTGCACGTCTAGCCTCT TTR BES- 
9R
TCTTACCATGGTTTGCCACT
T
294
TTR BES- 
lOF
GTGAGGACCACGAGTCAGGT TTR BES- 
lOR
TGCCCTTCATTTCTGTTTCC 503
TTR-IF GATGGCTTCTTACCGTCTGC TTR-IR GCATCCAGGACTTTGACCAT 1041
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Table 4.3: Primers and expected product sizes for optimized PCR conditions 2
F orw ard
P rim er
Sequence (S' to 3') Reverse
P rim er
Sequence (S' to 3') Size
TTR-2F TGCTGGTGAATCCAAGTGTC TTR-2R CAAAGGGCTCCCAAGTCC 122
TTR-3F AAAACCAGTGAATTTGGAGAGC TTR-3R ATTCATGGAATGGGGAAATG 127
TTR-4F TGTGTTCACAGCCAACGACT TTR-4R TTGTCTCTGCCCGAGTTTCT 212
Table 4.4: Primers and expected product sizes for optimized PCR conditions 3
F orw ard
P rim er
Sequence (S' to 3 ') Reverse
P rim er
Sequence (S' to 3') Size
ITIH4-6F GTGCAGCTGCTGGAAAGAG ITIH4-6R CTTTGAAGAACAGCCGGAAG 653
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4.2.4,4. PCR Product Assessment
PCR products were checked on a 3% super fine resolution (SFR) agarose electrophoresis 
gel stained with ethidium bromide (Amresco, Solon, OH, USA) and UV light was used for 
product visualisation using an Alphalmager™ (Alpha Innotech Coiporation, San Leandro, 
CA, USA). An aliquot of the PCR product was mixed with 3 p,! loading dye and applied to 
the gel which was electrophoresed at 150V for 30 min. The molecular weights of the 
fragments were estimated by running a 100 bp DNA molecular weight ladder (New 
England BioLabs® Inc., Ipswich, MA, USA) alongside the PCR products.
4.2.4.5. Sequencing Reaction
Following DNA amplification, excess PCR primers and dNTPs were degraded by adding 2 
pi Exosap-IT® (USB® Coiporation, Cleveland, OH, USA) and incubating for 1 hr at 3T^C 
and 15 min at 72®C. Three microlitres of the cleaned PCR product was then mixed with 4 
pi Big Dye® V3.1 mix (Applied Biosystems), 2.36 pi QH2O and 3.2 mM of the appropriate 
primer. This was placed in a thermal cycler and undei*went 30 cycles of 96®C for 10 sec, 
55“C for 5 sec and 60"C for 4 min. The samples were then held at 4“C. Sequencing 
reactions were set up from both the forward and reverse PCR primers.
The products were purified using 10 pi Cleanseq® magnetic beads (Agencourt Bioscience 
Coiporation, Beverly, MA, USA). The products bound to the beads and they were washed 
twice with 73% ethanol (73 pi for 3 min and 100 pi for 30 sec). The ethanol was aspirated
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off and excess ethanol allowed to evaporate. A 40 pi aliquot of 0.1 mM EDTA was added 
to elute the products from the beads. Twenty microlitres of each sample was then loaded 
onto an ABI 3100 automated sequencer (Applied Biosystems) and analysed using 
Sequencher™ software (Gene Codes Corporation, Ann Arbor, MI, USA).
4,2.5. Genotyping
Single nucleotide polymorphisms were identified by the Sequencher™ software and 
manually checked. The choice of SNP to be genotyped was based upon the degree of 
heterozygosity shown by the multiple peaks on the chromatogram and the position of the 
SNP i.e. exonic versus intronic. Three methods of genotyping were then used. The choices 
of method were based on the suitability and ease of genotyping the SNP in question with 
that technique.
4.2.5.I. PCR-Restriction Fragment Length Polymorphism
Restriction enzymes were chosen using NEB cutter V2.0 software
(http://tools.neb.com/NEBcutter2/index.Dhp) and obtained from New England BioLabs® 
with the associated buffers. Where possible, enzymes were chosen that cut at only at the 
polymorphic site.
PCR was carried out (using porcine genomic DNA samples) and the PCR products checked 
by visualisation on 3% SFR agarose electrophoresis gel stained with ethidium bromide as
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described previously. The products were then digested using the appropriate restriction 
enzyme (see Table 4.5) and with the recommended buffer and incubation times. Following 
incubation, 3 pi of loading dye were added to the digested products and 6  pi of each sample 
ran on a 3% SFR agarose electrophoresis gel stained with ethidium bromide for 
approximately 30 min at 150V and UV light used for product visualisation. The molecular 
weights of the fragments were estimated by running a 100 bp DNA molecular weight 
ladder alongside. Genotype scoring was then performed manually.
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4.2,5.2. Pyrosequen cing
PCR and sequencing primers were designed using PSQ Assay Design Software Vl.O 
according to the manufacturer’s guidelines and primers were supplied by Integrated DNA 
Technologies Inc. (lA, USA). One of each set of PCR primers must be HPLC purified and 
biotinylated (see Table 4.6 for primers).
A 25 pi reaction containing 2 pi porcine genomic DNA, 0.5 mM each dNTP, 2.5 pi lOx 
PCR buffer, 3.75 mM MgCb, 1.25 U Amplitaq Gold® DNA polymerase and 0.5 mM each 
forward and reverse primer was set up. The mixture was placed in GeneAmp® PCR 
System 9700 thermal cycler with a heated lid and underwent initial dénaturation at 94°C 
for 10 min. This was followed by 20 cycles of amplification with a dénaturation step at 
94®C for 30 sec and annealing step for 30 sec. The annealing step used a touchdown 
program to decrease the temperature from 62°C to 52°C in 0.5”C steps each cycle. This 
was followed by an extension step at 72”C for 30 sec. Following the 20 touchdown cycles, 
35 cycles of 94”C for 30 sec, 58®C for 30 sec and IT Q  for 30 sec were performed which 
were then followed by a final extension step at 72®C for 7 min. The samples were then held 
at 4°C before being checked as previously.
The resulting PCR product, with one biotinylated strand, was mixed with 45 pi binding 
buffer (10 mM Tris-HCl, 2 M NaCl, 1 mM EDTA, 0.1% w/v Tween 20, pH 7.6) and 3 pi 
of Sti'eptavidin Sepharose™ beads (Amersham Biosciences, Piscataway, NJ, USA) and 
agitated for 15 min at room temperature to allow immobilization of a single stranded
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template to the beads. In the meantime, 0.16 pi of sequencing primer (100 mM stock 
solution) was added to 39.84 pi annealing buffer (20 mM Tris-Acetate, 2 mM MgAcz, pH 
7.6) and a PSQ 96 well plate prepared with the solution. Following agitation, a Vacuum 
Prep Tool™ (Biotage Inc., Foxboro, MA, USA) was used to capture the beads and wash 
with 70% ethanol for 5 seconds, dénaturation solution (0.2 M NaOH) for 5 seconds and 
wash buffer (10 mM Tris-Acetate, pH 7.6) for 5 sec. The vacuum was removed and the 
beads released into the sequencing primer/annealing buffer solution before being heated to 
80°C for 2 min and cooled to room temperature.
Pyrosequencing® was performed at room temperature using an automated PSQ 96 MA and 
the associated software (Biotage Inc.). A preprogrammed sequence of the nucleotides 
dATP, dGTP, dCTP and dTTP was added in the presence of polymerase, sulfurylase, 
apyrase and luciferase (PyioGold Reagents, Biotage Inc.). The genotype scoring was done 
using PSQ 96 SNP software with default parameters set.
4.2.53. SNaPshor
PCR and internal primers as described in Table 4.7 were designed using PrimerS software 
and primers were supplied by Sigma-Proligo (TX, USA).
PCR was earned out with the optimised conditions. Following DNA amplification, excess 
PCR primers and dNTPs were degraded by adding 2 pi Exosap-IT® and incubating for 45 
min at 37"C and 15 min at 80°C. The SNaPshot® reaction was then set up on ice as
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follows; 1 pi SNaPshot® multiplex ready reaction mix (Applied Biosystems), 0.5 pi 20X 
SNaPshot® buffer (400 mM Tris-Base, 10 mM MgCh, pH 9), 3 pi 0.2 pM extension 
primer, 1.5 pi PCR product, 4 pi QH2O. The mixture was placed in GeneAmp® PCR 
System 9700 thermal cycler with a heated lid and underwent 20 cycles of amplification 
with a dénaturation step at 96®C for 10 sec and annealing step of 50°C for 30 sec. This 
was followed by an extension step at 60°C for 30 sec. Post-extension products were then 
purified using 0.4 pi CIP (New England BioLabs® Inc.), 0.2 pi Buffer 3 (New England 
BioLabs® Inc.) and 0.9 pi QH2O with a 1 hr incubation of 37°C followed by 75°C for 15 
min.
The final product was diluted 1:2 with QH2O and 1 pi of the diluted final product was 
denatured with 9.4pl Hi-Di™ Foimamide (Applied Biosystems) and 0.15pl 120LIZ® size 
standard (Applied Biosystems) at 95°C for 5 min before being placed on ice for at least 2 
min. The fragments were then run on an ABI PRISM 3100 DNA automated sequencer and 
analysed using GeneMapper® V3.5 software (Applied Biosystems).
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4.2.6. Genotyping Assessment
In compliance with Genus, Pic. protocol, the genotyping scores for each SNP were 
validated by two people.
4.2.7. Statistical Analysis
Genotype frequency was analysed using the PROC FREQ program and linkage 
disequilibrium and associated measurements were analysed using the PROC ALLELE 
progi'am of SAS 9.1 (The SAS Institute, Cary, NC, USA).
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4.3.Results
4.3.1. SNP Discovery
A total of 71 SNP were discovered from the pool of genomic DNA as shown in Table 4.8, 
Twenty-nine were found in the CRP gene, 13 in the Hp gene, 26 in the Pig-MAP (ITIH4) 
gene and 3 in the TTR gene.
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4.3.2. Genotyping
Seventeen SNP were chosen as the best candidates for genotyping across the boar samples; 
of these, 5 were found in the Hp gene, 5 in the Pig-MAP gene, 4 in the CRP gene and 3 in 
the TTR gene.
4.3.2.1. Genotyping of Hp SNP
Of the 5 SNP genotyped in the Hp gene, 3 were intronic polymoiphisms. These were: 
FSAD0024 (A-G substitution) genotyped by PCR-RFLP, FSAD0025, (G-C substitution) 
and FSAD0026, (A-G substitution), both genotyped by Pyi'osequencing®. Two SNP were 
identified using BBS data; FSAD0014, (A-C substitution) and FSAD0016 (C-T 
substitution), and were genotyped using PCR-RFLP. Examples of genotype scoring are 
shown in Figure 4.2.
4.3.2.2. Genotyping o f CRP SNP
Four SNP were genotyped in the CRP gene with 2 located in the 3’ untranslated region. 
FSAD0006 (C-T substitution) was located at nt 960 of the gene sequence and FSAD0003 
(C-T substitution) at nt 808, genotyped using Pyi'osequencing® and PCR-RFLP, 
respectively. Two SNP were identified using BBS data; FSAD0013 (C-T substitution) and 
FSAD0020 (C-T substitution), and were genotyped using PCR-RFLP and SNaPshot®, 
respectively. Examples of genotype scoring are shown in Figure 4.3.
155
4.3.2.3. Genotyping o f Pig-MAP SNP
Five SNP were genotyped in the Pig-MAP gene; 4 were intronic polymorphisms. These 
were as follows; FSAD0027 (A-G substitution), FSAD0031 (C-T substitution) and 
FSAD0035 (C-T substitution), all genotyped using PCR-RFLP and FSAD0034 (C-T 
substitution) genotyped using Pyi'osequencing®. One SNP was identified using BBS data, 
FSAD0036 (C-T substitution) and it was genotyped by Pyi'osequencing®. Examples of 
genotype scoring are shown in Figure 4.4.
4.3,2,4. Genotyping o f TTR SNP
Three SNP were genotyped in the TTR gene. FSAD0038 (a silent A-T substitution) was 
located at nt 462 (in exon 4 of TTR) and genotyped using PCR-RFLP. The remaining 2 
SNP were identified using BBS data; FSAD0037 (G-T substitution) and FSAD0039 (G-T 
substitution) which were genotyped by SNaPshot®. Examples of genotype scoring are 
shown in Figure 4.5.
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Figure 4.2: Genotype scoring of SNP found in the Hp gene
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Figure 4.2: Genotype scoring of SNP found in the Hp gene. A: FSAD0025; 
pyi’ogram™ showing GC polynioi'phism (indicated above trace) In this instance, the SNP 
is preceded by two G nucleotides, this gives rise to a double peak for G in the CC genotype 
and a triple peak for G in the GC genotype. B: FSAD0026; pyi'ogi'am™ showing AG 
polymorphism (indicated above trace). C; FSAD0024; PCR-RFLP showing AG 
polymoi-phism (digestion by PflFI, position of relevant bands indicated). D: FSAD0014 
showing AC polymorphism (digestion by Bbsl, position of relevant bands indicated). E: 
FSAD0016 showing CT polymoiphism (digestion by Alul, position of relevant bands 
indicated).
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Figure 4.3: Genotype scoring of SNP found in the CRP gene.
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Figure 4.3: Genotype scoring of SNP found in the CRP gene. A: FSAD0006 
pyi’ogi’am™ showing CT polymoiphism (indicated above ti'ace). B: FSAD0020
SNaPshot® output showing CT polymoiphism (indicated above trace). C: FSAD0003 
PCR-RFLP showing CT polymorphism (digestion by BsaJI, position of relevant bands 
indicated). D: FSAD0013 showing CT polymorphism (digestion by ScrFI, position of 
relevant bands indicated).
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Figure 4.4: Genotype scoring of SNP found in the Pig-MAP gene.
CC B
■ r - r r r - - - - - - - r -
■ - .......... .. i .  ^ ISO
TT
TT
I
CC
JL
CT
*W
w
V_JV__ L _  I
,CT
A T C T
GG AG AA D CC CT TT
314 bp 223 bp 167 bp
150 bp 56 bp
352 bp
179 bp 156 bp 132 bp
E  TT CT CC
669 bp 486 bp
183 bp
161
Figure 4.4: Genotype scoring of SNP found in the Pig-MAP gene. A: FSAD0034; 
pyi-ogram™ showing CT polymorphism (indicated above trace). B: FSAD0036; 
pyi-ogram™ showing CT polymoiphism (indicated above trace). C: FSAD0027; PCR- 
RFLP showing AG polymorphism (digestion by Nlalll, position of relevant bands 
indicated). D: FSAD0031; PCR-RFLP showing CT polymorphism (digestion by BseRI, 
position of relevant bands indicated). E: FSAD0035; PCR-RFLP showing CT
polymorphism (digestion by Hin fl, position of relevant bands indicated).
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Figure 4.5: Genotype scoring of SNP found in the TTR gene
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Figure 4.5; Genotype scoring of SNP found in the TTR gene. A: FSAD0037; 
SNaPShot® output trace showing GT polymorphism (indicated above trace). B: 
FSAD0039; SNaPShot® output trace showing CA polymorphism (indicated above trace). 
C: FSAD0038; PCR-RFLP showing AT polymorphism (digestion by Alul, position of 
relevant bands indicated).
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4.3.3. Allele Frequency
Allele frequency was calculated for each SNP in each of the lines used in this study (Tables 
4.9 -  4.12). Allele frequencies showed normal variability in all genes, however in all 4 
genes, mono-allelic SNP were found within individual lines. In the Hp gene, mono-allelic 
SNP were found in Line C for FSAD0024, FSAD0025 and FSAD0026 and in Line E for 
FSAD0024 and FSAD0025. In the CRP gene, mono-allelic SNP were found in Line C and 
Line E for FSAD0006. In the Pig-MAP gene, FSAD0034 was mono-allelic in Line E. In 
the TTR gene, Lines A and B were mono-allelic for FSAD0037. In addition, genotype 
frequency was analysed for each SNP across the 7 lines. In all cases, there was a 
significant difference (p<0.0001) between the 7 lines used in the study.
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4.3.4. Linkage Disequilibrium and Hardy-Weinberg Equilibrium
4,3.4.1. Haptoglobin Gene
For each SNP, Hardy-Weinberg equilibrium (HWE) tests were performed, none were in 
agreement with Hardy-Weinberg distribution and all were highly significanct (p<0.001) 
(Table 4.13). The 5 SNP were in high linkage disequilibrium (LD) with each other (Table 
4.14). Specifically FSAD0024, FSAD0025 and FSAD0026 are all in complete LD.
4.3.4.2. C-reactive Protein Gene
For each SNP, HWE tests were perfoimed, again, none of the SNP were in agieement with 
Hardy-Weinberg distribution and showed high significance (p<0.001) (Table 4.15). Three 
of the SNP were found in strong LD with each other, with FSAD0003 in complete LD with 
FSAD0020 (Table 4.16).
4.3.4.3. Pig-MAP Gene
For each SNP, HWE tests were performed, and 2 (FSAD0035 and FSAD0036) out of the 5 
SNP were in agreement with Hardy-Weinberg distribution. Three SNP (FSAD0027, 
FSAD0031 and FSAD0034) deviated from HWE with moderate to high significance 
(p<0.05) (Table 4.17). The 5 SNP were in sti’ong LD with each other (average D' for each 
combination was 0.851), with FSAD0031 and FSAD0035 in complete LD (Table 4.18).
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4.3.4.4. Transthyretin Gene
For each SNP, HWE tests were performed, and 1 (FSAD0038) out of the 3 SNP was in 
agieement with Hardy-Weinberg distribution. The remaining 2 SNP (FSAD0037 and 
FSAD0039) deviated from HWE with high significance (p<0.05) (Table 4.19). The 3 SNP 
were in weak LD with each other (average D' for each combination was 0.425) (Table 
4.20).
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Table 4,13: Hardy-Weinberg distribution for SNP within the Hp gene. Data taken
from SAS 9.1 output.
Obs Locusl Locus2 NIndiv Test ChiSq DF ProbChi
1 FSAD0014 FSAD0014 338 HWE 62.972 1 2.0965E-15
2 FSAD0014 FSAD0016 338 LD 203.347 1 3.885E-46
3 FSAD0014 FSAD0024 338 LD 176.803 1 2.4181E-40
4 FSAD0014 FSAD0026 338 LD 174.402 1 8.0871E-40
5 FSAD0014 FSAD0025 336 LD 204.210 1 2.5188E-46
6 FSAD0016 FSAD0016 342 HWE 83.181 1 7.4877E-20
7 FSAD0016 FSAD0024 342 LD 291.608 1 2.2193E-65
8 FSAD0016 FSAD0026 342 LD 287.984 1 1.3672E-64
9 FSAD0016 FSAD0025 340 LD 250.411 1 2.1129E-56
10 FSAD0024 FSAD0024 343 HWE 70.482 1 4.6444E-17
11 FSAD0024 FSAD0026 343 LD 338.758 1 1.1894E-75
12 FSAD0024 FSAD0025 341 LD 294.264 1 5.8555E-66
13 FSAD0026 FSAD0026 343 HWE 69.952 1 6.0767E-17
14 FSAD0026 FSAD0025 341 LD 290.606 1 3.6685E-65
15 FSAD0025 FSAD0025 341 HWE 88.607 1 4.8165E-21
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Table 4.14: Linkage Disequilibrium Measures for SNP within the Hp Gene. Data
taken from SAS 9.1 output file.
Locus 1 Locus 2 Haplotype Frequency LD. Coeff. Lewontin’s
D’
FSAD0014 FSAD0016 1-1 0.0125 -0.1912 -0.9388
FSAD0014 FSAD0016 1-2 0.4757 0.1912 0.9388
FSAD0014 FSAD0016 2-1 0.4047 0.1912 0.9388
FSAD0014 FSAD0016 2-2 0.1071 -0.1912 -0.9388
FSAD0014 FSAD0024 1-1 0.0095 -0.1754 -0.9486
FSAD0014 FSAD0024 1-2 0.4787 0.1754 0.9486
FSAD0014 FSAD0024 2-1 0.3692 0.1754 0.9486
FSAD0014 FSAD0024 2-2 0.1426 -0.1754 -0.9486
FSAD0014 FSAD0026 1-1 0.0095 -0.1739 -0.9481
FSAD0014 FSAD0026 1-2 0.4786 0.1739 0.9481
FSAD0014 FSAD0026 2-1 0.3662 0.1739 0.9481
FSAD0014 FSAD0026 2-2 0.1456 -0.1739 -0.9481
FSAD0014 FSAD0025 1-1 0.0094 -0.1919 -0.9533
FSAD0014 FSAD0025 1-2 0.4772 0.1919 0.9533
FSAD0014 FSAD0025 2-1 0.4043 0.1919 0.9533
FSAD0014 FSAD0025 2-2 0.1091 -0.1919 -0.9533
FSAD0016 FSAD0024 1-1 0.3743 0.2200 1.0000
FSAD0016 FSAD0024 1-2 0.0380 -0.2200 -1.0000
FSAD0016 FSAD0024 2-2 0.5877 0.2200 1.0000
FSAD0016 FSAD0026 1-1 0.3713 0.2200 1.0000
FSAD0016 FSAD0026 1-2 0.0409 -0.2182 -1.0000
FSAD0016 FSAD0026 2-2 0.5877 0.2182 1.0000
FSAD0016 FSAD0025 1-1 0.3774 0.2079 0.8634
FSAD0016 FSAD0025 1-2 0.0358 -0.2079 -0.8634
FSAD0016 FSAD0025 2-1 0.0329 -0.2079 -0.8634
FSAD0016 FSAD0025 2-2 0.5539 0.2079 0.8634
FSAD0024 FSAD0026 1-1 0.3732 0.2328 1.0000
FSAD0024 FSAD0026 1-2 0.0029 -0.2328 -1.0000FSAD0024 FSAD0026 2-2 0.6239 0.2328 1.0000FSAD0024 FSAD0025 1-1 0.3768 0.2216 1.0000FSAD0024 FSAD0025 2-1 0.0352 -0.2216 -1.0000
FSAD0024 FSAD0025 2-2 0,5880 0.2216 1.0000
FSAD0026 FSAD0025 1-1 0.3739 0.2198 1.0000
FSAD0026 FSAD0025 2-1 0.0381 -0.2198 -1.0000FSAD0026 FSAD0025 2-2 0.5880 0.2198 1.0000
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Table 4.15: Hardy-Weinberg distribution for SNP within the CRP gene. Data taken
from SAS 9.1 output.
Obs Locusl Locus2 NIndiv Test ChiSq DF ProbChi1 FSAD0003 FSAD0003 343 HWE 22.319 1 0.000002
2 FSAD0003 FSAD0013 342 LD 315.936 1 0.000000
3 FSAD0003 FSAD0006 182 LD 3.335 1 0.067803
4 FSAD0003 FSAD0020 342 LD 142.805 1 0.000000
5 FSAD0013 FSAD0013 342 HWE 25.950 1 0.000000
6 FSAD0013 FSAD0006 182 LD 3.125 1 0.077090
7 FSAD0013 FSAD0020 341 LD 135.307 1 0.000000
8 FSAD0006 FSAD0006 182 HWE 43.424 1 0.000000
9 FSAD0006 FSAD0020 182 LD 6.229 1 0.012571
10 FSAD0020 FSAD0020 342 HWE 83.006 1 0.000000
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Table 4.16; Linkage Disequilibrium Measures for SNP within the CRP gene. Data
taken from SAS 9.1 output.
Locusl Locus2 Haplotype Frequency LD Coeff Lewontin’s
D’
FSAD0003 FSAD0013 1-1 0.0088 -0.1816 -0.9686
FSAD0003 FSAD0013 1-2 0.7397 0.1816 0.9686
FSAD0003 FSAD0013 2-1 0.2456 0.1816 0.9686
FSAD0003 FSAD0013 2-2 0.0059 -0.1816 -0.9686
FSAD0003 FSAD0006 1-1 0.5566 0.0268 0.1451
FSAD0003 FSAD0006 1-2 0.1852 -0.0268 -0.1451
FSAD0003 FSAD0006 2-1 0.1577 -0.0268 -0.1451
FSAD0003 FSAD0006 2-2 0.1005 0.0268 0.1451
FSAD0003 FSAD0020 1-1 0.7515 0.0912 1.0000
FSAD0003 FSAD0020 2-1 0.1272 -0.0912 -1.0000
FSAD0003 FSAD0020 2-2 0.1213 0.0912 1.0000FSAD0013 FSAD0006 1-1 0.1660 -0.0263 -0.1365
FSAD0013 FSAD0006 1-2 0.1032 0.0263 0.1365FSAD0013 FSAD0006 2-1 0.5482 0.0263 0.1365
FSAD0013 FSAD0006 2-2 0.1825 -0.0263 -0.1365
FSAD0013 FSAD0020 1-1 0.1321 -0.0894 -0.9827FSAD0013 FSAD0020 1-2 0.1201 0.0894 0.9827
FSAD0013 FSAD0020 2-1 0.7462 0.0894 0.9827FSAD0013 FSAD0020 2-2 0.0016 -0.0894 -0.9827
FSAD0006 FSAD0020 1-1 0.6518 0.0278 0.3076FSAD0006 FSAD0020 1-2 0.0625 -0.0278 -0.3076FSAD0006 FSAD0020 2-1 0.2218 -0.0278 -0.3076FSAD0006 FSAD0020 2-2 0.0639 0.0278 0.3076
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Table 4.17: Hardy-Weinberg distribution for SNP within the Pig-MAP gene. Data
taken from SAS 9.1 output.
Obs Locusl Locus2 NIndiv Test ChiSq DF ProbChi
1 FSAD0027 FSAD0027 342 HWE 4.947 1 0.02614
2 FSAD0027 FSAD0031 340 LD 272.787 1 0.00000
3 FSAD0027 FSAD0035 342 LD 152.240 1 0.00000
4 FSAD0027 FSAD0034 342 LD 33.866 1 0.00000
5 FSAD0027 FSAD0036 282 LD 173.898 1 0.00000
6 FSAD0031 FSAD0031 341 HWE 10.985 1 0.00092
7 FSAD0031 FSAD0035 341 LD 183.221 1 0.00000
8 FSAD0031 FSAD0034 341 LD 43.562 1 0.00000
9 FSAD0031 FSAD0036 282 LD 211.912 1 0.00000
10 FSAD0035 FSAD0035 343 HWE 0.048 1 0.82620
11 FSAD0035 FSAD0034 343 LD 83.217 1 0.00000
12 FSAD0035 FSAD0036 283 LD 114.778 1 0.00000
13 FSAD0034 FSAD0034 343 HWE 16.197 1 0.00006
14 FSAD0034 FSAD0036 283 LD 27.622 1 0.00000
15 FSAD0036 FSAD0036 283 HWE 3.253 1 0.07131
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Table 4.18: Linkage Disequilibrium Measures for SNP within the Pig-MAP gene.
Data taken from SAS 9.1 output.
Locusl Locus2 Haplotype Frequency LD Coeff Lewontin's D'
FSAD0027 FSAD0031 1-1 0.0415 -0.2128 -0.9588
FSAD0027 FSAD0031 1-2 0.3644 0.2128 0.9588
FSAD0027 FSAD0031 2-1 0.5850 0.2128 0.9588
FSAD0027 FSAD0031 2-2 0.0091 -0.2128 -0.9588
FSAD0027 FSAD0035 1-1 0.0289 -0.1636 -0.8500
FSAD0027 FSAD0035 1-2 0.3761 0.1636 0.8500
FSAD0027 FSAD0035 2-1 0.4463 0.1636 0.8500
FSAD0027 FSAD0035 2-2 0.1487 -0.1636 -0.8500
FSAD0027 FSAD0034 1-1 0.0151 -0.0601 -0.7988
FSAD0027 FSAD0034 1-2 0.3898 0.0601 0.7988
FSAD0027 FSAD0034 2-1 0.1705 0.0601 0.7988
FSAD0027 FSAD0034 2-2 0.4245 -0.0601 -0.7988
FSAD0027 FSAD0036 1-1 0.0915 -0.1759 -0.9375
FSAD0027 FSAD0036 1-2 0.2932 0.1759 0.9375
FSAD0027 FSAD0036 2-1 0.6035 0.1759 0.9375
FSAD0027 FSAD0036 2-2 0.0117 -0.1759 -0.9375
FSAD0031 FSAD0035 1-1 0.4736 0.1771 1.0000
FSAD0031 FSAD0035 1-2 0.1525 -0.1771 -1.0000
FSAD0031 FSAD0035 2-2 0.3739 0.1771 1.0000
FSAD0031 FSAD0034 1-1 0.1839 0.0673 0.9669
FSAD0031 FSAD0034 1-2 0.4422 -0.0673 -0.9669
FSAD0031 FSAD0034 2-1 0.0023 -0.0673 -0.9669
FSAD0031 FSAD0034 2-2 0.3716 0.0673 0.9669
FSAD0031 FSAD0036 1-1 0.6397 0.1910 0,9623
FSAD0031 FSAD0036 1-2 0.0075 -0.1910 -0.9623
FSAD0031 FSAD0036 2-1 0.0536 -0.1910 -0.9623
FSAD0031 FSAD0036 2-2 0.2992 0.1910 0.9623
FSAD0035 FSAD0034 1-1 0.1832 0.0955 0.9805
FSAD0035 FSAD0034 1-2 0.2905 -0.0955 -0.9805
FSAD0035 FSAD0034 2-1 0.0019 -0.0955 -0.9805
FSAD0035 FSAD0034 2-2 0.5243 0.0955 0.9805
FSAD0035 FSAD0036 1-1 0.4902 0.1467 0.9701
FSAD0035 FSAD0036 1-2 0.0045 -0.1467 -0.9701
FSAD0035 FSAD0036 2-1 0.2042 -0.1467 -0.9701
FSAD0035 FSAD0036 2-2 0.3011 0.1467 0.9701
FSAD0034 FSAD0036 1-1 0.1947 0.0573 0.9480
FSAD0034 FSAD0036 1-2 0.0031 -0.0573 -0.9480
FSAD0034 FSAD0036 2-1 0.4996 -0.0573 -0.9480
FSAD0034 FSAD0036 2-2 0.3025 0.0573 0.9480
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Table 4.19: Hardy-Weinberg distribution for SNP within the TTR gene. Data taken
from SAS 9.1 output.
Obs Locus 1 Locus2 NIndiv Test ChiSq DF ProbChi1 FSAD0038 FSAD0038 342 HWE 0.0751 1 0.784102 FSAD0038 FSAD0037 342 LD 81.3593 1 0.000003 FSAD0038 FSAD0039 340 LD 18.1309 1 0.000024 FSAD0037 FSAD0037 343 HWE 5.0263 1 0.024965 FSAD0037 FSAD0039 341 LD 12.6487 1 0.000386 FSAD0039 FSAD0039 341 HWE 26.6080 1 0.00000
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Table 4.20: Linkage Disequilibrium Measures for SNP within the TTR gene. Data
taken from SAS 9.1 output.
Locusl Loeus2 Haplotype Frequency LD Coeff Lewontin's
D'
FSAD0038 FSAD0039 2-1 0.2925 -0.0548 -0.3381
FSAD0038 FSAD0039 2-2 0.2369 0.0548 0.3381
FSAD0037 FSAD0039 1-1 0.1757 0.0374 0.5134
FSAD0037 FSAD0039 1-2 0.0354 -0.0374 -0.5134
FSAD0037 FSAD0039 2-1 0.4797 -0.0374 -0.5134
FSAD0037 FSAD0039 2-2 0.3092 0.0374 0.5134
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4.4.Discussion
Previous studies have sequenced APP genes and identified a small number of SNP within 
them. However, these studies have been performed on small numbers of animals and not 
always on the same breed or commercial lines, making it difficult to compare the data 
(Chomdej et a l, 2004, Ponsuksili et a l, 2002, Baskin et a l, 1998, Archibald et a l, 1996). 
The aim of this study was to identify SNP within the APP genes of a commercial boar 
population consisting of 7 lines of animals and to select SNP from each gene to be 
genotyped across the population. The data from this study is to be used in conjunction with 
the phenotypic data from Chapter 3 in order to determine associations between genotype 
and phenotype (Results in Chapter 5). Any associations that are found may prove useful if 
APP are to be used as biomarkers of herd health.
Sequencing a DNA pool consisting of the lines of interest identified 71 SNP, of which 17 
were selected to be genotyped across the boar population. Selection criteria were based 
upon ease and method of genotyping and the time constiaints of this study. Genotyping 
was earned out using one of three methods; PCR-RFLP, Pyi'osequencing® and SNaPshot®. 
Each of these methods has advantages and disadvantages as discussed, but the choice of 
methods allowed each SNP to be genotyped accurately and allowed for a high volume of 
samples to be analysed quickly and efficiently. However, both PCR-RFLP and 
Pyi'osequencing® appeared to be the more robust and ‘user-friendly’ of the three methods; 
being simple to perform and resulting in relatively low numbers of retests, hence making 
them more efficient overall.
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Of the 17 SNP genotyped for across the population, most were found in intronic regions of 
sequence or were identified using BES data. Only one was identified within an exonic 
region (FSAD0038), and it was a silent mutation. Initially, it was thought that only non- 
synonymous polymorphisms found within coding regions of the genome could be of any 
value, however, it is now thought that polymoiphisms in the non-coding regions of genome 
may contribute to gene expression, particularly where they are found in regulatory regions 
(Knight, 2003), If this is indeed the case, then it is possible that the SNP genotyped in this 
study may yet prove to have associations with APP concentrations in serum. Additionally, 
non-coding polymoiphisms may be in LD with undiscovered coding SNP making them 
useful as markers if an association occurs.
Only one of the 17 SNP genotyped in this study had previously been described. This was 
the exonic polymoiphism, FSAD0038, which was found in the TTR gene (Archibald et a l, 
1996). Interestingly, this SNP was only reported in one study, a previous sequencing study 
failed to identify it. This lends weight to the belief that it can be difficult to compare data 
from different studies (Duan et a l, 1995).
Analysis of the individual SNP revealed that the majority of them were not in Hardy- 
Weinberg distribution. This is not suiprising considering that HWE is based upon a large 
randomly mated population with no selection, mutation or migration occurring. In contrast, 
this study used a small commercial pig population under selection for desired 
characteristics and it is likely that gene pooling has occuned over time. Additionally, the 
majority of the SNP were found in strong LD with each other within genes. This may be an
181
effect of selective breeding but more likely due to the small distances between the SNP 
which decreases the chance of recombination occurring.
Generally, where a large number of SNP are found in strong or complete LD with each 
other, they can be used as markers for each other and only one marker from the group 
would be selected for genotyping. In this case, time was limited and there was not the 
opportunity to genotype more SNP. However, should the data gained from this study prove 
to be of significance, this point can be re-addressed with the SNP targeted in any future 
studies being evaluated for LD before genotyping the population and selected SNP being in 
lower LD with each other.
The allele frequencies of the tested SNP varied significantly across lines. Each line has 
been bred to meet particular criteria for production traits and may be a composite of several 
breeds. It would appear that the APP genes have either been affected by this breeding or 
that different breeds express different polymorphisms. In particular, several lines are 
monoallelic for certain SNP, for example Line A (Landrace) and Line B (LW) are 
monoallelic for FSAD0037 (TTR), Line C (Duroc) is monoallelic for FSAD0006 (GRP) 
and FSAD0016, FSAD0024, FSAD0025, FSAD0026 (all Hp). Line E (based on the 
Hampshire breed) is monoallelic for FSAD0024 and FSAD0025 (both Hp) and FSAD0034 
(Pig-MAP). The difference in allele frequencies between lines may prove to be of 
significance in later studies if there is an association with APP concentration, and it should 
be noted that it is pure bred lines that are expressing this and not the lines based on breed
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crosses (as breed composites, these should be more polymorphic than a line based on a pure 
breed).
This study identified novel SNP within the APP genes and has genotyped 17 of these across 
a boar population. Statistical analysis of these results has shown that there are significant 
line differences between the SNP. This data will be further utilized in a genotype- 
phenotype association study (Chapter 5). Additionally, the results indicate that genotyping 
of the remaining SNP may prove useful if the resources are available, particularly SNP 
which are found to be in low LD with each other.
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Chapter V
5. Association between SNP in APP Genes and Baseline APP 
Serum Concentration
5.1. Genetic Association Studies
The aim of genetic association studies is to identify associations between genetic 
polymorphisms, for example SNP, and the trait of interest, in this case, the baseline 
concentration of APP. There are two ways to identify associations, either look for a 
direct association or an indirect association. Direct associations use polymorphisms 
which are candidate causal variants, for example, a nonsynonymous SNP, However, 
non-coding polymorphisms can also be considered candidate causal variants as they 
may cause variation in gene expression and regulation (Cordell and Clayton, 2005). 
Indirect association studies use polymorphisms which are in non-random association or 
linkage disequilibrium (LD) with a causal variant. However, indirect association 
studies are more difficult to analyse and less powerfril than direct associations. In 
addition, they are a weaker association compared to a direct one and require a number 
of polymorphism to be identified (Cordell and Clayton, 2005, Wang and Todd, 2003).
5.1.1. Linkage Association
Linkage is the tendency for the alleles o f genes to be passed together and in the same 
sequence from one generation to the next making it possible to follow transmission of 
the alleles from one generation to the next. This is due to the alleles being situated 
close together on the gene which makes it unlikely that a recombinant or cross-over
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event will occur during meiosis. Linkage analysis involves finding a model to explain 
the inlieritance pattern of phenotypes and genotypes observed in a population. They are 
useful in instances where traits do not show normal Mendelian inheritance patterns and 
linked genes can be used as genetic markers where the exact location of the causal gene 
is unknown (Nicholas, 2005, Lander and Schork, 1994).
5.1.2. Statistical Analysis
Two relatively simple but appropriate statistical methods for determining association 
between genotype and a quantitative phenotype are linear regression and analysis of 
variance (ANOVA). Both require the data to be nonnally distributed, and in some cases 
transformation, such as a log transformation, may be required (Balding, 2006).
5.1.2.1, Linear Regression
Linear regression describes the relationship between X and Y and can determine how 
much of the variation in Y can be explained by the relationship with X. This can be 
shown by the equation;
Y/ = Po +(3]X/ + 6 / z = 1, 2, 3, ....n
Where:
Y/ = value of Y for the observation
Po -  the intercept i.e. the value of Y when x = 0
Pi = the slope i.e. measures the change in Y per unit change in X
£/= the random error associated with the i^ '^  obseiwation
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(Quinn and Keough, 2002)
5.1.2.2. Analysis o f  Variance
In order to compare groups of samples, analysis of variance (ANOVA) assumes normal 
distribution of the residuals. Whereas a ^-test compares 2 gi'oups of samples, ANOVA 
compares 3 or more gi'oups to assert whether the variability of the gioup means differs 
more than would be expected by chance. If there is a significant difference, then the 
difference between individual gi'oups can be tested using a series of Nests comparing 
the residual variance (Altman and Bland, 1996),
In statistical software programs, for example, SAS 9.1, an ANOVA procedure can be 
expressed as a linear model in which the model is used to predict the response for each 
observation. The difference between the actual and predicted response is termed the 
residual error and most models minimise the sum of squares of residual errors; this is 
known as least squares regi-ession (SAS, 2004).
5.1.2.3. General Linear Model
An extension of these two methods is the general linear model (GLM). In the GLM, it 
is assumed that there is a normal distribution of the values in the population (again 
transformations can be used), that there is a linear relationship between the 2  variables 
and that the variance is the same for all responses. It is based upon the same equation as 
the linear model but with more variables;
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Y; po^o/ P1X]; "F. . .p^ X/f( "F i 1, 2, 3j .. ,.n
Where;
Y; = is the response
Pyt = are unknown parameters to be estimated 
Xi = are design variables
6 /= the random errors associated with the observations
The use of GLM allows the testing of linear combinations o f the X variables, linear 
combinations of the Y variables and linear combinations of both the X and Y variables. 
This enables the analysis of a wide range of variables using a variety of tests including 
ANOVA, regression, analysis of covariance and multivariate analysis of variance 
(Dobson, 2002).
One of the most important features of a GLM is that of the model used. The model 
must be correctly specified otherwise the estimates of the parameters will be inaccurate 
and the resulting equation will not describe the data properly (SAS, 2004).
The aim of this study was to identify associations between APP baseline concentrations 
in a boar population from a high health herd and SNP genotyped in the APP genes (as 
described in Chapter 4).
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5.2. Materials and Methods
5.2.1. Boars
A sub-population {n = 345) of the high health pig herd described in Chapter 3 was used 
in this study as only boars in this sub-population had both phenotypic (serum samples) 
and genetic (tail sample) material available for testing. The boar have been described 
in sections 3.21 to 3.24 and were from 7 pig lines comprising pure breed and synthetic 
lines as previously described.
5.2.2. Genotyping
Genotyping was carried out as described in Chapter 4. In short, SNP were identified 
from pooled DNA and 17 were chosen to be genotyped across the boar population using 
PCR-RFLP, Pyi-osequencing® or SNaPshot®. Of the 17 SNP genotyped, 5 were located 
in the Hp gene, 4 in the CRP gene, 5 in the Pig-MAP gene and 3 in the TTR gene.
Genotypic data was verified by 2  people as per company protocol and was analysed for 
allele frequencies, HWE and LD as described in section 4.2.6.
5.2.3. Acute Phase Protein Determination
The four APP; Hp, CRP, Pig-MAP and TTR were measured in semm samples from the 
genotyped boars in duplicate as described in sections 3.2.5. Internal control samples 
were included with each assay run to ensure assay accuracy and validity. Wliere
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possible, animals were bled twice to enable an average baseline level to be used for 
analysis.
5.2.4, Statistical Analysis
All analyses were carried out using SAS 9.1 statistical software (SAS Institute, Cary, 
NC, USA). Data was log transformed prior to analysis in order to render skewed 
distributions as close to normal distribution as possible. Associations of the genotypes 
with the APP concentrations were evaluated using a general linear model (PROC GLM) 
with line and SNP genotype as fixed effects. This can be shown as;
Y,j = p. + Li + Gy +
where Y^is the trait measured in the nth. animal of the hh line andyth genotype; p, is the 
overall mean for the trait. L,- is the fixed effect of the zth line and Gy is the fixed effect of 
theyth genotype.
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5.3. Results
5.3.1. Genotyping
Allele frequencies, HWE and LD results have been described previously in sections 
4.33 and 4.34.
5.3.2. Serum Concentrations of APP in a High Health Population
Serum concentrations of Hp, CRP, Pig-MAP and TTR across a population of boar from 
a high health herd are shown in Figures 5.1 -  5.4, respectively. The mean Hp, CRP and 
Pig-MAP concentrations were 0.34 g/L (range = 0 -  2.65 g/L), 29.9 mg/L (range = 0.9 -  
485.2 mg/L) and 1.22 mg/ml (range = 0.11 -  9.63 mg/ml) respectively. The mean TTR 
concentration was 331.3 pg/ml (range = 119.2 -  820.3 |ig/ml). Summary values are 
shown in Table 5.1.
5.3.3. Serum Concentrations of APP across Pig Lines
Serum concentrations of Hp, CRP, Pig-MAP and TTR in all lines are shown in Figures 
5.5 -  5.9, respectively. Summary values are given in Tables 5.2 -  5.6.
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Table 5.1: Summary values of Hp, CRP, Pig-MAP and TTR concentration in a 
high health boar population (« = 345)
Hp (g/L) CRP (mg/L) Pig-MAP (mg/ml) TTR (pg/ml)
n 343 345 342 343
Min. 0 0.9 0 . 1 1 119.2
Max. 2.65 485.2 9.63 820.3
Median 0.25 12.7 1.09 311.7
Mean 0.34 29.9 1 . 2 2 330.8
SEM 0 . 0 2 3.06 0.04 6 . 1 1
SD 0.34 56.76 0.79 113.07
Abbreviations: n: no. o j f pigs. SEM: standard error of the mean. SD: standard
deviation.
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Figure 5.1; Serum concentrations of Hp (g/L) across a high health boar population 
(n = 343).
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Figure 5.2: Serum concentrations of CRP (mg/L) across a high health boar
population (n = 345).
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Figure 5.3: Serum concentrations of Pig-MAP (mg/ml) across a high health boar 
population (n = 342).
194
80
70
60
.S> ^0a.
“S 40
oz 30
20
10
0 □  C l m  I  I" I  I 1  I I  I "I" ------ 1 I ^  I I
100 200 300 400 500 600 700 800 >850
Figure 5.4: Serum concentrations of TTR (pg/ml) across a high health boar
population (n = 343).
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Figure 5.5: Hp concentration (g/L) across 7 pig lines. The line within the box marks the 
median; the boundaries of the box represent the and 75* percentiles; whiskers above 
and below the box indicate the 10* and 90* percentile and the points outside the end of the 
whiskers are outliers.
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Figure 5.6: CRP concentration (mg/L) across 7 pig lines. The line within the box marks 
the median; the boundaries of the box represent the 25* and 7 5 * percentiles; whiskers 
above and below the box indicate the 10* and 90* percentile and the points outside the end 
of the whiskers are outliers.
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Figure 5.7: Pig-MAP concentration (mg/ml) across 7 pig lines. The line within the box 
marks the median; the boundaries of the box represent the 25* and 75* percentiles; 
whiskers above and below the box indicate the 1 0 * and 90^ '’ percentile and the points 
outside the end of the whiskers are outliers.
200
a:
1 0 0 0
800 -
600 -
400 '
200  -
A C D E
Pig Line
Figure 5.8: TTR concentrations (jag/ml) across 7 pig lines. The line within the box 
marks the median; the boundaries of the box represent the 25*'^  and 75^ '’ percentiles; 
whiskers above and below the box indicate the 1 0 *^’ and 90^ '^  percentile and the points 
outside the end of the whiskers are outliers.
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5.3.4. Association of Genotype with APP Concentration
5.3.4.1. Haptoglobin
There was a significant association between FSAD0016, FSAD0024, and FSAD0025 and 
the serum concentration of Hp, however there was no association found with FSAD0014 or 
FSAD0026 as shown in Table 5,6. There was no association found between line and Hp 
serum concentration.
5.3.4.2. CRP
There was no association found between genotype and the serum concentration of CRP. 
There were significant associations between line and CRP concentration as shown in Table 
5.7.
5.3.4.3. Pig-MAP
There was no association found between genotype and the serum concentration of Pig- 
MAP. There were significant associations between line and Pig-MAP concenti'ation as 
shown in Table 5.8.
5.3.4.4. TTR
There was no significant association found between genotype and the serum concenti'ation 
of TTR. FSAD0039 had an association with baseline TTR concentrations approaching 
significance at p=0.07. There were significant associations between line and TTR 
concentration as shown in Table 5.9.
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Table 5.6: Association of pig line and genotype in the Hp gene with Hp serum
concentration.
FSAD0014 FSAD0016 FSAD0024 FSAD0025 FSAD0026
Line 0.6503 0.2811 0.1087 0.1316 0.3122
Genotype 0.3908 0.0093** 0.0051** 0.0094** 0.1412
* * p < 0 .0 1
Table 5.7: Association of pig line and genotype in the CRP gene with CRP serum 
concentration
FSAD0003 FSAD0006 FSAD0013 FSAD0020
Line 0.0157* 0,0427* 0.0169* 0.5251
Genotype 0.8908 0.2376 0.9528 0.6984
*p < 0.05
Table 5.8: Association of pig line and genotype in the Pig-MAP gene with Pig-MAP 
serum concentration
FSAD0027 FSAD0031 FSAD0034 FSAD0035 FSAD0036
Line 0.0280* 0.0244* 0.0834 0.0820 0.0030**
Genotype 0.3624 0.2975 0.2118 0.4019 0.2986
*p<0.05, **p<0.01
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Table 5.9: Association of pig line and genotype in the TTR gene with TTR serum
concentration
FSAD0038 FSAD0037 FSAD0039
Line <0 .0 0 0 1 *** <0 .0 0 0 1 *** <0 .0 0 0 1 ***
Genotype 0.7761 0.8704 0.0708
***p< 0 . 0 0 1
5.3.5. Effect of Hp SNP Genotypes on Hp Serum Concentration
In Table 5.10, the least mean squares (LSMEAN) of the mean Hp concentration are given 
for the genotypes of FSAD0014, FSAD0016, FSAD0024, FSAD0025 and FSAD0026. A 
significant difference was obtained for LSMEAN between the genotypes of these SNP as 
indicated. The untransfoiTned data is shown in Figure 5.9.
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Table 5.10: Least squares means of mean Hp concentration by Hp SNP genotype
SNP Genotype LSMEANFSAD0014 AA 0.185
AC 0.189
CC 0 . 2 2 2
FSAD0016 CC 0.262ab
CT 0.193û
TT 0T536
FSAD0024 AA 0.251c
AG 0.233d
GO 0.146cdFSAD0025 GG 0.246c
GC 0.233f
CC 0A50efFSAD0026 CC 0.231
CT 0.217
TT 0,166
Identical script indicates significant difference (p<0.05) between genotypes
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Figure 5.9: Mean Hp (g/L) depending on genotype of SNP in Hp gene. Untransformed 
data shown for A: FSAD0014, B: FSAD0016, C: FSAD0024, D: FSAD0025, E: 
FSAD0026.
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5.4. Discussion
The aim of this study was to identify associations between SNP in the APP genes and 
baseline serum concentrations of the respective proteins. Prior to this study, similar work 
has only been earned out in humans where significant associations have been reported 
between SNP and both CRP and Hp serum concentrations (Wang et a l, 2006, Suk et a l, 
2005, Teye et a l, 2006).
The boars used in this study were a sub-population of the herd examined in Chapter 3. This 
herd showed significant differences in CRP, Pig-MAP and TTR concentrations between 
lines, however no differences were apparent in Hp concentrations. As previously, the APP 
concentrations in the sub-population were shown to be skewed due to overall low APP 
concentrations. This can be considered normal for a high health herd and is commonly 
exhibited. The mean APP concentrations were within reported ‘normal’ ranges for boar 
apart from Pig-MAP (discussed previously in Chapter 3) and there were few outliers, 
indicating that there were little or no external influences (for example, sub-clinical disease 
or trauma) on the protein concentr*ations.
The association analysis revealed that there was a significant association between 
FSAD0016, FSAD0024 and FSAD0025 and Hp serum concentration and identified the 
genotypes responsible for lower Hp concentrations in FSAD0016 (allele T) and higher Hp 
concentrations in FSAD0024 (allele A) and FSAD0025 (allele G). However, there are no 
associations found between line and Hp concentration. There were no significant 
associations found between any other genotypes and serum protein concentration, however,
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an association approaching significance was found between FSAD0039 and TTR 
concentrations, with the C allele associated with higher baseline concentrations. 
Associations between line and protein concentration were reported for FSAD0003, 
FSAD0006 and FSAD0013 (CRP), FSAD0027, FSAD0031 and FSAD0030 (Pig-MAP) 
and for all 3 SNP located on the TTR gene.
The association between genotype and semm concentration for Hp indicates that there is a 
genetic component to the control of Hp baseline concentrations. It is possible that all 3 
SNP influence Hp concentrations, however, due to the high LD measurements and that 
none of the SNP are within coding regions of the genes, it is more likely that they are 
linked to one or more SNP that do change protein expression levels. This association may 
prove useful because we can use genotyping infomiation to identify animals with low and 
high baseline concentiations and investigate the effects of breeding for other immune or 
performance traits on them.
The lack of association between line and Hp is not surprising considering that no 
differences in serum concentration between lines were reported earlier. It also means that 
Hp could potentially be used as a marker of health across pig populations as line effects 
need not be considered. The association between genotype and Hp concentration would 
allow animals to be selected for either a high or a low baseline concentration and enable a 
comparative study of the response of the animals under disease challenge. It is likely that it 
is the response of an animal to infection rather than the initial baseline concentrations that 
will have implications for future breeding strategies.
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The lack of association between genotype and APP concentration for CRP, Pig-MAP and 
TTR was suiprising. This was particularly true in CRP where evidence from human studies 
made it a likely candidate for associations to be found with. However, there were multiple 
associations between line and APP concentration for CRP, Pig-MAP and TTR. This 
appears to indicate that there are intrinsic differences between the lines in APP regulation 
and expression. These differences are normally indicative of genetic control, but this has 
not been shown in this study. It should still be considered possible that associations may 
exist amongst the SNP not tested, particularly as the SNP tested for were all in high LD 
with one another and this may be an area to be explored at a later time. Alternatively, it is 
possible that baseline levels of CRP, Pig-MAP and TTR are associated with other genes 
contributing to the immune response such as the cytokine genes, IL- 6  and IL-1.
This is the first study to show that Hp serum concentration in boar is associated with Hp 
genotype. This may prove useful in future breeding stiategies or if Hp is used as a marker 
of herd health. In addition, it has shown that the SNP genotyped in CRP, Pig-MAP and 
TTR genes are not associated with serum concentrations of these proteins; however, there 
are associations between pig line and APP serum concentration. These results suggest that 
the concentrations of these proteins are under some form of genetic control.
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Chapter VI
6. Concentrations and Heritability Estimates of Porcine Acnte 
Phase Proteins in a Pig Popnlation
6.1.Components of Variation
When studying a phenotypic trait, such as APP serum concentrations, it is often 
described in terms of the trait’s variance. Variance can be described as the sum of the 
squares of the deviation between an individual measurement and the group mean. The 
total amount o f variance (Vp) in a phenotypic trait is the sum of the variance caused by 
all the individual components. These include the non-genetic component 
(environment, Ve) and the genetic components (Vg) which is composed of the additive 
genetic component (V^), the dominant genetic component (V^) and the interaction 
between genes (V/). This can be expressed as:
Vp = Vg + Vp
=  Vy( +  V /) +  V / +  y  g
By separating the components of variance, it is possible to estimate the importance of 
the various components, in particular, the effects of environment versus genetics. The 
importance o f genetics in determining Vp is the heritability o f the trait (Falconer and 
Mackay, 1996).
2 1 0
6.1.1. Heritability
Heritability can be described in two ways; heritability in the broad sense and 
heritability in the narrow sense. Heritability in the broad sense (H^^) is the extent to 
which genotype detemiines phenotype in a particular population in a particular 
environment;
= Vc/Vp
— V g / ( V £  +  V g )
Heritability in the narrow sense or heritability (h^) is the additive component of genetic 
variance and is passed on from parent to offspring;
i f  = Vx/Vp
This is of gi'eat importance in animal breeding programmes as it detemiines the extent 
to which the offspring will resemble their parents. It is measured on a 0 - 1 scale (this 
can also be expressed as a percentage) with the higher value indicating higher 
heritability (Burton et a l,  2005, Falconer and Mackay, 1996).
6.1.2. Estimating Heritability
There are several methods for estimating heritability; all use the resemblance between 
relatives as a basis. Three of the most common methods are now described.
2 1 1
6,1,2.1. Regression A nalyses
This is a relatively simple analysis in which a trait is measured in both offspring and 
parents and compared using regi'ession analysis. The slope of regression of offspring on 
parents gives the i f  estimate. Parent-offspring regression can be performed as a one- 
parent test where either the mother or father is compared with the offspring to give an 
estimate which is half of the heritability or as a mid-parent-offspring test where the two 
parents are averaged and which gives an estimate of the total heritability (Falconer and 
Mackay, 1996).
6.1.2.2. Analysis o f  Variance
In this method, the phenotypic variance is divided into components attributed to the 
differences between the progeny of different males, differences between the progeny of 
females mated to the same males, differences between the progeny of females mated to 
different males and differences between progeny of different females. An ANOVA test 
is then performed. These tests are often utilised in full-sib designs where siblings share 
sire and dam and gives an estimate which is equal to or gi'eater than the heritability or 
half-sib designs where siblings share one parent and gives an estimate of a quarter o f the 
heritability (summarised in Table 6.1) (Falconer and Mackay, 1996).
2 1 2
Table 6.1: Composition of phenotypic covariances and heritability estimations.
Relatives Covariance Regression (b) or 
correlation (t)
Offspring and one parent KVx b = '/2 t f
Offspring and mid-parent b = h^
Half sib t=  ‘/ . t f
Full sib t = > !6 h^
(Falconer and Mackay, 1996)
6,1.23. Maximum Likelihood Analyses
As populations usually contain a number of different classes of relatives, an analysis is 
required that can simultaneously estimate the resemblance between individuals and 
calculate the relationships between them. The method of choice in animal breeding 
research for this analysis is tenued ‘restricted maximum likelihood’ (REML). It is a 
method of estimating variance and covariance components and has the advantages of 
not requiring a balanced design and can cope with missing data (Patterson and 
Thompson, 1971). Several statistical packages are equipped to use REML including 
SAS 9.1 and ASRLML; ASREML, in particular, is a frequently used program and was 
designed specifically for use in analysing breeding data (Gilmour et a l, 1995).
6.1.3. Experimental Design
In order to estimate heritability accurately, it is necessary to consider the design of the 
experiment and the method. Often the method selected is influenced by practical 
constraints but experimental design is an area which can be altered. In the case of 
heritability studies, experimental design involves the number of samples and the
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relationship between them, which can be affected by cost, availability of space, labour 
or animals available (Falconer and Mackay, 1996). In an ideal study, the number of 
samples should be sufficient where an effect is of scientific significance to be also 
statistically significant. This not only provides statistically valid results but is also 
economical (prevents waste of resources) and ethical, especially where animal or human 
subjects aie used (Tenth, 2001). There are different approaches to determining sample 
size, however the most popular is to determine the ‘power’ of a test of a hypothesis.
6.1.3.1. Statistical Power
Statistical power is the probability of obtaining a statistically significant result using a 
statistical test in a properly run study. It is affected by 3 parameters; the significance 
level (a) of the test, the sample size {n) and the actual effect size (0) (Bausell and Li, 
2002). In order to detennine sample size, a power analysis is carried out involving the 
following;
- specifying a hypothesis test
- specifying the significance level of a test 
specifying an effect size
- obtaining historical values or an estimate of the parameters needed to complete 
the test
- specify a target value of the power of the test 
(Tenth, 2001).
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There are various procedures within statistical packages such as SAS 9.1 or on-line 
procedures (e.g. Java applets for power and sample size) that will cany out sample-size 
calculations based upon pilot studies or historical data (Tenth, 2007).
The aim of this study was to determine heritability estimates for the serum 
concentrations of Hp, CRP, Pig-MAP and TTR in a high-health pig population.
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6.2.Methods and Materials
6.2.1. Animals
A population of 297 (120 male, 177 female) were provided for this study by Genus Pic., 
(PIC). The pigs were bom between July and September 2005 and were bled at 
approximately 7 months of age. The pigs were from 10 sires bred to approximately 6  
dams (pure lines) each with the number of piglets from each sire ranging from 23 to 4 4 . 
The sires were from 7 pig lines representing cun'ent commercial sire and dam genetics;
" Line A: Landrace (1 sire)
Line B; LW (1 sire)
Line C: Duroc (2 sires)
- Line D: Synthetic pure line (75% Duroc, 25% LW) (1 sire)
- Line E: Synthetic pure line (Hampshire based) (1 sire)
Line F: Synthetic pure line bred for gi'owth (1 sire)
- Line G: Synthetic pure line bred for g iw th  (derived from Line F) (3 sires)
6.2.2. Experimental Design
Pigs were born on the BLU unit which consists of breeding, gestation, faiTowing and 
nursery units. All pigs were processed within 24 hr of birth; each pig was weighed, 
identified with ear tags, a tissue sample taken for DNA and given an iron dextran 
injection. At weaning (approx 16 days), pigs were transferred to nursery units where 
they were housed until 70 days o f age. At this time pigs were put ‘on-test’ (described in 
Chapter 3); pigs were screened and the best pigs grouped by line and sex and transfeiTed
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to the MTG unit. Pigs were bled on one occasion on either BLU (n=238) or on MTG 
(n=59).
6.2.3. Farm Health Status
The farms were all considered to be of a high health status and were porcine
reproductive and respiratory syndrome (PRRS) negative, M. hyopneumoniae negative 
and swine influenza virus (SIV) negative. Boars at site lA  (Figure 3.1) were routinely 
vaccinated for H. parasuis, erysipelas and ileitis and for erysipelas and ileitis at site IB.
Monthly bleeds were carried out by a licensed veterinarian in order to check for
notifiable diseases and for certification purposes.
6.2.4. Blood Collection
Blood was collected by a licensed veterinarian by puncturing the external jugular vein 
and collecting into anticoagulant (EDTA). Tubes were mixed several times and stored 
on ice until returned to the laboratory. Upon return, tubes were centrifuged at 800 xg 
for 10 mill and the plasma decanted and frozen at -80°C until shipment on ice to the
UK. On arrival in the UK, tubes were immediately stored at -20°C until required for 
analysis.
6.2.5. Determination of Acute Phase Protein Concentration
The concentration o f Hp, CRP, Pig-MAP and TTR were determined as described in 
Sections 3.2.5.1  — 3.2.5.4. Internal controls were ran in each assay.
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6.2.6. Data Analysis
6,2,6.1. Pilot Trial for Full Trial Sample Estimation
In order to determine the number of samples required to obtain a statistically significant 
result, a pilot trial was carried out using the log-transfonued Hp concentrations of 155 
progeny firom 5 sires. The data was analysed using a sire model with the PROC 
MIXED progi’am of SAS 9.1 with farm as a fixed effect and sire and dam as random 
effects. The covariance estimates from SAS were then used to calculate heritability 
using the t=hV4 relationship.
To determine the number of samples required in the full scale study, a power analysis 
was performed using http ://www.math.uiowa. edu/~rlenth/Power/ (Tenth, 2006) using 
data from the pilot trial.
6.2,6.2, Statistical Analysis
All data was log-transfonned in order to render skewed data as close to normal 
distributions as possible. Data was initially analysed using a sire model with the PROC 
MIXED program of SAS 9.1 (SAS, 2004) in order to investigate and identify fixed 
effects.
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6.2.6.3. Heritability Estimation
Analysis was earned out using ASReml v2 software (Gilmour et a l, 1995) and log 
transformed data. Each APP was analysed separately and variance components and 
genetic parameters were estimated using a restricted maximum likelihood (REML) 
method. An animal model was used including line, sex, farm as fixed effects with 
animal and dam as random effects. The heritability was then estimated using the ratio 
of animal variance to phenotypic variance.
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6.3.Results
6.3.1. Precision of APP Tests
As the APP tests were run alongside those of Sections 3.2.5.1 -  3.2.5.4, the CV values 
have been included in Table 3.1.
6.3.2. Serum Concentrations of APP in a High Health Pig Herd
Serum concentrations of Hp, CRP, Pig-MAP and TTR across a high health herd are 
shown in Figures 6.1 -  6.4 respectively. The mean Hp, CRP and Pig-MAP 
concentrations were 0.65 g/L (range = 0.02 - 8.05 g/L), 214.7 mg/L (range = 8.6-753.6 
mg/L) and 0.77 mg/ml (range = 0 -  5.52 mg/ml) respectively. The mean TTR 
concentration was 275.2 pg/ml (range = 41.5 -  785.4 p.g/ml). Summary values are 
shown in Table 6.2.
Table 6.2: Summary values of Hp, CRP, Pig-MAP and TTR concentrations in a 
high health pig herd.
Hp (g/L) CRP (mg/L) Pig-MAP (mg/ml) TTR (tig/ml)
n 297 297 297 297
Min. 0.02 8.6 0.00 41.5
Max. 8.05 753.6 5.52 785.4
Median 0.50 202.8 0.57 258.3
Mean 0.65 214.9 0.77 275.2
SEM 0.04 7.11 0.04 9.28
SD 0.72 122.56 0.71 159.99
deviation.
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Figure 6.2: Serum concentrations of CRP (mg/L) across a high health pig herd (« 
= 297).
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Figure 6.3: Serum concentrations of Pig-MAP (mg/ml) in a high health pig herd {n 
= 297).
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Figure 6.4; Serum concentrations of TTR (pg/ml) in a high health pig herd (n 
297).
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6.3.3. Comparison of Serum Concentrations of APP between Sexes
Serum concentrations of Hp, CRP, Pig-MAP and TTR for male and females are shown 
in Figures 6.5 -  6.8. Summary values are given in Table 6.3. There was a significant 
difference (p < 0.05) in semm Hp concentrations between male and female pigs with 
female pigs exhibiting higher concentrations of Hp. The difference in serum 
concentrations of CRP in male and female pigs, with the latter having a higher 
concentration, was approaching significance at p=0.06. No significant difference was 
found between males and females for Pig-MAP and TTR.
6.3.4. Comparison of Serum Concentrations between Farm Units
Serum concentrations of Hp, CRP, Pig-MAP and TTR for both units (BLU and MTG) 
are shown in Figures 6.9 -6 .13 . Summary values are given in Table 6.4. There was a 
significant difference (p < 0.05) in semm CRP concentrations between the two units 
with higher CRP concentrations found on the BLU unit. No significant differences 
were found between units for Hp, Pig-MAP and TTR.
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Figure 6.5: Hp concentrations (g/L) in male (n=120) and female pigs («=177). The
line within the box marks the median; the boundaries of the box represent the 25^  and 
percentiles; whiskers above and below the box indicate the 10^  ^and percentile 
and the points outside the end o f the whiskers are outliers.
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Figure 6.6: CRP concentrations (mg/L) in male («=120) and female pigs («=177).
The line within the box marks the median; the boundaries of the box represent the 25 '^’ 
and 75 ’^’ percentiles; whiskers above and below the box indicate the 10 and 90^  ^
percentile and the points outside the end of the whiskers are outliers.
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Figure 6.7: Pig-MAP concentrations (mg/ml) in male (/i=120) and female pigs 
(w=177). The line within the box marks the median; the boundaries of the box represent 
the 25^ and 75^ ’^ percentiles; whiskers above and below the box indicate the lO'*’ and
90 ’^^ percentile and the points outside the end of the whiskers are outliers.
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Figure 6.8: TTR concentrations (pg/ml) in male (/i==120) and female pigs («=177).
The line within the box marks the median; the boundaries of the box represent the 25^ 
and 75* percentiles; whiskers above and below the box indicate the 10 and 90* 
percentile and the points outside the end of the whiskers are outliers.
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Table 6.3: Summary values of Hp, CRP, Pig-MAP and TTR concentrations 
betvreen male and female pigs in a high health herd.
Hp (g/L) CRP (mg/L) Pig-MAP mg/ml) TTR Lig/m!)
M F M F M F M F
n 120 177 120 177 120 177 120 177
Min. 0.02 0.03 8.6 43.1 0.00 0.00 52.9 41.5
Max. 2.80 8.05 753.6 566.3 4.15 5.52 785.4 675.7Median 0.32 0.58 145.0 234.7 0.58 0.57 270.3 242.5Mean 0.50 0.76 182.3 237.0 0.79 0.76 288.8 266.1
SEM 0.05 0.06 12.42 8.07 0.07 0.05 16.24 11.01
SD 0.52 0.81 136.11 107.34 0.76 0.68 177.92 146.42
Abbreviations: M: Male. F: Female. N: no. of pigs. SEM: standard eiTor of the 
mean. SD: Standard deviation.
Table 6.4: Summary values of Hp, CRP, Pig-MAP and TTR concentrations across 
2 high health farm units.
Hp (g/L) CRP (mg/L) Pig-MAP mg/ml) TTR ug/ml)
BLU MTG BLU MTG BLU MTG BLU MTGn 238 59 238 59 238 59 238 59Min. 0.02 0.02 40.3 8.6 0 0.01 41.5 52.9Max. 8.05 2.28 712.1 753.6 5.52 3.66 675.7 785.4Median 0.53 0.33 220.8 137.0 0.61 0.52 228.1 324.0Mean 0.69 0.50 229.0 157.8 0.80 0.63 250.4 375.6SEM 0.05 0.06 7.61 16.56 0.05 0.08 9.55 22.21SD 0.76 0.45 117.42 127.22 0.73 0.65 147.38 170.60
eiTor o f the mean. SD: Standard deviation.
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Figure 6.9: Hp concentration (g/L) across two high health pig units. The line 
within the box marks the median; the boundaries of the box represent the 25* and 75*
percentiles; whiskers above and below the box indicate the 10 and 90 percentile and 
the points outside the end of the whiskers are outliers. BLU: Bluegrass (n -  238). 
MTG: Mt. Gilead («=59).
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Figure 6.10: CRP concentrations (mg/L) across two high health pig units. The line 
within the box marks the median; the boundaries of the box represent the 25 ’^’ and 75^  ^
percentiles; whiskers above and below the box indicate the 10^  ^and 90 '^’ percentile and 
the points outside the end of the whiskers are outliers. BLU: Bluegrass (n= 238).
MTG: Mt. Gilead («=59).
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Figure 6.11: Pig-MAP concentrations (mg/ml) across two high health pig nnits.
The line within the box marks the median; the boundaries of the box represent the 25 ’^^ 
and 75^ percentiles; whiskers above and below the box indicate the 10 and 90^ ^^  
percentile and the points outside the end of the whiskers are outliers. BLU: Bluegrass 
(«=238). MTG: Mt. Gilead («=59).
233
ù:
1000
800 -
600 -
400  -
200 -
BLU MTG
Farm
Figure 6.12: TTR concentrations (pg/ml) across two high health pig units. The line 
within the box marks the median; the boundaries of the box represent the 25^ '" and 75 
percentiles; whiskers above and below the box indicate the 10 and 90^ ’' percentile and 
the points outside the end of the whiskers are outliers. BLU: Bluegi ass («= 238).
MTG: Mt. Gilead («=59).
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6.3.5. Comparison of Serum Concentrations of APP across Pig Lines
Semm concentrations of Hp, CRP, Pig-MAP and TTR in all lines are shown in Figures 
6.13-6.16 respectively. Summary values are given in Tables 6.5 -  6.8. There was a 
significant difference found between lines for Hp (p < 0.0001), CRP (p = 0.0001) and 
TTR (p < 0.0001). There was no significant difference in Pig-MAP concentration 
between pig lines. Individual significance values for the lines can be found in Tables 
6 .9 -6 .11 .
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Figure 6.13: Hp concentrations (g/L) across 7 pig lines. The line within the box 
marks the median; the boundaries of the box represent the 25th and 75th percentiles; 
whiskers above and below the box indicate the 10th and 90th percentile and the points 
outside the end of the whiskers are outliers. Line A; Landrace; Line B: LW; Line C; 
Duroc; Line D: Synthetic pure line; Line E: Synthetic pure line; Line F: Synthetic pure 
line bred for growth; Line G: Synthetic pure line bred for growth.
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Figure 6.14: CRP concentrations (mg/L) across 7 pig lines. The line within the box 
marks the median; the boundaries of the box represent the 25th and 75th percentiles; 
whiskers above and below the box indicate the 10th and 90th percentile and the points 
outside the end of the whiskers are outliers. Line A: Landraee; Line B: LW; Line C: 
Duroe; Line D: Synthetic pure line; Line E: Synthetic pure line; Line F: Synthetic pure 
line bred for growth; Line G: Synthetic pure line bred for growth.
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Figure 6.15: Pig-MAP concentrations (mg/ml) across 7 pig lines. The line within 
the box marks the median; the boundaries of the box represent the 25th and 75th 
percentiles; whiskers above and below the box indicate the 10th and 90th percentile and 
the points outside the end of the whiskers are outliers. Line A: Landrace; Line B: LW; 
Line C: Duroc; Line D: Synthetic pure line; Line B: Synthetic pure line; Line F: 
Synthetic pme line bred for growth; Line G: Synthetic pure line bred for gi'owth.
238
2
ùl
1000
800
600 -
400
200
Pig Line
Figure 6.16: TTR concentrations (|^g/ml) across 7 pig lines. The line within the box 
marks the median; the boundaries of the box represent the 25th and 75th percentiles; 
whiskers above and below the box indicate the 10th and 90th percentile and the points 
outside the end of the whiskers are outliers. Line A: Landrace; Line B: LW; Line C: 
Duroc; Line D: Synthetic pure line; Line E: Synthetic pure line; Line F; Synthetic pure 
line bred for growth; Line G: Synthetic pure line bred for growth.
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6.3.6. Sample Size Estimation
Using the covariance data from SAS 9.1, heritability was initially estimated at 1 (100%). 
However, farm and farm*sire effects were not included at this point.
The power analysis showed that with the use of 10 sires, 4 dams and 20 offspring per sire 
there was an 84% chance of detecting a significant sire variation. These numbers were 
used in order to obtain enough samples for the full scale trial.
6.3.7. Heritability
The heritability was estimated using the ratio of animal variance to phenotypic variance, 
this gave heritability estimates for Hp, CRP, Pig-MAP and TTR of 0.15 (0.00), 0.13 (0.04), 
0.12 (0.03) and 0.07 (0.02) respectively (standard error is indicated in brackets). The 
estimates for Hp, CRP and Pig-MAP are considered indicative of low heritable traits. The 
heritability estimate for TTR is extremely low.
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6.4.Discussion
The aim of this study was to estimate heritability of Hp, CRP, Pig-MAP and TTR in a high 
health pig population. Although the heritability of Hp had been determined previously 
(Henryon et a l, 2006), prior to this study, no heritability studies of CRP, Pig-MAP and 
TTR have been carried out in livestock, however similar studies have been earned out in 
human populations.
The pigs used in this study were a mixture of male and female and were bled on two 
different units. As previously, APP concentrations showed skewed distribution towards the 
lower ranges. However, Hp, CRP and TTR all showed higher mean concentrations than the 
previous studies (Chapters 3 and 5) while Pig-MAP showed a lower mean concentration. 
The difference in the mean concentrations could be attributed to the inclusion of female 
pigs in this study or the effect of the farm where the pigs were bled. Despite the 
differences, Hp, Pig-MAP and TTR concentrations were all within the accepted ‘noimal 
healthy’ ranges (Campbell et a l, 2005, Martin et a l, 2005, Petersen et a l, 2004). The 
mean CRP concentration was approximately double that of the reported healthy range 
(Parra et a l, 2006).
Comparison of the APP concentrations between male and female pigs revealed significant 
differences in Hp concentiations with females exhibiting higher Hp concentrations than 
males. This coiroborates a recent study carried out by Pineiro et a l, who also reported that 
there was a significant difference in Pig-MAP concentrations between males and females 
which was not seen in this study (Pineiro et a l, 2007a). The difference in concentrations of
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CRP between male and female pigs was approaching significance with females showing 
higher CRP concentiations; a significant difference has been reported previously with 
females showing higher concentrations (Pineiro et a l, 2007c). The difference in baseline 
APP concentiations between sexes suggests that different physiological mechanisms could 
be involved with APP production possibly through hoimonal interactions in the HPA.
Differences in CRP concentrations were also obseiwed between the two farm units in which 
the pigs were bled. This may have been due to some form of stimulus occuiring on the 
BLU unit such as changes in routine, different husbandry techniques (Pineiro et a l, 2007b) 
or because only male pigs were housed at MTG whilst male and female were housed at 
BLU (as discussed, female pigs in this study had higher concentrations of CRP). It is 
unlikely to be due to sub-clinical disease as both farms are high health units and no 
difference was obseiwed in Hp, Pig-MAP or TTR.
As previously discussed in Chapter 3 and 5, differences were found between the pig lines 
and APP concentrations. Surprisingly, Hp showed a line difference in this study with Line 
C (Duroc) showing a significantly higher Hp concentration than all other lines except Line 
A (Landrace) whereas Line D (Synthetic line) showed a significantly lower Hp 
concenh-ation than Lines A, C, E (Synthetic) and G (Synthetic). Pig-MAP did not show 
any line differences in contrast to the earlier studies. The differences in the studies could 
be atti'ibuted to the inclusion of females in this study, particularly as there are sex 
differences in Hp concentration. This indicates that the use of APP as biomarkers must 
take into account the sex of the pig herd in question; whether it is a mixed sex herd or
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single sex. As so many factors appear to control herd baseline APP concentrations their use 
as biomarkers of health on a herd level might be more problematic than originally thought.
The pilot study of the heritability of Hp concentrations showed an extremely high 
heritability of 1, at this point the estimate was seen as inaccurate and was probably the 
result of not including faim and farm*sire factors. However, the lowering of the estimate 
to a more realistic 0.6 and input of the covariance data into a power and sample size 
analysis provided the infoimation needed to estimate the number of samples required for 
the full scale heritability study. The use of this number of samples (taken to be the 
minimum required), meant that the full scale study was of an adequate size to identify 
significant effects (in this case heritability) (Tenth, 2001).
The heritability estimates were performed using ASReml with data obtained horn SAS 9,1. 
This is common practice in order to identify fixed effects, (for example sex, line and faim) 
and to gain more information on the data such as least square means. Each APP was 
analysed using the same progi*am in order that direct comparisons could be made of the 
data and this also took into account any fixed effects that could have an influence on the 
heritability estimate.
The heritability estimates were low for each of the APP measured which was not 
unexpected as heritability estimates for immune traits and/or disease resistance are 
generally low (Wilkie and Mallard, 2000). A previous study had found that the heritability 
of Hp in boars was 0.14 which is similar to the finding in this study (Henryon et a l, 2006),
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however the heritability of CRP, Pig-MAP and TTR concentrations have never been 
estimated before in pigs. The low heritability estimates mean that breeding for baseline 
APP concentrations (whether high or low) will prove to be inefficient at the present time 
without good genetic markers and that alternate breeding strategies would be required. 
Overall the results indicate that the majority of variance in APP concentrations is due to 
components such as line and sex rather than the influence of SNP in the genes. This 
indicates that more studies are required to fully understand the sources of variation and that 
care must be taken when canying out genetic studies involving the APP.
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Chapter VII
7. General D iscussion
The aim of this thesis was to investigate the porcine APP in a high health pig population 
and the relevant conclusions have been discussed in the previous chapters. This chapter 
will review the most significant findings and highlight areas which are worthy of future 
investigations.
Acute phase proteins are produced by the hepatocytes in response to infection, trauma or 
inflammation. They are currently used as an indicator of disease (including sub-clinical 
disease) and their measurement has been suggested as a biomarker of health and welfare in 
livestock and companion animals (Petersen et a l, 2004, Gruys et a l, 1994). The 
measurement of porcine APP as an indicator of underlying problems (for example, sub- 
clinical disease) in production systems was first suggested by Eckersall (1987), and since 
then a great deal of research has been performed including a major EU Shared Cost project. 
It has also been proposed that APP may be useful in breeding for disease resistance.
Despite the high number of studies involving porcine APP, very little was known about 
their control or their genetics. Previous to this study, the porcine APP genes had been 
mapped in pigs (Chomdej et a l, 2004, Ponsuksili et a l, 2002, Baskin et a l, 1998, 
Archibald et a l, 1996); however it was not known what, if any, genetic associations there 
may be with the APP serum concentrations as had been demonstrated in humans. This 
thesis set out to investigate the porcine APP in a high health setting (so as to obtain baseline
249
concentiations with low disease presence) and determine whether there were genetic 
associations.
It was first necessary to develop and validate an immunoassay for the measurement of 
CRP; as commercial assays were costly and development of a method for assay automation 
would be a boon to analytical operation. Unfortunately the immunoturbidimetric assay 
most suitable for automation had a limit of sensitivity too high for use with non-stimulated 
CRP concentiations as found in the serum h'om the healthy animals in this study. Although 
measurement of APP has developed considerably over the years, the basis of the ELISA 
developed and validated in this study was a relatively simple one using the CRP ligand; 
phosphocholine, and the cross-reactivity of anti-human CRP to pCRP. Although not ideal, 
this approach had considerably gieater success than the use of anti-serum to pCRP in both 
the sandwich ELISA and immunoturbidimetric assay due to non-specificity of the antibody. 
Investigation of this showed that polyclonal anti-serum to pCRP produced in sheep or 
chicken reacted with several protein bands some of which were assumed to be aggregates 
of the monomer. This assumption was further strengthened by the appearance of the bands 
in purified pCRP following various purification protocols. Studies of human CRP have 
found that CRP is glycosylated and that glycosylation varies with different disease states 
(Das et a l, 2003). It is possible that this is occurring in pigs and this may account for the 
extra protein bands viewed in purified pCRP and in the antibody cross-reactions. 
Glycosylation is apparent in other APP such as AGP and can have effects on protein 
function which may be of importance (Hochepied et a l, 2003). However the extia bands 
could be due to non-specific cross reactions which lead to the poor correlation results
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between both the sandwich ELISA and immunoturbidimetric assays and the commercial 
assay used for validation puiposes.
In order to overcome these issues, there are two pathways that could be taken. The first 
would be the production of monoclonal antibodies against pCRP and use of them in an 
ELISA. The second would be to adapt the immunoturbidimetric assay protocol developed 
in Chapter 2 for use with latex beads to which a specific polyclonal or mix of monoclonal 
antibodies are conjugated. This would give the high specificity and sensitivity required in a 
robust and automated format.
The developed pCRP assay was used in Chapter 3 in an investigation of baseline 
concentiations of porcine APP in a boar population. ‘Normal’ ranges of the porcine APP 
have been previously published (Paira et a l, 2006, Campbell et a l, 2005, Martin et a l, 
2005) and it was expected that the results of this study would corroborate the proposed 
ranges. However, although the herd mean concentrations of Hp, CRP and TTR all fell 
within the previously reported healthy ranges; Pig-MAP showed a mean concentration 
similar to one previous study (Henryon et a l , 2006) but almost twice that of studies earlier 
than 2006. This could be atti'ibuted to differing ages of the pigs in the studies, sex or breed 
but it demonstrates the need for APP results to be interpreted with caution, in conjunction 
with one another and with gieater collaboration between laboratories in developing quality 
assurance schemes. As CRP, Pig-MAP and Hp all show significant correlations with one 
another, it would be possible to measure 2 of the positive APP rather than all 3. This would 
prove to be more cost and time effective if the most suitable APP are chosen for
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measurement. Line differences were also apparent in CRP, Pig-MAP and TTR indicating 
that there is genetic variation in APP baseline concentiations. It also gives rise to the 
possibility of selecting lines to look for associations with selection traits.
Chapter 4 investigated the 4 porcine APP genes and identified 71 SNP, many of which 
were novel, and 17 of which were genotyped across a boar population. The results showed 
allele frequency differences between lines giving strength to the argument that selective 
breeding has had an effect on the APP. The SNP within each gene were found to be in high 
LD with each other, meaning that if further investigations take place it will only be 
necessary to genotype one or two of them per gene. The use of genotyping in animal 
breeding has become widespread and is an efficient way of selecting desirable animals, 
particularly if the phenotypic trait takes time to develop or is difficult to measure. This 
avoids the cost of feeding and housing animals unnecessarily and improves accuracy of 
selection. This is only possible if a phenotypic trait can be linked to a genotype, however 
SNP in LD with the causative polymorphism can be used satisfactorily (Dekkers, 2004).
Associations between Hp baseline concentiations and SNP genotype were identified 
between 3 of the SNP in the Hp gene. No associations were found between baseline 
concentrations and CRP, Pig-MAP and TTR SNP. Interestingly, there were no associations 
between pig line and Hp concentrations. This would make Hp better suited to being a 
marker of herd health in boars as no line effects need to be taken into account. The 
advantages of using Hp as a marker is that there is a gi'eater understanding of the 
relationships between serum concentiations of Hp and disease states than with any other
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APP. Additionally, the assay for Hp is robust, has been extensively validated and is 
efficient in coping with large number of samples; however as with all APP tests at the 
present time, it requires the facilities of a laboratory for analysis. If APP are to be used as 
markers of animal health, more research is required in order to make testing of samples 
more efficient and either portable or incorporated into on-farm testing procedures. This 
could be accomplished by the use of body fluids other than blood (for example, saliva or 
urine) thus removing the need for veterinary or licensed personnel, and by adapting assays 
into point-of-care-tests, for example, dipstick testing. The alternative is the multiplexing of 
assays allowing the simultaneous measurement of several APP; this would have the 
advantage of producing an acute phase index.
The use of CRT, Pig-MAP and TTR as biomarkers should not be discounted at the present 
time. Although no associations with genotype were identified in this study, the data and 
samples are available for further genotyping of the remaining SNP and it is possible that 
associations may be discovered. Pig line does has a significant association with baseline 
concentrations of these proteins which makes use of them as biomarkers of health more 
problematic as this would have to be taken into account. This does raise the question of 
whether APP concentrations and/or their SNP genotype are associated with production 
traits, as each line will have been selected for a particular ti'ait. If this were to be the case, 
then measurement of the APP could provide alternative markers for production tiaits.
Although not tested for in this thesis, association of APP with production traits has been 
suggested. This is in part due to the amino acid requirements of an acute phase reaction in
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which muscle proteins are catabolised as a source of energy and for the supply of amino 
acids (Reeds and Jahoor, 2001). Studies have also shown that immune traits and 
production tiaits are inversely correlated (Clapperton et ah, 2005a). If APP are found to be 
associated with production traits then it is possible that either high or low baseline 
concentrations will be the aim of selection. This thesis provides evidence that this is 
possible and has, in the case of Hp, identified 3 SNP which could be genotyped and 
selectively bred if an association with production tiaits was found at a later date.
The final study in this thesis investigated a mixed sex pig herd and estimated the 
heritability of the 4 porcine APP. As previously reported, there were sex differences 
apparent in Hp and to a lesser extent, in CRP baseline concentrations and as a result, line 
differences were now found in Hp. Sexual dimoiphism in the APP concentrations indicates 
that APP production may be under hormonal control, most likely through the HPA. This 
has been substantiated by human studies comparing male and female trauma patients 
undergoing inflammatory events which shows that females experience lower inflammation 
(Hsieh et a l, 2007).
Heritability estimates were low in all APP especially for TTR. However, the heritability 
estimate for Hp was similar to a previously reported estimate (Henryon et a l, 2006). 
Although this means that APP baseline concentrations are only a lowly heritable trait this 
can be overcome by the identification of SNP and associations with phenotype. This would 
allow genotyping at an early age and selection to occur; in turn, this may improve the 
heritability estimates and allow a breeding plan to be established.
254
Breeding for APP concentrations may be useful if, as previously discussed, they are 
associated with production traits. However, it is also likely that they may become a factor 
in breeding for resistance to disease. Acute phase proteins can be used as an indication of 
an organism’s state of immunocompetence, it is unknown whether high or low baseline 
APP concentrations would be more beneficial for an animal. High concentrations may 
have benefits in protecting the animal from infection but it is possible that in doing so they 
could divert nutrients from muscle growth whereas low concentrations may not protect the 
animal effectively. It is also likely that the kinetics of the APR should be investigated in 
relation to disease resistance and/or inflammatory events such as vaccination and that 
studies should centre around whether fast or slow responders show associations with their 
genetic background and/or production traits.
The studies carried out in this thesis were using high health populations of pigs and it is 
likely that in a conventional environment that there will be changes in heritability estimates 
and associations with genotype. This will be due to the effect of the environment on APP 
concenti’ations which will typically be higher than that which has been reported in this 
thesis. Indeed this has been reported to be the case in comparisons of SPF and 
conventional pig units (Petersen et a l, 2002b) and which should lead to more variability 
in APP concentrations and as a result, analysis may reveal additional associations. Studies 
of APP under both high health and conventional conditions are required in order to assess 
the effects of environment on APP and potential implications for associations with 
desirable breeding tiaits. This is especially important in pig breeding as boars are
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commonly kept under SPF/high health conditions whereas their progeny may be in 
conventional herds. This work could be carried out in a similar fashion to the studies 
reported in this thesis or alternatively, a population of pigs could be housed under high 
health conditions for a period of time and APP concentrations measured, then moved into a 
conventional herd and measured. This would provide a direct comparison and a wealth of 
information.
In conclusion, this thesis has demonstrated that baseline porcine APP concentrations are 
affected by different factors including sex and pig line. This may mean that interpreting 
APP results in a herd situation is difficult but with proper understanding and 
implementation of routine testing, they have the potential to be used as biomarkers. There 
is potential for use in breeding decisions as demonstrated by the identification of SNP and 
their association with serum concentrations and APP baseline concentrations have been 
identified as heritable traits, albeit at a low level. Additionally, this thesis has demonstrated 
that further research and understanding of the control mechanisms of APP production in 
pigs is needed before they potentially become viable biomarkers of porcine health and 
welfare.
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